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 Nonsense mediated decay (NMD) is a cellular surveillance mechanism originally 
identified for its role in targeting mRNAs containing nonsense codons for rapid 
degradation.  Nonsense codons, or premature termination codons (PTCs), are a common 
result of genomic mutation, alternative splicing, and programmed frameshifts that bring a 
premature termination codon into the reading frame.  Degradation of the mRNA 
encoding PTCs is thought to prevent the translation and build-up of potentially harmful 
truncated proteins within the cell.  The phenomenon of NMD is evolutionarily conserved, 
as destabilization of PTC-containing mRNA occurs in all eukaryotes examined.  Trans-
acting factors responsible for the destabilization of PTC-containing mRNA were 
identified in a series of informational suppressor screens performed in yeast and C. 
elegans.  Combined, these screens identified seven genes that are conserved throughout 
eukaryotes.  Homologs of genes identified in the original screens have been analyzed 
biochemically to determine how these trans-acting factors can recognize a premature 
termination codon.  Two models of PTC-recognition have resulted from these 
biochemical studies; the primary model suggests a PTC causes aberrant translation 
termination that mimics an abnormally long 3’UTR.  The second models suggests factors 
remain associated with the mRNA after intron splicing, and these factors recruit the 
NMD machinery to the mRNA, marking it for degradation.  However, while analyzed 
biochemically, many questions remain about the mechanism of NMD.  Have all the genes 
iv 
required for NMD been identified?  What are the roles of NMD pathway genes in vivo?  
How does NMD differentiate a native termination codon from a premature termination 
codon?  Work presented in this thesis focuses on these questions.  Here we present a 
forward genetic screen in Drosophila, which isolated alleles of known and potentially 
novel components of the NMD pathway.  We use alleles isolated from this screen to 
investigate the mechanism of NMD function in vivo.  Finally, we analyze cis-acting 
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Regulation of RNA metabolism is a key mechanism in controlling proper levels 
of gene expression.  In particular, modulation of RNA degradation rates provides an 
integral regulatory step in maintaining steady state message levels.  The more rapidly a 
transcript is degraded the less protein that can be made from that transcript.  Thus, RNA 
degradation provides an additional layer of regulation of the quantity of protein that can 
be translated at a given time or location (Besse and Ephrussi, 2008).  Several RNA 
degradation mechanisms function in targeting specific transcripts for rapid decay.  This 
specificity is necessary to avoid nonspecific alterations in gene expression.  
Multiple pathways that identify transcripts for degradation have been investigated.  
Some of these pathways, including the miRNA and siRNA pathways, use a template-
based homing mechanism to down-regulate specific transcripts based on sequence 
(Okamura, 2012).  Others, including nonstop (Vasudevan et al., 2002) and no-go decay 
(Harigaya and Parker, 2010), have a more general surveillance role, seeking out general 
defects without discretion as to the particular transcript being targeted.  The nonsense 
mediated mRNA decay (NMD) pathway is another such surveillance mechanism 
(Kervestin and Jacobson, 2012).  NMD targets a wide range of mRNAs for rapid 
degradation and is unique in targeting transcripts containing premature termination 
codons (PTCs).  Premature termination codons can result from a variety of mechanisms 
including genomic mutations, frameshifts, and alternative splicing which bring a PTC 
into the open reading frame (McGlincy and Smith, 2008).  An important feature of NMD 
is that it is able to differentiate PTCs from the natural termination codons present at the 
end of all coding sequences; a difficult task as PTC location is inherently variable since it 
may occur anywhere in the transcript.  NMD is thought to prevent the translation of 
potentially harmful truncated proteins, which would result from the presence of a PTC.  
Current research in NMD focuses on several questions; 1) Have all the genes required for 
NMD been identified?  2) How does NMD differentiate a natural termination codon from 
a premature termination codon?  3) What roles does the NMD pathway play in vivo?  
This thesis describes my work investigating the NMD pathway using Drosophila 
melanogaster.     
The phenomenon of NMD was originally observed in yeast (Losson and Lacroute, 
1979), was later shown to affect RNA metabolism in humans (Baserga and Benz, 1988), 
and is evolutionarily conserved throughout eukaryotes (Culbertson and Leeds, 2003; 
Gatfield et al., 2003).  Two main lines of evidence suggested this conserved mechanism 
was regulated by trans-acting factors.  First, PTC-containing transcripts displayed a 
decreased half-life compared to transcripts containing a natural termination codon, 
resulting in low steady-state levels of nonsense transcripts (Baserga and Benz, 1988; 
Belgrader et al., 1994; Chia et al., 1987; Losson and Lacroute, 1979).  Second, 
destabilization of PTC-containing mRNA was disrupted by the translation inhibitor, 
cycloheximide, (Leeds et al., 1992; Peltz et al., 1993).  Additionally, PTC-containing 
transcripts associate with polysomes (Leeds et al., 1991), suggesting the PTC-dependent 
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mRNA destabilization was translation-dependent.  Together, the low steady state levels, 
the increased decay rate, translation dependence, and functional conservation of the 
phenomenon suggested the existence of a conserved trans-acting surveillance machinery.  
However, the gene or genes responsible for the selective destabilization of transcripts 




 In 1980, a large-scale analysis of frameshift suppressors was undertaken in yeast 
(Culbertson et al., 1980; Cummins et al., 1980).  Lines that contained a tRNA mutation, 
SUF1, suppressed a histidine mutation, his4-38, by decoding a four basepair codon.  This 
allowed for readthrough of the +1 frameshift mutation encoded by the his4-38 mutation.  
The +1 frameshift mutation brought a nonsense codon into the reading frame (Donahue et 
al., 1981); thus making it an NMD substrate.  In the presence of a mutation in the NMD 
pathway, the nonsense codon containing transcript was stabilized, resulting in further 
suppression of the his mutant phenotype.  The stabilization of his-38 transcript was later 
shown to occur independently of the SUF1 mutation, suggesting these mutations that “up” 
the suppression of the his mutant phenotype play an independent role in mRNA 
destabilization (Leeds et al., 1991).  This analysis identified two separate mutations 
called UPF for “UP-Frameshift suppressor” (Culbertson et al., 1980).  Three genes 
named UPF1, UPF2 and UPF3 were eventually identified using these and similar 
methods (Cui et al., 1995; He and Jacobson, 1995; Lee and Culbertson, 1995; Leeds et al., 
1991; 1992).  Cloning and further characterization of the UPF genes in yeast revealed all 
three genes were required to destabilize a broad variety of PTC-containing transcripts, 
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were dependent on active translation, and were necessary for viability in yeast (Cui et al., 
1995; He and Jacobson, 1995; Leeds et al., 1991; 1992).  These data suggested all three 
genes were involved in the same translation-dependent pathway, which functioned to 
clear the organism of transcripts that could result in truncated proteins.   
 
 
C. elegans screens 
 Informational suppressor screens in C. elegans also identified mutations in genes 
affecting stability of PTC-containing transcripts (Cali et al., 1999; Hodgkin et al., 1989).  
Two mutants were utilized in these screens: unc-54(r293) contains a deletion that 
removes most of the 3’UTR, including the poly-adenylation signal of myosin heavy chain.  
lin-29(n546) introduces a nonsense codon into the coding region of a heterochronic gene.  
Lines carrying either unc-54(r293) or lin-29(n546) were mutagenized and recessive 
suppressor mutations were identified in the F2 generation by reversion (suppression) of 
the original mutant phenotype.  These screens resulted in the isolation of six mutants, 
each of which suppressed mutations in unc-54, lin-29, and an additional mutant, tra-3 
(Hodgkin et al., 1989).  The mutant suppression was allele-specific, certain classes of 
mutation were suppressible; however, not all alleles in the same gene were suppressed by 
this new class of informational suppressors (Hodgkin et al., 1989).  On their own, these 
suppressor mutations exhibited a gross morphological defect, either a swollen bursa in 
males or protruding vulva in hermaphrodites.  Hence they were named Smg for 
“Suppressor with Morphogenetic effect on Genitalia” (Hodgkin et al., 1989).  The genes 
identified in this screen included smg-1, smg-2, smg-3, smg-4, smg-5, and smg-6 
(Hodgkin et al., 1989).  The small number of alleles isolated of smg-4 and smg-6, one and 
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two alleles, respectively, led to the conclusion that this screen was not saturated for genes 
affecting this pathway.  A second screen was performed using a method that prohibited 
identification of alleles of smg-1, smg-2 and smg-5, these provided 90% of the alleles in 
the original screen.  The second screen also utilized a broader variety of chemical 
mutagens.  Using these methods, three alleles of an additional gene, smg-7, were 
identified (Cali et al., 1999).  A noncomplementation screen was also performed to 
identify additional alleles of smg-6 (Cali and Anderson, 1998).  Cloning of the smg genes 
(Cali et al., 1999; Chiu et al., 2003; Cui et al., 1995; Grimson et al., 2004; He and 
Jacobson, 1995; Page et al., 1999; Serin et al., 2001) showed smg-2, smg-3, and smg-4 
were orthologs of the yeast genes UPF1, UPF2, and UPF3, respectively.  
 
 
C. elegans RNAi reporter screen 
 In both yeast and C. elegans, the UPF and smg genes were not required for 
viability.  This raised the question: are there more NMD genes that would have been 
missed due to lethality upon loss of gene function?  To determine whether additional 
NMD genes were missed due to organismal lethality, an alternative screen was performed 
(Longman et al., 2007).  This screen utilized RNAi to knock down expression of ~86% of 
the genome of C. elegans.  Genes required for NMD were identified using an NMD-
sensitive fluorescent reporter consisting of a bicistronic transcript that contained GFP 
fused to a LacZ open reading frame containing a PTC.  Under wild-type conditions the 
reporter transcript was degraded by NMD, resulting in little or no GFP expression.  Upon 
RNAi knockdown of an NMD component, such as smg-2, the reporter was no longer 
targeted for degradation, resulting in GFP expression.  Animals carrying the reporter 
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were fed RNAi in liquid culture and screened for expression of GFP.  Two genes weakly 
stabilized the GFP reporter and also resulted in lethality; these were called smgl-1 and 
smgl-2 for “Smg-Lethal” (Longman et al., 2007).   
Orthologs of smgl-1 and smgl-2 are conserved in eukaryotes: smgl-1 is 
homologous to human NAG/NBAS and smgl-2 is homologous to human DHX34.  
Knockdown of NAG/NBAS or DHX34 in HeLa cells using RNAi resulted in stabilization 
of an NMD reporter.  This suggests these two new genes have a conserved NMD function 
in human cells (Longman et al., 2007).  Additionally, homologs of NAG/NBAS and 
DHX34 are conserved in zebrafish and morpholino knockdown of either gene results in 
stabilization of a PTC-containing reporter (Anastasaki et al., 2011).  However, while 
these data are consistent with NMD function, the role of these proteins has not been 
explored mechanistically with respect to other NMD genes, nor have mutants been 
isolated or tested.  Indeed, DHX34 belongs to a group of RNA helicases that may play a 
more general role in transcription (Fuller-Pace, 2006).  Finally, while a homolog of 
DHX34 is found in Drosophila, no homolog of NAG/NBAS is conserved in this organism 
(Mühlemann et al., 2008).  
While the screen described above identified two potential new factors involved in 
NMD, there are several caveats to the approach.  First, RNAi, especially when performed 
on a large scale, is susceptible to both off-target effects as well as inefficient knock-down 
(Qiu et al., 2005; Qu et al., 2011); therefore, many genes out of the 86% of the genome 
screened were likely missed.  Second, this screen utilized a bacterial delivery system that 
results in differential RNAi knockdown in C. elegans tissues, so particular genes, such as 
those required for NMD in the nervous system, would have been missed (Timmons et al., 
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2001).  Additionally, RNAi knockdown frequently causes lethality; thus, the authors 
screened both living and dead animals, a method that may have missed genes due to 
lethality prior to efficient expression of the reporter transgene.  Finally, the RNAi 
approach does not provide the functional data that can be provided by an allelic series, 
making further analysis of the role of identified genes more difficult.   
 
 
Protein interaction screens 
 In addition to in vivo screens, two protein interaction screens have successfully 
identified proteins that could play a role in NMD.  UPF2 was identified in a yeast 
suppressor screen (Cui et al., 1995) and was simultaneously isolated in a yeast two-
hybrid using UPF1 as bait (He and Jacobson, 1995).  SMG-8 and SMG-9 were identified 
by coimmunoprecipitation with SMG-1 in HeLa cells (Yamashita et al., 2009).  Both 
proteins were shown to play a minor role in NMD function, likely through regulation of 
the kinase activities of SMG-1 (Yamashita et al., 2009).  However, mutant analysis of the 
C. elegans homolog of smg-8 demonstrated this gene does not contribute to NMD in C. 
elegans (Rosains and Mango, 2012).  Thus, more mutational analysis is necessary to 
determine whether SMG-8 and SMG-9 contribute to NMD in other organisms.  
 
 
Forward genetic screen for NMD genes in Drosophila 
 Work to investigate NMD in Drosophila has primarily resulted from 
serendipitous discoveries leading to the isolation of homologs of NMD genes.  First, two 
mutations in Smg1 were isolated in a forward genetic screen for resistance to the 
insecticide, cyromazine, in Drosophila (Chen et al., 2005).  The two alleles of Smg1 were 
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shown to have no effect on the levels of PTC-containing transcripts in vivo, which led to 
the conclusion that loss of Smg1 has no effect on NMD in vivo (Chen et al., 2005).  
Another unexpected discovery was made during a forward genetic mosaic screen for 
genes on the X-chromosome affecting tracheal morphogenesis in Drosophila (M. 
Metzstein, in prep).  The screen utilized a fluorescent reporter to positively mark 
homozygous mutant cells (Lee and Luo, 2001).  A class of mutants was recognized that 
had no morphogenesis defects, but exhibited a drastic increase in fluorescent reporter 
expression compared to wild-type cells.  Mapping and sequencing revealed the defect 
resulted from mutations in components of the NMD pathway (Metzstein and Krasnow, 
2006).  Three NMD components are found on the X-chromosome: Upf1, Upf2, and Smg1.  
Alleles of each of these genes were isolated and analyzed for their role in NMD in 
Drosophila.  A single allele of Smg1 was examined that, like previously analyzed alleles, 
was viable, but unlike the previous study (Chen et al., 2005) showed a minor transcript-
specific NMD defect.  This suggests Smg1 does play a minor role in NMD in vivo 
(Metzstein and Krasnow, 2006).  Analysis of alleles of Upf1 and Upf2 provided the first 
in vivo data on these genes in Drosophila.  Two lethal alleles of Upf1 were isolated, 
however, the lethality prohibited further analysis in this study.  Three alleles of Upf2 
were isolated, two of which were loss of function alleles resulting in lethality.  One allele, 
Upf225G, was a strong hypomorph that resulted in approximately a 10% rate of viability 
(Metzstein and Krasnow, 2006).  Analysis of Upf225G and the alleles of Smg1 provided 
the basis for investigation of NMD in Drosophila.  While these alleles provided tools to 
begin analysis of NMD genes in Drosophila, there were still no alleles of the Drosophila 
orthologs of the NMD genes Smg5 and Smg6 (Gatfield et al., 2003).  
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 Drosophila provides a powerful system to circumvent shortcomings that may 
have prohibited the original screens from identifying all NMD genes.  First, Drosophila 
is a complex organism.  Yeast contain orthologs of only three (Cui et al., 1995; He and 
Jacobson, 1995; Leeds et al., 1991; 1992) of the seven NMD genes identified in C. 
elegans (Cali et al., 1999; Hodgkin et al., 1989), suggesting more factors may be 
involved in the process as the complexity of the organism increases.  Second, the small 
number of alleles of some of the NMD genes recovered in the C. elegans screens (Cali 
and Anderson, 1998; Cali et al., 1999; Hodgkin et al., 1989), and subsequent 
identification of genes using RNAi (Longman et al., 2007) and immunoprecipitation 
(Yamashita et al., 2009), suggests saturation for alleles of NMD genes has not been 
achieved.  Additionally, the knockdown and biochemical approaches did not provide 
mutants for the identified components, preventing full loss of function analysis of these 
potentially novel NMD genes.  Third, mosaic generation in Drosophila provides a way to 
avoid lethality and developmental defects associated with loss of NMD (Xu and Rubin, 
1993).  In the original screens mutations were identified by virtue of suppression of a 
mutant phenotype requiring viability, so lethal mutants would have been missed. 
Taking advantage of the mosaic techniques available, we undertook the first 
forward genetic screen specifically for genes involved in NMD in Drosophila.  Our 
screen utilized an NMD-sensitive fluorescent reporter that allowed for efficient 
identification of NMD genes in vivo (Metzstein and Krasnow, 2006).  In this system, 
reporter expression is usually low due to targeting of the reporter transcript by NMD.  
However, expression increases dramatically in the presence of an NMD mutation due to 
stabilization of the transcript, resulting in a concordant increase in fluorescent protein 
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(Frizzell et al., 2012; Metzstein and Krasnow, 2006).  We combined the NMD reporter 
with tissue directed FLP-mediated mitotic recombination to create homozygous mutant 
cells in an otherwise heterozygous mutant background (Xu and Rubin, 1993).  This 
approach also allowed us to screen F1 animals for mosaic increase in reporter expression.  
Unlike the original screens in yeast and C. elegans, which required homozygous mutants 
to detect a phenotype, this mosaic approach allows us to bypass any developmental 
defects associated with NMD genes.  Additionally, our approach allows for 
straightforward detection of NMD mutations.  A concern in the original informational 
suppressor screens was the detection of false positives due to reversions of the mutant 
phenotypes; however, we avoided this by using a transgenic reporter system instead of a 
suppressible mutant allele.     
 Chapter 2 of this thesis describes our forward genetic screen and the resulting 
alleles of NMD genes.  On the X-chromosome all the recovered genes were homologs of 
mutants previously identified in the C. elegans (Cali and Anderson, 1998; Cali et al., 
1999; Hodgkin et al., 1989) and yeast screens (Cui et al., 1995; He and Jacobson, 1995; 
Leeds et al., 1991; 1992), however, potentially novel NMD genes were isolated on the 
right arm of the third chromosome (3R).  Our screen covered ~40% of the Drosophila 
genome, likely saturated the X chromosome, and extensively covered but did not saturate 
the right arm of the third chromosome (Frizzell et al., 2012).  Chapter 3 describes 
preliminary analysis of alleles isolated on 3R that represent a potentially novel class of 








Mechanism of nonsense mediated decay 
Cell culture experiments in mammalian (Nicholson et al., 2009) and Drosophila 
cells (Gatfield et al., 2003), crystallography (Clerici et al., 2009; Kadlec et al., 2004), and 
mutant analysis in yeast (He and Jacobson, 1995; He et al., 1997) and C. elegans (Page et 
al., 1999) have established protein interactions that occur when a transcript contains a 
premature termination codon.  Studies of interactions between NMD proteins utilized 
homologs of the seven NMD genes found in the original yeast and C. elegans screens.  
These interactions are generally functionally conserved between orthologs in different 
species.  This results in a protein interaction model of NMD after PTC recognition.   
Recognition of a premature termination codon causes Upf1, an ATP-dependent 
RNA helicase, to bind the mRNA.  Upf1 binds to Upf2, which likely activates the 
helicase activity of Upf1 (Clerici et al., 2009).  The function of this helicase activity is 
unclear, but may result in the remodeling of the NMD messenger ribonucleoprotein 
(mRNP), which in turn allows for subsequent cleavage and recycling steps (Franks et al., 
2010).  Upf2 binds Upf3 (Kadlec et al., 2004), which interacts with the mRNA.  This has 
been shown in mammalian tissue culture to interact with the exon junction complex 
(Buchwald et al., 2010; Le Hir et al., 2001), which stimulates NMD in mammalian cells 
(Gehring et al., 2005; Ivanov et al., 2008; Palacios et al., 2004) and plants (Kertész et al., 
2006).   
In metazoans additional components are involved in NMD and are thought to 
provide a regulatory role.  Smg1 is a phosphoinositide-like kinase (PIKK) that 
phosphorylates Upf1 (Grimson et al., 2004).  Phospho-Upf1 provides a binding substrate 
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for the proteins Smg5, Smg7, and Smg6 (Okada-Katsuhata et al., 2011).  Smg5 and Smg7 
in turn recruit phosphatase 2a to the complex to de-phosphorylate Upf1 (Anders et al., 
2003; Page et al., 1999).  This phosphorylation cycle may function to recycle components 
of the NMD complex (Isken et al., 2008).  Smg6, an endonuclease, cleaves the mRNA 
near the premature termination codon, resulting in rapid decay of uncapped and 
unadenylated free ends by the 3’-5’ exosome and the 5’-3’ exonuclease Xrn1 (Eberle et 
al., 2009; Gatfield and Izaurralde, 2004; Huntzinger et al., 2008).  
 
 
Role of NMD in development 
Upf1, Upf2, and Upf3 are conserved in all eukaryotes examined and loss of 
function of any of these genes results in stabilization of NMD target transcripts.  Upf1, 
Upf2, and Upf3 loss of function mutations in yeast (Cui et al., 1995; Leeds et al., 1991; 
1992) or C. elegans (Cali et al., 1999; Hodgkin et al., 1989) do not affect viability; thus, 
NMD is not an essential process in these organisms.  However, loss of Upf1 in plants 
(Arciga-Reyes et al., 2006; Yoine et al., 2006), Upf1 or Upf2 in Drosophila (Avery et al., 
2011; Frizzell et al., 2012; Metzstein and Krasnow, 2006), zebrafish (Wittkopp et al., 
2009), and mice (Medghalchi et al., 2001; Thoren et al., 2010; Weischenfeldt et al., 2008), 
results in lethality; thus, NMD is likely essential for development in these organisms.  
The third member of this evolutionarily conserved core, Upf3, is not essential for 
viability in Drosophila (Avery et al., 2011).  In vertebrate lineages, Upf3 has undergone a 
duplication.  The two paralogs, Upf3a and Upf3b (Upf3x) are not lethal individually 
(Huang et al., 2011), however, the double knockout has yet to be performed in mice.  
Humans carrying a hemizygous mutation in Upf3b survive to adulthood with a form of 
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X-linked mental retardation (Tarpey et al., 2007).  Upf3b knockout mice are viable 
(Huang et al., 2011).  Taken together, this suggests that the paralogs of Upf3 compensate 
for defects that may arise in the other gene (Chan et al., 2009); however, whether this 
occurs in vivo is not yet clear (Huang et al., 2011).  The lack of redundancy of Upf3 in 
Drosophila is interesting as there is only one conserved Upf3 ortholog, yet loss of 
function of Upf3 is not lethal (Avery et al., 2011).  One hypothesis is that Upf3 may be 
required for targeting only a subset on NMD transcripts, thus representing a branch of the 
NMD pathway that is not absolutely required for viability.  The variability in lethality 
associated with loss of NMD genes could result from functional differences in NMD 
between organisms; different methods of targeting transcripts and different branches of 
NMD may have arisen throughout evolution.  In plants (Kertész et al., 2006), zebrafish 
(Wittkopp et al., 2009), and mammals (Le Hir et al., 2001), the exon junction complex 
(EJC) can stimulate NMD transcript targeting; however, while the EJC is present in 
Drosophila, it does not appear to play a role in NMD (Gatfield et al., 2003).  Upf3 
interacts with the EJC in mammalian cells, suggesting that the Upf3-EJC may provide an 
important level of regulation for a vertebrate specific NMD pathway (Buchwald et al., 
2010).   
 Smg7 is the only auxiliary NMD gene conserved in plants (Benkovics et al., 2011; 
Kerényi et al., 2008), whereas Smg1, Smg5, Smg6, and Smg7 are conserved between C. 
elegans and vertebrates (Aronoff et al., 2001; Chiu et al., 2003; Culbertson and Leeds, 
2003; Denning et al., 2001; Serin et al., 2001).  Smg1, Smg5 and Smg6 are conserved in 
Drosophila, but Smg7 appears to be absent (Gatfield et al., 2003).  Based on sequence 
and structure, Smg7 may be functionally redundant with Smg5 (Chiu et al., 2003).  While 
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the biochemical roles of Smg1, 5, 6 and 7 are well understood (Kashima et al., 2006; 
Okada-Katsuhata et al., 2011), their in vivo roles have only recently begun to be 
examined.  Smg1 is required for embryonic viability in mice (McIlwain et al., 2010), 
supporting the hypothesis that NMD is essential for viability in complex organisms.  
However, morpholino knockdown of Smg1 in zebrafish (Wittkopp et al., 2009) and 
mutant analysis in Drosophila (Chen et al., 2005; Metzstein and Krasnow, 2006) showed 
Smg1 plays only a minor role in development and NMD function in these organisms, 
suggesting that phosphorylation of Upf1 is not essential for NMD.  However, this 
interpretation is confounded by experiments in zebrafish, which show morpholino 
knockdown of Smg5 or Smg7 results in severe developmental defects (Wittkopp et al., 
2009).  This suggests that dephosphorylation of Upf1 is important for viability in 
zebrafish.  Alternatively, Smg5 and Smg7 may be involved in developmental processes 
other than NMD (Wittkopp et al., 2009).  Analysis of NMD genes by morpholinos is 
subject to off-target effects, which could result in the developmental defects observed.  
Additionally, the zebrafish morphant animals were not tested directly for stabilization of 




Analysis of NMD function in vivo 
Several hypotheses have been proposed as to why NMD may cause organismal 
lethality, two of which are the “vacuum cleaner” and “swiss-army knife” models (Neu-
Yilik et al., 2004).  The vacuum cleaner model suggests NMD acts to clear cells of excess 
debris from nonsense transcripts, and lethality in NMD mutants results from a build-up of 
14
defective mRNA and truncated proteins that should have been degraded.  The swiss-army 
knife model suggests NMD clears cells of a small number of specific transcripts, the 
regulation of which is essential for development (Neu-Yilik et al., 2004).  Other models 
postulate that lethality occurs because NMD genes have other functions unrelated to 
NMD in more complex organisms (Hwang and Maquat, 2011).  The best way to test 
these models is through methods that allow us to investigate NMD in different cells, 
tissues, and throughout developmental stages.  Development and analysis of allelic series 
of NMD genes in Drosophila is one way to begin differentiating these different models of 
NMD function in vivo.  
 Our screen for genes involved in NMD in Drosophila isolated six alleles of Smg6, 
the first alleles of this gene to be isolated in this organism (Frizzell et al., 2012).  Our 
results indicate that Smg6 is not absolutely required for viability or for NMD function in 
vivo.  Analysis of Smg6 has been performed by morpholino knockdown in zebrafish 
(Wittkopp et al., 2009) and suggested loss of Smg6 was equal to or more severe than loss 
of Upf1 developmentally.  This surprising result could be explained by morpholino off-
target affects.  Additionally, mutant analysis in C. elegans has shown Smg6 is involved in 
NMD (Cali and Anderson, 1998; Hodgkin et al., 1989; Page et al., 1999).  However, 
since the NMD genes are not required for viability in this organism, we cannot ascertain 
essential developmental roles associated with loss of individual NMD components.  
Recent studies in Drosophila S2 cells (Huntzinger et al., 2008) and mammalian cells 
(Eberle et al., 2009) demonstrated that Smg6 is an endonuclease that cleaves NMD target 
mRNAs near the premature termination codon (Gatfield and Izaurralde, 2004).  In 
Drosophila, it was suggested that the endonuclease function of Smg6 is the primary mode 
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of cleavage resulting in the rapid decay of target transcripts (Gatfield and Izaurralde, 
2004; Huntzinger et al., 2008).  Work in yeast (He and Jacobson, 2001) and mammalian 
cells (Chen and Shyu, 2003; Couttet and Grange, 2004; Muhlrad and Parker, 1994) has 
shown a deadenylation independent decapping mechanism is also utilized by NMD.  The 
partial loss of NMD function seen in Drosophila Smg6 mutants suggests an alternative 
degradation pathway, like the one seen in yeast and mammals, may also be utilized in 
Drosophila.  Chapter 4 addresses methods to further examine the role of Smg6 in vivo, 
focusing on the endonuclease domain of Smg6, which is disrupted in many of the mutant 
alleles (Frizzell et al., 2012).  Additionally, this chapter addresses ideas to identify other 
degradation pathways utilized by NMD in Drosophila.  
 
 
How does NMD distinguish between normal or premature  
termination codons? 
Biochemical analysis of NMD genes has resulted in a model of how PTC-
containing transcripts are targeted by NMD.  Two alternative, though nonexclusive, 
models have been proposed based on studies in a number of systems.  A mammalian cell 
culture-based model for PTC recognition depends on the exon junction complex (EJC).  
The EJC-complex model was based on a series of observations that the presence of an 
intron downstream of the PTC caused destabilization of the transcript (Belgrader et al., 
1994; Carter et al., 1996; Cheng et al., 1994; Zhang et al., 1998).  The EJC is a 
multiprotein complex that is deposited on the mRNA upon splicing (Le Hir et al., 2000).  
The EJC remains associated with the RNA until the pioneer (first) round of translation 
(Lejeune and Maquat, 2005), at which point the ribosome displaces EJCs from the 
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mRNA.  Since genes typically encode a termination codon in the final exon, all EJCs are 
displaced by the translating ribosome.  This results in no EJC bound to naturally 
terminating transcripts, allowing for interactions between the ribosome, release factors 
and poly-A binding protein to stimulate efficient translation termination (Fig. 1.1).   
However, if a premature stop is recognized before an exon-exon junction, the ribosome 
will not continue to remove the EJCs downstream of the PTC, leaving any associated 
downstream EJC as a mark of a PTC.  A component of the NMD complex, Upf3, 
interacts with the EJC upon translocation of the mRNA from the nucleus to the cytoplasm 
(Buchwald et al., 2010; Singh et al., 2007).  The interaction between Upf3, the EJC, 
NMD components, and the translation release factors eRF1 and eRF3 is called the SURF 
complex (Kashima et al., 2006) (Fig. 1.2).  The presence of an NMD component 
associated with the mRNA in the SURF complex is thought to prime transcripts for 
targeting by NMD.  However, this model does not account for messages that have no 
introns, or have PTCs in the final exon that are still subject to NMD.  Additionally, 
experiments in Drosophila tissue culture indicate the EJC does not contribute to 
transcript recognition, suggesting this method of targeting is not conserved (Gatfield et al., 
2003).  
An alternative model was primarily established in yeast (Amrani et al., 2004), and 
is now supported by data from C. elegans, Drosophila, plants and mammalian tissue 
culture.  This model postulates the length of the 3’ UTR is key to determining transcript 
stability (Amrani et al., 2004).  The mechanism by which length is measured involves 
interactions between the translating ribosome and proteins associated with the poly-A-tail 
(Behm-Ansmant et al., 2007).  When a translating ribosome recognizes the termination 
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codon, it interacts with the release factors eRF1 and eRF3.  Efficient termination occurs 
when release factors also interact with poly-A binding protein (PABP) associated with 
the 3’UTR.  Thus, when the translating ribosome terminates at a normal stop codon, this 
interaction occurs efficiently, which results in ribosome release and recycling of the 
transcript for entry into steady-state translation.  In the case of a premature termination 
codon, the release factors cannot interact with poly-A-binding protein due to an increase 
in the physical distance between the factors.  The NMD protein, Upf1, interacts with the 
release factors in a competitive manner that prevents efficient binding of poly-A-binding 
protein.  Upf1 then remains associated with the mRNA and recruits other NMD proteins 
to the transcript, which stimulates cleavage and decay (Eberle et al., 2008; Hogg and 
Goff, 2010; Singh et al., 2008) (Fig. 1.3).  Currently, this is thought to be the primary 
mode of target recognition in all organisms, with the EJC model stimulating NMD in 
some specific cases in invertebrates (Singh et al., 2008) and plants (Kertész et al., 2006).    
  Genome wide studies in yeast (He et al., 2003), C. elegans (Barberan-Soler et al., 
2009; Ramani et al., 2009), Drosophila S2 cells (Hansen et al., 2009; Rehwinkel et al., 
2005), and mammals (Lewis et al., 2003; Nguyen et al., 2012) have shown NMD targets 
a variety of transcripts, up to 10% of the genomes in some organisms.  However, many of 
these targets lack the features that are predicted to be required for NMD targeting, 
including uORFs, long 3’UTRs, or introns in the 3’UTR (Kervestin and Jacobson, 2012).  
The lack of known features in many NMD targets suggests that other previously 
unknown features may also be required for targeting by NMD.  The fluorescent NMD 
reporter utilized in our screen uses the simian viral small t antigen intron and 
polyadenylation signal as a 3’UTR; this SV40 3’UTR is targeted for degradation by 
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NMD (Metzstein and Krasnow, 2006), but is unlike many reporters used in tissue culture 
and C. elegans, as it lacks a premature termination codon.  Chapter 5 discusses work 
performed to map the cis-acting factors within the SV40 3’UTR required for targeting 




Work described in this thesis addresses three main questions related to the 
function of the NMD pathway.  Chapters 2 and 3 describe work establishing whether all 
NMD genes have been identified.  Chapter 4 addresses how NMD genes can be 
investigated functionally.  Finally, Chapter 5 investigates NMD targeting of the SV40 
3’UTR and how new and previously described methods may be utilized for NMD 
targeting models in Drosophila.    
  
19
 Figure 1.1 Normal translation termination.  mRNA containing a normal termination 
codon is translated by the ribosome; release factors bind the ribosome upon recognition 
of the termination codon, and interact with poly-A binding protein associated with the 
poly-A tail.  This signals efficient translation termination and the mRNA enters steady 
state translation with a low rate of decay.  Ribosome is represented in dark grey.  Release 













Figure 1.2  PTC-containing mRNA with EJC bound.  mRNA containing a PTC is 
translated by the ribosome, the release factors bind the ribosome upon recognition of the 
termination codon, however recognition of the PTC-bound mRNA is stimulated by the 
presence of the EJC.  The NMD factor Upf3 binds the EJC and recruits other NMD 
components to the PTC-containing transcript, resulting in cleavage and degradation of the 
transcript.  Release factors are represented by magenta triangles.  Ribosome is 
































































































































Figure 1.3  Targeting for PTC-containing mRNA, no EJC.  mRNA containing a PTC is 
translated by the ribosome, the release factors bind the ribosome upon recognition of the 
termination codon, however the distance between the release factors and the poly-A tail 
prohibits efficient translation termination.  Upf1 competitively interacts with poly-A 
binding protein to bind release factors, which stimulates assembly of the rest of the NMD 
factors, resulting in cleavage of the PTC-containing transcript and rapid decay.  
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Drosophila mutants show NMD pathway activity is
reduced, but not eliminated, in the absence of Smg6
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ABSTRACT
The nonsense-mediated mRNA decay (NMD) pathway is best known for targeting mutant mRNAs containing premature
termination codons for rapid degradation, but it is also required for regulation of many endogenous transcripts. Components of
the NMD pathway were originally identified by forward genetic screens in yeast and Caenorhabditis elegans. In other
organisms, the NMD pathway has been investigated by studying the homologs of these genes. We present here the first unbiased
genetic screen in Drosophila designed specifically to identify genes involved in NMD. By using a highly efficient genetic mosaic
approach, we have screened ~40% of the Drosophila genome and isolated more than 40 alleles of genes required for NMD. We
focus on alleles we have obtained in two known NMD components: Upf2 and Smg6. Our analysis of multiple alleles of the core
NMD component Upf2 reveals that the Upf2 requirement in NMD may be separate from its requirement for viability, indicating
additional critical cellular roles for this protein. Our alleles of Smg6 are the first point mutations obtained in Drosophila, and we
find that Smg6 has both endonucleolytic and nonendonucleolytic roles in NMD. Thus, our genetic screens have revealed that
Drosophila NMD factors play distinct roles in target regulation, similar to what is found in mammals, but distinct from the
relatively similar requirements for NMD genes observed in C. elegans and yeast.
Keywords: Drosophila; NMD; Smg6; Upf2; nonsense-mediated decay
INTRODUCTION
Nonsense-mediated mRNA decay (NMD) is a cellular path-
way that selectively targets mRNAs containing premature
termination codons (PTCs) for rapid degradation (Chang
et al. 2007) and is thought to function to prevent the trans-
lation and build-up of potentially harmful truncated protein
products (Cali and Anderson 1998). Trans-acting factors
involved in NMD were originally identified in suppressor
screens performed in yeast (Leeds et al. 1991, 1992) and
Caenorhabditis elegans (Hodgkin et al. 1989; Cali et al. 1999).
These screens took advantage of PTC-containing alleles of
genes whose truncated protein products, rather than being
toxic, possess residual function. Since NMD targets these
transcripts, the truncated proteins cannot be made, effec-
tively resulting in a complete loss-of-function phenotype.
Loss of function of genes required for NMD results in
stabilization of such PTC-containing transcripts, allowing
for production of the truncated protein products and
amelioration of the mutant phenotype. These screens
identified three genes required for NMD in yeast—UPF1,
UPF2 (also called NMD2), and UPF3 (Upf, up-frameshift
suppressor) (Leeds et al. 1991, 1992)—and seven in C.
elegans—smg-1 through smg-7 (smg, suppressor with mor-
phogenetic effect on genitalia) (Hodgkin et al. 1989; Cali
et al. 1999). Cloning of these genes has revealed that
UPF1, UPF2, and UPF3 are orthologous to smg-2, smg-3,
and smg-4, respectively, thus defining an evolutionarily
conserved core machinery for NMD (Cui et al. 1995; He
and Jacobson 1995; Lee and Culbertson 1995; Cali et al.
1999; Page et al. 1999; Aronoff et al. 2001; Serin et al.
2001; Chiu et al. 2003; Grimson et al. 2004). All eukary-
otes analyzed contain orthologs of these core genes, and,
in all cases examined, they are known to be required for
NMD (Kere´nyi et al. 2008). The four other genes identi-
fied in C. elegans (smg-1, smg-5, smg-6, smg-7) are gener-
ally conserved only in metazoa, although there is evidence
that a homolog of Smg7 is also required for NMD in
plants (Luke et al. 2007). Smg5 and Smg7 are structurally
similar (Fukuhara et al. 2005), although not redundant
for their function in NMD, and some organisms, in-
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The design of the suppressor screens used to identify
NMD genes demanded that compromising NMD function
would not in itself result in lethality. Indeed, this is the case
in yeast and C. elegans: Complete absence of core NMD
components and NMD activity is compatible with viability
(Leeds et al. 1991, 1992; Cui et al. 1995; He and Jacobson
1995; Lee and Culbertson 1995; Cali et al. 1999; Page et al.
1999; Aronoff et al. 2001; Grimson et al. 2004). However,
for most eukaryotes, disruption of NMD gene function is
lethal (Hwang and Maquat 2011), and this essential role has
limited the ability to identify NMD genes as suppressors of
PTC-containing alleles in these organisms.
Since the initial screens, the only unbiased forward ge-
netic screen that has been performed to identify genes re-
quired for NMD has been an RNAi-based approach in C.
elegans. This screen did not rely on suppression, but
instead used an NMD-sensitive reporter whose expression
increased upon disruption of NMD activity (Longman
et al. 2007). This screen identified two new NMD genes,
smgl-1 and smgl-2 (smg lethal), whose knockdown leads to
defective NMD and also organismal lethality. Knockdown
of smgl-1 and smgl-2 in human cells (Longman et al. 2007)
and zebrafish (Anastasaki et al. 2011) also leads to
impairment of NMD. However, no mutations in smgl-1
or smgl-2 have been reported in any organism.
The primary mechanism that distinguishes premature
from normal termination codons seems to involve de-
tection of 39-UTR length (Amrani et al. 2004; Longman
et al. 2007; Eberle et al. 2008). Such a mechanism also
plays a role in mammalian cells and plant cells, but there is
also an important contribution from interactions between
NMD components and splicing-deposited exon junction
complexes (Lejeune and Maquat 2005; Kerte´sz et al. 2006;
Eberle et al. 2008). Recognition of a PTC is thought to
result in the recruitment of the core NMD protein Upf1
(SMG-2 in C. elegans), an ATP-dependent RNA-helicase,
to the targeted mRNA, triggering degradation (Kashima
et al. 2006). In both yeast and mammalian cells, degrada-
tion is known to occur through deadenylation-indepen-
dent decapping, dependent on the recruitment of the
decapping proteins DCP1 and DCP2 by Upf1 (Lejeune
et al. 2003; Swisher and Parker 2011). This is followed by
degradation by 59–39 exonucleases, such as XRN1 (He
et al. 2003). However, there is now considerable evidence
that in metazoan cells, degradation can also occur through
endonucleolytic cleavage in the vicinity of the PTC (Gatfield
and Izaurralde 2004; Huntzinger et al. 2008; Eberle et al.
2009). The endonuclease responsible for this cleavage is
likely to be the NMD component Smg6. Smg6 contains
a C-terminally located PIN-endonuclease domain that
is required for cleavage of target mRNAs (Glavan et al.
2006; Huntzinger et al. 2008; Eberle et al. 2009). Smg6 is
thought to be recruited to target mRNAs by virtue of its
14-3-3-like domain, which can bind phosphorylated Upf1
(Fukuhara et al. 2005). In mammalian cells, Smg6 is also
recruited to target mRNAs through direct recruitment to
the EJC (Kashima et al. 2010). Smg6 function has primarily
been analyzed in cell culture, and while some genetic anal-
ysis has been performed in C. elegans (Hodgkin et al. 1989;
Page et al. 1999), a role for SMG-6 endonuclease function
has not yet been analyzed in this organism.
Roles of Drosophila NMD factors have been well es-
tablished in cell culture experiments (Gatfield et al. 2003;
Rehwinkel et al. 2005; Huntzinger et al. 2008). These
experiments have shown that all the Drosophila homologs
of known NMD genes are required for NMD and that loss
of any of these genes leads to similar defects in NMD. Less
is known about how NMD genes function in intact animals.
Previous genetic analysis has identified alleles of Upf1-3 and
Smg1 (Chen et al. 2005; Metzstein and Krasnow 2006; Avery
et al. 2011). All of these have been shown to have function in
NMD, although, interestingly, some of these roles differ. For
instance, while Upf1 and Upf2 seem to be absolutely
required for NMD and organismal viability, loss of Smg1
or Upf3 leads to viable animals with a reduction, but not
a complete loss, of NMD pathway activity. Why intact
animals and cell culture show these differences is not
understood, but probably indicate additional layers of
pathway regulation.
Here, we present a novel forward genetic screen in
Drosophila that uses an NMD-sensitive reporter combined
with a genetic mosaic approach. This has allowed us to
isolate more than 30 mutations in the known NMD genes
Upf1, Upf2, Smg1, and Smg6. Our alleles of Upf2 have
revealed that differential interactions of Upf2 with other
core NMD components are correlated with whether these
alleles are required for viability. The Smg6 mutations are
the first obtained in Drosophila, and we have used genetic
and molecular criteria to show that several of these are
complete loss of function. We find that mutants carrying
these null alleles still show considerable NMD pathway
function, thus revealing that Smg6 is not absolutely
required for NMD in vivo.
RESULTS AND DISCUSSION
Tissue-directed mosaic screen for mutations
affecting NMD
To identify novel genes required for NMD as well as alleles
of known NMD genes, we performed a large-scale forward
genetic screen in Drosophila. The screen uses the simian
virus 40 small t antigen intron and polyadenylation signal
(SV40 39 UTR), which is targeted for degradation by the
NMD pathway in Drosophila (Metzstein and Krasnow
2006). Transgenic reporter constructs that use the SV40 39
UTR as their termination signal result in a low level of
expression in wild-type backgrounds; however, the signal
increases dramatically when genes involved in NMD are
inactivated (Fig. 1A,B). Fluorescent protein reporters with
Frizzell et al.
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the SV40 39 UTR can thus be used to monitor NMD
pathway activity on a single-cell level, and this allowed us to
perform a screen for genes involved in NMD using a genetic
mosaic approach. Importantly, this mosaic approach allowed
us to bypass the organismal lethality associated with
strong loss of NMD function. Furthermore, by using a
live-cell marker, we could score for NMD defects in F1
generation animals, greatly increasing the screen throughput.
Our screen used the e22c-GAL4 driver, which is expressed
in the early embryonic ectoderm and later is restricted to
ectodermally derived epithelium (Duffy et al. 1998), in-
cluding the larval epidermis. This driver served two purposes
in our screen (Fig. 1C). Expression of FLP recombinase
driven by e22c-GAL4 early in development produces animals
with mosaicism in ectodermal derivatives. Later in develop-
ment, e22c-GAL4 drives expression of an NMD-sensitive
fluorescent reporter in larval epidermal cells. Importantly,
we found that this expression in epidermal cells is uniform
(Fig. 1D), so differences in reporter levels caused by muta-
tions in NMD genes could be readily identified.
To test our mosaic strategy, we crossed our mosaic gen-
erating reporter line to animals carrying known mutations
in the core NMD components Upf1 and Upf2 (Fig. 1E; data
not shown). Animals entirely mutant for null mutations in
either of these genes show 100% early larval lethality and
have strong defects in NMD (Metzstein and Krasnow 2006;
Avery et al. 2011). We found that animals with tissue-
directed mosaics of Upf1 or Upf2 were viable to the L3
larval stage, and we could easily detect increased expression
in homozygous epidermal cells, confirming the feasibility of
our approach for identifying organismal lethal mutations
affecting NMD. We also found that mutants of the NMD
auxiliary factor Smg1, which is viable and has weak defects
in NMD (Chen et al. 2005; Metzstein and Krasnow 2006;
Avery et al. 2011), produced an obvious mosaic phenotype
(Fig. 1F). Thus, our strategy should allow us to isolate alleles
of both essential and nonessential NMD genes.
We screened for mutations affecting NMD on the X
chromosome and the right arm of the third chromosome
using chemical mutagenesis and our mosaic approach (Fig.
2). While we identified our new mutants in mosaic animals,
for characterization of their roles in the NMD pathway, we
studied the alleles in nonmosaic, homozygous animals. In
this way, we were able to determine the degree to which the
new mutation is required for NMD. We were also able to
assess whether the new mutation was lethal or viable in
FIGURE 1. Mosaic approach used to detect animals with mutations in genes affecting NMD. (A) y w FRT19A/Y; e22c-GAL4 UAS-nlsDsRed2::SV40
39UTR/+ L3 (nonmosaic) larva shows uniform, low-level DsRed expression in epidermal nuclei. (B) y w Upf225G FRT19A/Y; e22c-GAL4, UAS-
nlsDsRed2::SV40 39UTR/+ (nonmosaic) L3 larva, taken at the same exposure as A, shows uniform, high-level DsRed expression in epidermal
nuclei, due to stabilization of the reporter mRNA. (C) UAS-FLP expression in the early embryonic ectoderm driven by e22c-GAL4 catalyzes
recombination in heterozygous mitotic cells, resulting in homozygous mutant and wild-type sister cells. Cells that have not undergone
recombination remain heterozygous. Expression of an NMD-sensitive reporter UAS-nlsDsRed2::SV40 39UTR, which encodes a nuclear-
localized red-fluorescent protein, is driven by e22c-GAL4 in the larval epidermis. In heterozygous and the wild-type sister cells, the reporter
mRNA is targeted for degradation by NMD and shows a low level of DsRed fluorescence (light red). When a gene required for NMD is
mutated, the homozygous mutant cell is recognized by an increase in fluorescence (increased red color). (Circles) Centromeres; (rectangles)
FRT sites; (*) EMS-generated mutations. (D) y w FRT19A; e22c-GAL4, UAS-nlsDsRed2::SV40 39UTR, UAS-FLP/+ mosaic L3 larva shows
uniform DsRed expression in epidermal nuclei. (Yellow asterisks) Underlying tracheal nuclei that also express DsRed. These are easily
distinguished from epidermal cells under the microscope. (E) y w Upf126A FRT19A/y w FRT19A; e22c-GAL4, UAS-nlsDsRed2::SV40 39UTR, UAS-
FLP/+ L3 larva shows mosaic increased DsRed expression in epidermal nuclei: Low-level DsRed expression is punctuated with brighter,
homozygous mutant nuclei (yellow arrowheads). (F) y w Smg132AP FRT19A/y w FRT19A; e22c-GAL4, UAS-nlsDsRed2::SV40 39UTR, UAS-FLP/+
L3 larva shows mosaic DsRed expression in epidermal nuclei: Low-level DsRed expression is punctuated with brighter, homozygous mutant
nuclei (yellow arrowheads). Scale bars, (A,B) 1 mm; (D–F) 0.5 mm.
Drosophila NMD screens
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homozygous animals, giving insight into the requirement
of the NMD pathway into organismal survival.
X-chromosome screen has isolated numerous alleles
of known NMD genes
We identified 27 X-chromosome mutants, including both
lethal and viable alleles (Table 1). Complementation tests
revealed that all of these are alleles of the known NMD
genes Upf1, Upf2, and Smg1, in which mutations had been
previously isolated (Chen et al. 2005; Metzstein and
Krasnow 2006). The most interesting phenotypic diversity
we found was in our alleles of Upf2. When tested in ho-
mozygous animals, we found that six of these alleles were
lethal and six were viable. This phenotypic difference pro-
vided us an opportunity to study the effects of Upf2 mu-
tations in vivo. Upf2 is thought to function primarily as
a bridge between the other two core components of the
NMD complex, Upf1 and Upf3. Binding of Upf2 to Upf3
has been mapped to a conserved MIF4G domain (Fig. 3A),
while binding of Upf2 to Upf1 occurs primarily through
a C-terminally localized domain, with a contribution from
a domain close to the N terminus (He et al. 1997; Kadlec
et al. 2004; Clerici et al. 2009). Upf2 also contains two
other MIF4G domains of unknown function (Fig. 3A). To
identify which domains of the Upf2 protein are necessary
for viability, we sequenced the coding region of Upf2 in
eight of our alleles (four lethal and four viable) (Fig. 3A).
Our analysis of these Upf2 alleles revealed an interesting
pattern: Lethal mutations are predicted to disrupt the second
MIF4G domain but leave the other protein domains intact.
Two previously characterized lethal alleles of Upf2 are also
predicted to disrupt the second MIF4G domain (Metzstein
and Krasnow 2006); although these are also protein
truncations, this disruption is not very specific. We did
recover mutations that are predicted to disrupt the Upf2
interaction with Upf1 and that were not lethal. When we
assayed NMD pathway activity in these viable mutants, we
found that there was always residual pathway activity (Fig.
3B). These results suggest that pathway activity correlates
with viability. This agrees with previous results showing
that complete loss of the Upf1/Upf2 interaction is not
compatible with viability (Avery et al. 2011). However, we
cannot currently rule out that the second MIF4G domain
has a cellular function independent of its role in NMD
and disruption of this function also results in organismal
FIGURE 2. Screens to identify genes required for NMD on X and 3R. In the P0, males carrying the appropriate FRT are mutagenized by
treatment with EMS and mated en masse to reporter-containing females. In the F1 generation, candidate NMD-mutant L3 larvae are identified by
mosaic epidermal reporter expression, collected, and individually mated to flies containing marked FRTs. F2 larvae are scored for transmission of
the mosaic-expression phenotype, collected, and crossed to balancer-containing animals to establish stocks. (Middle column) Numbers of animals
identified in each generation. (e22RF) Genotype e22c-GAL4, UAS-nlsDsRed2::SV40 39UTR, UAS-FLP.
TABLE 1. 27 alleles recovered on the X chromosome
Upf1 Upf2 Smg1
Allele Viability Allele Viability Allele Viability
42 Lethal 14-01-3M Lethal 7-24-3 Viable
A92A Lethal 3-01-3R Lethal 8-9A Viable
8-7H Lethal 7-5A Lethal 7-10-2 Viable
14D Lethal C41 Lethal 11-29-3-1 Viable
C51 Lethal C9 Viable
C2 Lethal C73 Viable
2-8A Viable 8D2 Viable
4-5F Viable A6 Viable
C72 Viable A91 Viable
3D Viable 6B Viable
C52 Viable 11-2-10B Viable
13D Viable
X-chromosome screen mutants. All alleles of Upf1 are lethal, and
all alleles of Smg1 are viable, while alleles of Upf2 can be either
lethal or viable.
Frizzell et al.
1478 RNA, Vol. 18, No. 8
 Cold Spring Harbor Laboratory Press on February 14, 2013 - Published by rnajournal.cshlp.orgDownloaded from 
37
lethality. Finally, we noted that three of the four viable
Upf2 alleles were male sterile (data not shown), suggesting
a role for Upf2 in the male germline (Table 2). Whether
this role is directly related to its role in NMD has not yet
been determined.
We obtained four alleles of Upf1 but did not find that
any of them are compatible with viability (Table 1), sug-
gesting that even subtle perturbations in Upf1 structure are
disruptive to protein function. In addition to Upf1 and
Upf2, we isolated 11 alleles of Smg1. It has previously been
observed that complete loss of Smg1 leads to no effect on
viability and only a slight decrease in NMD function
(Chen et al. 2005; Metzstein and Krasnow 2006). Indeed,
we found that all 11 alleles were viable (Table 1).
Based on the large number of Upf1, Upf2, and Smg1
alleles, we believe that we have saturated the X chromo-
some for genes required for NMD and that can be mutated
by EMS, the chemical mutagen we used. Notably, we did
not isolate any alleles of CG32533, the Drosophila homolog
of the C. elegans gene smgl-2 (Longman et al. 2007), which
is located on the X chromosome. In addition to not
identifying mutations in CG32533 in our screen, we also
tested its function using an RNAi approach (A Chapin and
MM Metzstein, unpubl.) and did not detect an NMD
defect. Combined, these data suggest that smgl-2 does not
play a significant role in NMD in Drosophila. However,
since EMS mutagenesis and RNAi knockdown do not affect
all genes equally, it will be necessary to obtain mutations in
smgl-2 by some other means to definitively test the role of
this gene in NMD in Drosophila.
Third chromosome screen has isolated first
Drosophila alleles of Smg6
We screened the right arm of the third chromosome and
identified 13 mutants. Similar to the X chromosome, after
identifying the mutants with our mosaic approach, we studied
the role of the genes affected in wholly mutant animals. By
a complementation test with a chromosomal deficiency, we
found that six of our 13 lines were likely to be mutations in
Smg6 (Supplemental Fig. S1). In all cases, the Smg6 mu-
tation was viable in trans to the deficiency. These six alleles
also failed to complement each other (using the assay of
reporter expression) (Supplemental Fig. S1). Three of the
lines were viable as homozygotes. However, the remaining
three lines were homozygous lethal, suggesting that
extraneous lethal mutations are present on these chromo-
somes. The other seven lines complemented the deficiency
for both viability and reporter enhancement and will be
characterized further in a later study.
To identify the molecular changes in our candidate Smg6
alleles, we sequenced the Smg6 genomic locus in each of the
six mutant lines. A single mutation affecting the Smg6 gene
was identified in each line (Fig. 4A; Table 3). The identified
lesions are spread throughout the length of the Smg6 gene
and include premature termination codons, splice muta-
tions, and a single missense change. This missense change,
FIGURE 3. Characterization of Upf2 alleles. (A) Mutations in Upf2. Alleles shown above the gene model are hemizygous lethal; those below the
gene are hemizygous viable. 2-8A contains two mutations: a late glutamine to stop (black), as well as a serine-to-phenylalanine missense mutation
(gray). This latter change is in a nonconserved domain of Upf2, and we suspect it does not contribute to the Upf2 defect. (Filled boxes) Coding
sequences; (open boxes) 59 and 39 UTRs; (blue) bipartite Upf1 binding domain; (green) Upf3 binding domain; (purple) MIF4G domains (the
third one of which overlaps the Upf3 binding domain); (open arrow) direction of transcription. (B) Effect of viable Upf2 mutations on levels of
the PTC-containing transcript Adhn4 (Q83Stop). Values are the proportion of Adhn4 transcript relative to Adh+ transcript normalized to Upf225G,
in which Adhn4 is completely stabilized.
TABLE 2. Molecular analysis of Upf2 alleles
Allele Viability Mutation Residue change Male fertile
14-01-3M Lethal T1723A C575S N.A.
3-01-3R Lethal G1627A Q543Stop N.A.
7-5A Lethal A1694T K324Stop N.A.
C41 Lethal G1924A Q642Stop N.A.
2-8A Viable C1876T S384F No
C3298T Q1100Stop
4-5F Viable T494A L165Q No
C52 Viable T3065C L1022P No
13D Viable G175A A59T Yes
For mutation positions, bases are numbered with the A of the start
codon as 1, and introns are included. 7-5A appears to be identical
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found in the allele Smg62a, is of particular interest, because
it alters an invariantly conserved aspartate residue found in
all PIN domains (Fig. 4B) and is known from structural
studies to be part of the endonucleolytic catalytic core
(Glavan et al. 2006; Takeshita et al. 2007).
Complete loss of Smg6 still shows NMD-pathway
activity in Drosophila
To characterize the role of Drosophila Smg6 in NMD, we
analyzed mRNA levels of the well-characterized NMD
FIGURE 4. Molecular and phenotypic characterization of Smg6 alleles. (A) Mutations in Smg6. (Filled boxes) Coding sequences; (open boxes) 59
and 39 UTRs; (blue) 14-3-3-like protein binding domain; (green) PIN endonucleolytic cleavage domain; (open arrow) direction of transcription.
(B) Alignment of Smg6 PIN domains. These highly conserved domains are representative of PIN domains found in Smg6 and other PIN-domain-
containing proteins (Takeshita et al. 2007). (Dm) D. melanogaster; (Hs) Homo sapiens; (Ce) C. elegans. (*) Invariant catalytic residues; (gray
shading) residues conserved in all three species; (red shading) aspartic acid residue altered to a valine in Smg62a. (C) Effect of Smg6 mutations on
levels of the PTC-containing transcript Adhn4 (Q83Stop). Values are the proportion of Adhn4 transcript relative to Adh+ transcript normalized to
Upf225G, in which the Adhn4 is completely stabilized. Error bars indicate SD, n = 2. (D) Effect of Smg6 mutations on levels of the endogenous
NMD target tra in males. Levels for Smg6 alleles are normalized to FRT82B/Df animals; Smg132AP/Y and Upf225G/Y are normalized to FRT19A/Y.
Error bars indicate SEM, n = 3. (E) Percentage survival to adulthood of Smg6 mutants. Each of the alleles are in trans to an Smg6 deficiency. The
percentage is calculated relative to balancer-containing siblings. Error bars: 95% confidence interval of the binomial distribution. (F) Microarray
analysis of relative magnitude of NMD defects observed in Upf225G, Smg132AP, and two Smg6 alleles, Smg62a and Smg6292. For each mutant
genotype, we calculated transcript expression relative to its respective wild-type control. To compare the effect of different NMD genes with
transcript regulation, we first extracted targets that increased more than twofold in all four of our NMD-mutant conditions, giving a list of 87
genes (Supplemental Table S1). We then compared the magnitude of the increase observed in Smg132AP, Smg62a, and Smg6292 with that observed
in Upf225G. (Black bars) Transcripts that increased more in Upf225G relative to transcripts in Smg1 or Smg6; (gray bars) transcripts that increase
more in Smg1 or Smg6 alleles relative to Upf225G.
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target gene Adhn4, which contains a nonsense mutation
(Chia et al. 1987; Brogna 1999). Adhn4 has been shown to
be a bona fide NMD target in both cell culture and whole
animals (Brogna 1999; Gatfield et al. 2003; Chen et al.
2005; Metzstein and Krasnow 2006). Furthermore, Adh is
expressed in most, if not all Drosophila tissues (Chintapalli
et al. 2007), so by analyzing this gene we can assess the
role played by NMD in diverse cell types.
Steady-state mRNA levels depend on mRNA stability
and are thus a proxy for decay rates, and in Adhn4/Adh+
animals, Adhn4 mRNA is expressed at z10% of the amount
of the Adh+ transcript, due to NMD-dependent destabili-
zation of the mutant transcript (Brogna 1999; Chen et al.
2005; Metzstein and Krasnow 2006). We found that loss of
Smg6 function results in stabilization of the Adhn4 tran-
script to z30% of the amount of Adh+ transcript (Fig. 4C).
A similar degree of stabilization was observed in each of the
six Smg6 alleles in trans to a deficiency (Fig. 4C). In com-
parison, as previously reported, we found that Smg1mutants
had only a very slight effect on Adhn4 levels (Chen et al. 2005;
Metzstein and Krasnow 2006), whereas Upf225G, a strong
hypomorphic allele of the core NMD component Upf2 that
essentially abolishes NMD, leads to complete stabilization of
Adhn4 (Metzstein and Krasnow 2006). Loss of Smg6 leads to
considerably higher levels of Adhn4 than loss of Smg1, but
significantly, stabilization of Adhn4 in Smg6 is not nearly as
strong as that observed in Upf225G. This suggests that Smg6 is
not absolutely required for NMD in vivo. We found similar
results analyzing a PTC-containing allele of the develop-
mental gene eyes absent (eya) (Supplemental Fig. S2A).
To determine if any of our Smg6 alleles are definitively
null, we used the classic genetic test of comparing homozy-
gotes to the allele in trans to a deficiency. For this, we used
quantitative reverse transcription coupled PCR (qRT-PCR)
to measure the levels of the endogenous NMD-target gene
transformer (tra) in Smg6 mutant males (Fig. 4D) (this
analysis was possible using the alleles 292, 91a, and 2a, since
these were not associated with any linked lethal mutation).
Like Adh, tra is broadly expressed in Drosophila tissues and
has been shown to be a bona fide NMD target in both intact
animals (Metzstein and Krasnow 2006; Avery et al. 2011)
and S2 cell culture (Rehwinkel et al. 2005).
Similar to what we observed for Adhn4, we found that
loss of Smg6 function results in increased expression of tra
to a level intermediate between Smg1 and Upf225G. Of
particular note, we observed that the degree of stabilization
of tra was the same in Smg6292 homozygotes and Smg6292/
Df hemizygotes, defining this as a null allele. Additionally,
one of our other alleles, Smg652a, is predicted be a molecular
null, because it contains an early stop codon truncating the
coding region of Smg6 before any known functional do-
mains. Although we could not examine Smg652a homozy-
gotes due to a linked lethal mutation, we did find that
Smg652a displays a similar degree of tra stabilization in
trans to a deficiency, as does Smg6292. These results were
confirmed using two other endogenous NMD targets, Smg5
and Oda (Supplemental Fig. S2B; Gatfield and Izaurralde
2004; Rehwinkel et al. 2005; Avery et al. 2011). Thus, by both
molecular and genetic criteria, we have isolated the first
definitively null alleles of Smg6.
Interestingly, two of the Smg6 alleles that specifically
disrupt the PIN domain seem to retain residual activity.
Smg691a, a nonsense mutation just preceding the PIN
domain, and Smg62a, the missense mutation in the PIN
domain, have lower levels of tra stabilization than null
alleles, and this stabilization is increased when these alleles
are placed in trans to a deficiency (Fig. 4D; Supplemental
Fig. S2B). These results suggest that Smg6 has some
activity independent of the PIN domain and thus pre-
sumably independent of its role as an endonuclease.
In general, the severity of NMD mutations and organ-
ismal viability are correlated in Drosophila. The NMD genes
Upf1 and Upf2 are lethal as null alleles in Drosophila. The
strong hypomorphic allele of Upf225G is strongly disrupted
in NMD function, and mutant animals are only partially
viable, while a deletion of Upf3 has moderate effects on
NMD and is viable (Avery et al. 2011). Null alleles of Smg1
have mild effects on NMD and are fully viable (Chen et al.
2005; Metzstein and Krasnow 2006). We therefore investi-
gated the requirement for Smg6 for viability by analyzing
each of the Smg6 alleles in trans to a deficiency for their
survival to adulthood. In each case, loss of Smg6 leads to
only a moderate reduction in viability (Fig. 4E), further
demonstrating that Smg6 is not absolutely required for
NMD in Drosophila.
To determine on a more global level whether loss of
Smg6 activity had less effect on the NMD pathway than
loss of Upf2, we performed a microarray analysis. RNA
was extracted from Upf225G, Smg62a, and Smg6292 mu-
tant animals and hybridized to microarrays representing
the complete Drosophila transcriptome. We then tabu-
lated genes that increased twofold over matched wild-
type controls in all of our mutant conditions (Supple-
mental Table S1). We found that the large majority of
TABLE 3. Molecular analysis of Smg6 alleles







For mutation positions, bases are numbered with the A of the
start codon as 1, and introns are included. 70e is a 12-bp
deletion that removes the last two bases of the fourth exon
(uppercase) and 10 bp of the fourth intron (lowercase). 292 is
a point mutation that converts the G of the sixth intron splice
donor to an A.
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such genes had increased expression levels in Upf225G
mutants higher than the increase observed in Smg6
mutants (Fig. 4F). From this, we conclude that, for the
majority of endogenous NMD targets, Smg6 mutants still
possess residual NMD-pathway activity. When we tested
Smg132AP by the same assay, we found that it led to
generally lower levels of transcript stabilization com-
pared with Smg6 (Fig. 4F). These results are consistent
with our analysis of candidate transcripts, described
above.
Another phenotype associated with loss of NMD func-
tion in Drosophila is impairment of cell proliferation, both
in S2 cell culture as well as in vivo (Rehwinkel et al. 2005;
Metzstein and Krasnow 2006; Avery et al. 2011). We
examined cell proliferation mosaic analysis in the eye,
a technique that permits comparison of homozygous
mutant cell growth in the presence or absence of wild-
type cells (Stowers and Schwarz 1999). We find that,
similar to other NMD mutants (Metzstein and Krasnow
2006; Avery et al. 2011), Smg6 mutant cells are defective in
cell proliferation when in competition with wild-type
cells, as assayed by examination of mitotic clones within
the eye (Supplemental Fig. S4A–D). However, when com-
peting cells are removed, Smg6 mutant cells can essentially
proliferate as well as wild-type cells (Supplemental Fig.
S4E–H). These data show that while Smg6 is dispensable
for viability, it is still required for aspects of cell function
in vivo.
Conclusions
We have isolated point mutations in Drosophila Smg6,
which are the first mutant alleles of Smg6 characterized in
any organism since the initial identification of this gene in
C. elegans (Hodgkin et al. 1989). Since a number of our
Smg6 alleles clearly lack all function, this has allowed us to
assess the contribution of this gene to the NMD process in
vivo. We find that in Drosophila, Smg6 has only a moderate
role in targeting PTC-containing transcripts for degrada-
tion. In comparison, mutations in core NMD components,
such as Upf2, lead to complete stabilization of NMD targets
in vivo (Metzstein and Krasnow 2006; Avery et al. 2011).
Our results contrast with previous analysis of Smg6 in
Drosophila S2 cells using RNAi-mediated knockdown, in
which inactivation of Smg6 appeared to result in as strong
an effect on NMD targets as inactivation of other compo-
nents of the NMD pathway (Gatfield et al. 2003; Rehwinkel
et al. 2005). One explanation for this contradiction is that it
is not possible to assess the exact degree of gene in-
activation in RNAi knockdown experiments, making com-
parisons of the requirements of different genes in a process
difficult to assess.
It is interesting to compare our results of Smg6 muta-
tions in vivo with the study of this gene in other species. In
C. elegans, the organism in which Smg6 was first identified,
the NMD process seems to be as dependent on Smg6 as any
of the other NMD genes (Hodgkin et al. 1989). However,
because no description of the molecular nature of C. elegans
Smg6 alleles has been published, it is unknown if any of the
known alleles are null. Indeed, there is some evidence that
null alleles of C. elegans smg-6 are not viable, thus the alleles
allowing viable NMD-defective animals may indeed possess
residual function (Cali and Anderson 1998). In zebrafish,
Smg6 has been analyzed by morpholino knockdown in
intact fish and by expression of an Smg6 dominant-negative
construct in fish cell lines (Wittkopp et al. 2009). The
morpholino knockdown behaves very similarly to knock-
down of other NMD components, leading to early lethality
with distinct patterning and neural defects, suggesting that
Smg6 has similar roles to these other components in vivo.
However, because direct measurement of NMD-pathway
activity was not performed in the intact Smg6morphants, it
is possible that there is still residual pathway activity, as
observed in Drosophila. Measurements of NMD-pathway
activity were analyzed in fish cell culture and clearly show
a defect in NMD. Whether this defect is equivalent to
complete NMD-pathway loss was not analyzed.
Smg6 is an endonuclease that cleaves target mRNAs
around the site of the premature termination codon
(Huntzinger et al. 2008), and our data support this as an
important Smg6 function. All of our alleles of Smg6 are
predicted to disrupt the C-terminal endonucleolytic PIN
domain, including one that is a point mutation affecting
a key catalytic residue. However, since Smg6-null mutants
still show considerable NMD-pathway activity, this suggests
that in intact Drosophila there exists an Smg6-independent
degradation pathway. In yeast, NMD targets are thought to
be degraded by decapping followed by 59–39 exonucleolytic
degradation (Muhlrad and Parker 1994; He et al. 2003).
Inactivation of this pathway was shown not to have an
effect on NMD-mediated degradation in S2 cells (Gatfield
et al. 2003), but one possibility is that this mechanism is
only used in the absence of Smg6-mediated cleavage. Indeed,
mammalian cells are known to use multiple decay pathways
(Chen and Shyu 2003; Lejeune et al. 2003; Huang et al.
2011). Drosophila genetics may provide a powerful system
for identifying such alternative degradation pathways, be-
cause mutations in such genes would be predicted to act as
enhancers of the Smg6 phenotype.
Like Smg6, Smg1 is not absolutely required for NMD in
Drosophila (Chen et al. 2005; Metzstein and Krasnow
2006). Smg1 is a PIKK-family kinase that phosphorylates
the core NMD component Upf1 to provide a binding
platform for Smg6 (Kashima et al. 2006; Okada-Katsuhata
et al. 2012). If such binding were absolutely necessary for
Smg6 activity, we would expect that Smg1 mutations would
have at least as strong an NMD defect as Smg6 mutations.
However, we find just the opposite: Loss of Smg6 activity
leads to a significantly stronger NMD defect than loss of
Smg1, suggesting that Smg6 has activity independent of
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Smg1-mediated phosphorylation of Upf1. In mammalian
cells, Smg6 can interact with the NMD complex indepen-
dent of binding to phosphorylated Upf1 through interac-
tions between two N-terminal exon junction complex bind-
ing domains (Kashima et al. 2010). Drosophila is thought to
lack these domains, but it remains possible that Upf1-
phosphorylation-independent interactions can still occur.
Alternatively, the Drosophila genome may contain an al-
ternative kinase redundant with Smg1 that can phosphor-
ylate Upf1. This could explain why Smg1 has a relatively
weak affect on NMD in intact Drosophila and provide an
alternative mechanism of Smg6 entry into the NMD com-
plex. It should be possible to identify such a kinase by testing
other kinases in the Drosophila genome for synergistic effects
with Smg1 mutants on the NMD pathway.
Analysis of NMD in mammalian cells has suggested that
NMD is not a linear pathway, but potentially different
branches act in parallel to robustly regulate the abundance
of target mRNAs. For instance, there exist Upf3-dependent
and Upf3-independent NMD pathways targeting certain
nonsense transcripts in mammalian cells (Chan et al. 2007;
Yepiskoposyan et al. 2011). Our genetic screen and molec-
ular analysis presented here has also revealed that multiple
mechanisms function to regulate NMD in Drosophila. Finally,
the efficient screening method for NMD genes presented here
should be applicable to the entire Drosophila genome,
providing the opportunity to identify all of the compo-
nents contributing to these parallel mechanisms.
MATERIALS AND METHODS
Fly stocks
Drosophila melanogaster lines were raised at 25°C on cornmeal/
dextrose medium using standard conditions. Control chromo-
somes used for the screens were y w FRT19A and FRT82B (Xu and
Rubin 1993); the e22c-GAL4 and UAS-FLP stocks (Duffy et al.
1998) were used in all screen stocks to induce epidermal mosaics
using the GAL4/UAS system (Brand and Perrimon 1993) and
FLP/FRT systems (Xu and Rubin 1993). The nlsDsRed2::SV40
39UTR reporter transgene was provided by M. Galko (M.D.
Anderson Cancer Center). e22c-GAL4, UAS-nlsDsRed2::SV40
39UTR, UAS-FLP was built using standard recombination
methods (MM Metzstein, unpubl.). NMD alleles Upf225G,
Smg132AP, and Upf126A have been described previously (Metzstein
and Krasnow 2006). The breathless promoter btl-Gal4 was used in
combination with UAS-GFP as the reporter in the X-chromosome
complementation tests (Shiga et al. 1996). For the balancer
chromosomes, we used w*; ry506 Dr1/TM6B, P{Dfd-EYFP} Sb1
ca1 (Le et al. 2006) and FM7i, P{ActGFP}JMR3 (Reichhart and
Ferrandon 1998). Complementation tests and deficiency ex-
periments for Smg6 were performed using Df(3R)ED6220/TM6c
Tb, Sb (Ryder et al. 2007). Eye clones were generated using w;
ey-FLP; FRT82B P{w+ ry+}90E and y w; ey-GAL4, UAS-FLP;
FRT82B GMR-hid/TM6 (Stowers and Schwarz 1999). For NMD
tests, we used the PTC-containing alleles Adhn4 (Chia et al. 1987)
and eyacli-IID (Bui et al. 2000).
Mutagenesis and screen scheme
For mutagenesis, isogenized males were aged 1–3 d, starved
overnight, and fed 25 mM ethane methylsulfonate in 1% sucrose
for 24 h (Newsome et al. 2000). For the X-chromosome screen,
y w FRT19A/Y mutagenized males were mated en masse to y w
FRT19A; e22c-GAL4, UAS-nlsDsRed2::SV40 39UTR, UAS-FLP/
CyO virgins. F1 wandering third-instar larvae were collected in
glycerol and analyzed using a Leica MZ16 fluorescence stereo-
microscope. NMD mutants were identified by mosaic enhance-
ment of the DsRed reporter in the larval epidermis. Candidate
mutant F1 larvae were collected, rinsed in 13 PBS, placed in
individual vials, and allowed to complete development. Surviv-
ing F1’s were mated to sc cv ct v g f FRT
19A/Y, and F2 progeny
were retested for mosaic enhancement of DsRed expression;
mosaic animals were collected and mated to FM7c/Y males to
establish balanced mutant lines. We screened about 38,000
DsRed-expressing F1 animals. Of these, we expected 50% to be
females, which could exhibit mosaicism (the others are hemi-
zygous males and thus would not be expected to undergo FLP-
mediated recombination). We identified 122 mosaic larvae from
which we recovered 27 balanced mutant lines, representing a
recovery rate of z22%.
For the third chromosome, mutagenized w/Y; FRT82B males
were mated en masse to e22c-GAL4, UAS-nlsDsRed2::SV40 39UTR,
UAS-FLP /CyO; FRT82B virgins, and F1 animals were scored and
collected as described above. Candidate mutants were retested by
mating to y w; FRT82B Sb1/ TM6B ry Tb+ animals of the opposite
sex, and male progeny that retested were collected and mated to w;
Kr/CyO; D/ TM6c Tb, Sb or to w*; ry506 Dr1/TM6B, P{Dfd-EYFP},
Sb1 ca1 to establish mutant lines. We scored about 17,000 F1’s
(both males and females would be expected to be mosaics), and
we identified 81 mosaic larvae. Of these we were able to establish
13 balanced mutant lines, representing a recovery rate of z16%.
Complementation tests
X
There are three known NMD genes on the X chromosome with
previously isolated alleles (Metzstein and Krasnow 2006). Null
alleles of Upf1 and Upf2 are lethal, whereas null alleles of Smg1 are
viable (Chen et al. 2005; Metzstein and Krasnow 2006). Comple-
mentation tests were performed using these alleles. For Upf1
complementation tests, y w FRT19A */FM7c (where * indicates
EMS-induced mutation) virgins were mated to y w Upf113D
FRT19A/Dp(1;Y)BSC1[Upf1+] males, and F1 progeny were scored
for the absence of B+ females, which indicates failure to comple-
ment Upf1 for lethality. In cases in which complementation for
lethality occurred, the mutant lines were then crossed to y w
Upf113D FRT19A/Dp(1;Y)BSC1[Upf1+]; Btl-Gal4, UAS-GFP::SV40
39UTR/+ males, and F1 female third-instar larvae were scored for
enhancement of GFP. Failure to complement this phenotype
would have indicated that the candidate gene is a viable Upf1
hypomorph. However, we did not find any alleles of this class.
For Upf2 complementation tests, y w FRT*/FM7c virgins were
crossed to y w Upf214J v g f FRT19A/Y; P{w+, Upf2+}/+ males
(Metzstein and Krasnow 2006), and F1 animals were scored for the
absence of w B+ females, which indicates failure to complement
Upf2 for lethality. In cases in which complementation occurred,
Drosophila NMD screens
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the mutant lines were crossed to y w Upf214J v g f FRT19A/Y; P{w+,
Upf2+}/Btl-Gal4, UAS-GFP::SV40 39UTR males, and F1 female
third-instar larvae were scored for GFP enhancement. Failure to
complement indicates that the Upf2 allele is a viable hypomorph.
For Smg1 complementation tests, females from mutant lines were
crossed to y w Smg132AP FRT19A/Y; Btl-Gal4, UAS-GFP::SV40
39UTR/+ male larvae and were scored for GFP enhancement,
indicating failure to complement Smg1.
3R
Complementation tests were performed by crossing e22c-GAL4,
UAS-nlsDsRed2::SV40 39UTR, UAS-FLP/CyO; FRT82B*/TM6c Tb,
Sb females to Df(3R)ED6220/TM6c Tb, Sb animals, and third-
instar larvae were scored for DsRed enhancement. Lines that failed
to complement Smg6 were intercrossed to determine if the Smg6
mutations were lethal or had additional linked lethals.
RNA isolation and quantitative RT-PCR
Total RNA was isolated from five to 10 flash-frozen samples of
adult males using TRIzol reagent (Invitrogen) and phase-lock
tubes (5-prime), and the RNeasy mini kit (QIAGEN). Genomic
contamination was reduced by on-column DNase treatment
(Ambion). RNA concentration was determined using a spectropho-
tometer and normalized for reverse transcription using the MuMulv
reverse transcriptase Retroscript Kit (Ambion). Quantitative RT-
PCR was performed on a Bio-Rad iCycler thermocycler using SYBR
Green Supermix (Bio-Rad). All experimental reactions were per-
formed in triplicate with a minimum of three biological replicates.
For quantitation, samples were normalized to RpL32.
Analysis of Adhn4
Adhn4/CyO animals were mated to Df(3R)ED6220/TM6B, P{Dfd-
EYFP} Sb1 ca1. Males in the F1 generation Adh
n4/Adh+;
Df(3R)ED6220/+ were collected and mated to virgin FRT82B/
TM6B, P{Dfd-EYFP} Sb1 ca1 or FRT82B Smg6*/ TM6B, P{Dfd-
EYFP} Sb1 ca1 flies. Animals of genotype Adhn4/Adh+; FRT82B
Smg6*/Df(3R)ED6220 and Adhn4/Adh+; FRT82B/ Df(3R)ED6220
were collected by genotyping for the presence of the Adhn4.
Animals of genotypes Smg132AP/Y; Adhn4/Adh+ and Upf225G/Y;
Adhn4/Adh+ were collected in parallel. Two biological replicates
were collected for each genotype, and RNA isolation of five to
eight adult males was performed as described above. Samples
were normalized for RNA concentration and reverse-transcribed.
The cDNA from each sample was used as template DNA in a
PCR amplification of the Adh transcript. To distinguish the
Adh+ and Adhn4 alleles, the PCR product was digested using
PvuII and run on a 1% agarose gel (Supplemental Fig. S3). The
gels were imaged using an Alpha Innotech Gel Doc System and
quantitated using ImageJ (Abra`moff et al. 2004).
Analysis of eyacli-IID
eyacli-IID cn1 bw1 sp1/CyO males were mated to e22c-GAL4, UAS-
nlsDsRed2::SV40 39UTR/CyO; FRT82B*, where * represents Smg6+,
Smg62a, or Smg6292 virgins. Male progeny of genotype eyacli-IID cn1
bw1 sp1/ e22c-GAL4, UAS-nlsDsRed2::SV40 39UTR; FRT82B*/+
were mated to virgins of genotype Btl-Gal4, UAS-GFP::SV40
39UTR/+; Df(3R)ED6220/+. In the next generation, we collected
larvae of genotype eyacli-IID cn1 bw1 sp1/ Btl-Gal4, UAS-GFP::SV40
39UTR; FRT82B */Df(3R)ED6220 based on increased GFP expres-
sion (due to the Smg6 mutation) and a lack of DsRed expression.
A similar strategy was used on the X chromosome to collect larvae
that were either y w FRT19A or y w Upf225G FRT19A /Y; eyacli-IID cn1
bw1 sp1/ e22c-GAL4, UAS-nlsDsRed2::SV40 39UTR. RNA was
isolated as described above, reverse-transcribed, and amplified
using primers surrounding the eyacli-IID PTC mutation. We de-
termined the sequence of the RT-PCR product. eyacli-IID stabiliza-
tion was determined by measuring heights of the eya+ and eyacli-IID
sequencing peaks.
Microarray analysis
RNA was isolated from male larvae collected from 0 to 4 h after
the molt to third instar. To identify genotypes at this stage, we
used balancers marked with fluorescent reporters: ActGFP for the
X (Reichhart and Ferrandon 1998) and Dfd-EYFP for the third
(Le et al. 2006). For Smg6 experiments, we crossed FM7i,
P{ActGFP}JMR3/Y; Df(3R)ED6220/ TM6B, P{Dfd-EYFP} Sb1
ca1 males to either w; FRT82B/ TM6B, P{Dfd-EYFP} Sb1 ca1 or
w; Smg62a/ TM6B, P{Dfd-EYFP} Sb1 ca1, or w; Smg6292/ TM6B,
P{Dfd-EYFP} Sb1 ca1 virgins. For the X-chromosome NMD
genes, we crossed FM7i, P{ActGFP}JMR3/Y males to either y w
FRT19A or y w Smg132AP FRT19A, or y w Upf225G FRT19A/FM7i,
P{ActGFP}JMR3 virgins. Progeny from these crosses were staged,
and the appropriate genotypes were collected by scoring for the
absence of the fluorescent balancers. RNA from two biological
replicates of each genotype was reverse-transcribed, and the
cDNA was labeled with either Cy3 or Cy5 and hybridized to
Agilent 44K 2-color arrays. Data files were produced using
Agilent’s feature extraction software version 10.5. We normal-
ized each array to total signal.
Smg6 viability analysis
To test the viability of Smg6 alleles, virgin FRT82B or FRT82B Smg6*/
TM6B, P{Dfd-EYFP} Sb1 ca1 flies were mated to Df(3R)ED6220/
TM6B, P{Dfd-EYFP} Sb1 ca1 males, and progeny adults were ana-
lyzed for the presence and absence of the Sbmarker associated with
the balancer chromosome.
Eye clones
Mosaic eyes were generated by crossing w; ey-FLP; FRT82B P{w+
ry+}90E virgins to FRT82B or FRT82B* (where * is EMS-generated
mutation) males. Images at multiple planes were taken on an
Axioskop2 plus (Zeiss) microscope and analyzed using an ImageJ
stack analyzer and a stack focuser plug-in. Entirely mutant eyes
were generated by the GMR-hid technique (Stowers and Schwarz
1999).
SUPPLEMENTAL MATERIAL
Supplemental material is available for this article.
ACKNOWLEDGMENTS
We thank Michael Galko for UAS-nls:DsRed transgenes; Alex
Chapin and Jon Nelson for unpublished data; Shanhong Cheng,
Frizzell et al.
1484 RNA, Vol. 18, No. 8
 Cold Spring Harbor Laboratory Press on February 14, 2013 - Published by rnajournal.cshlp.orgDownloaded from 
43
Sarah Elliott, and Deborah Johnson for assistance in screening;
Barry Moore and Mark Yandell for help with array bioinfor-
matics; the Metzstein and Thummel laboratories for useful
discussions; and Gillian Stanfield, Carl Thummel, and members
of the Metzstein laboratory for their comments on the manuscript.
Fly stocks were obtained from the Bloomington Drosophila Stock
Center. This work was supported by National Institutes of Health
(NIH) University of Utah Developmental Biology Training Grant
5T32-HD07491 (to K.A.F.) and NIH 1R01GM084011 and a March
of Dimes Award 5-FY07-664 (to M.M.M).
Received February 20, 2012; accepted June 7, 2012.
REFERENCES
Abra`moff MD, Magalha˜es PJ, Ram SJ. 2004. Image processing with
ImageJ. Biophotonics international 11: 36–42.
Amrani N, Ganesan R, Kervestin S, Mangus DA, Ghosh S, Jacobson A.
2004. A faux 39-UTR promotes aberrant termination and triggers
nonsense-mediated mRNA decay. Nature 432: 112–118.
Anastasaki C, Longman D, Capper A, Patton EE, Ca´ceres JF. 2011.
Dhx34 and Nbas function in the NMD pathway and are required
for embryonic development in zebrafish. Nucleic Acids Res 39:
3686–3694.
Aronoff R, Baran R, Hodgkin J. 2001. Molecular identification of smg-4,
required for mRNA surveillance in C. elegans. Gene 268: 153–164.
Avery P, Vicente-Crespo M, Francis D, Nashchekina O, Alonso CR,
Palacios IM. 2011. Drosophila Upf1 and Upf2 loss of function
inhibits cell growth and causes animal death in a Upf3-indepen-
dent manner. RNA 17: 624–638.
Brand AH, Perrimon N. 1993. Targeted gene expression as a means of
altering cell fates and generating dominant phenotypes. Develop-
ment 118: 401–415.
Brogna S. 1999. Nonsense mutations in the alcohol dehydrogenase
gene of Drosophila melanogaster correlate with an abnormal 39 end
processing of the corresponding pre-mRNA. RNA 5: 562–573.
Bui QT, Zimmerman JE, Liu H, Bonini NM. 2000. Molecular analysis
of Drosophila eyes absent mutants reveals features of the conserved
Eya domain. Genetics 155: 709–720.
Cali BM, Anderson P. 1998. mRNA surveillance mitigates genetic
dominance in Caenorhabditis elegans. Mol Gen Genet 260: 176–184.
Cali BM, Kuchma SL, Latham J, Anderson P. 1999. smg-7 is required
for mRNA surveillance in Caenorhabditis elegans. Genetics 151:
605–616.
Chan W-K, Huang L, Gudikote JP, Chang Y-F, Imam JS, MacLean JA,
Wilkinson MF. 2007. An alternative branch of the nonsense-
mediated decay pathway. EMBO J 26: 1820–1830.
Chang Y-F, Imam JS, Wilkinson MF. 2007. The nonsense-mediated
decay RNA surveillance pathway. Annu Rev Biochem 76: 51–74.
Chen C-YA, Shyu A-B. 2003. Rapid deadenylation triggered by
a nonsense codon precedes decay of the RNA body in a mamma-
lian cytoplasmic nonsense-mediated decay pathway. Mol Cell Biol
23: 4805–4813.
Chen Z, Smith KR, Batterham P, Robin C. 2005. Smg1 nonsense
mutations do not abolish nonsense-mediated mRNA decay in
Drosophila melanogaster. Genetics 171: 403–406.
Chia W, Savakis C, Karp R, Ashburner M. 1987. Adhn4 of Drosophila
melanogaster is a nonsense mutation. Nucleic Acids Res 15: 3931.
doi: 10.1093/nar/15.9.3931.
Chintapalli VR, Wang J, Dow JAT. 2007. Using FlyAtlas to identify
better Drosophila melanogaster models of human disease. Nat
Genet 39: 715–720.
Chiu S-Y, Serin G, Ohara O, Maquat LE. 2003. Characterization of
human Smg5/7a: A protein with similarities to Caenorhabditis
elegans SMG5 and SMG7 that functions in the dephosphorylation
of Upf1. RNA 9: 77–87.
Clerici M, Moura˜o A, Gutsche I, Gehring NH, Hentze MW, Kulozik
A, Kadlec J, Sattler M, Cusack S. 2009. Unusual bipartite mode of
interaction between the nonsense-mediated decay factors, UPF1
and UPF2. EMBO J 28: 2293–2306.
Cui Y, Hagan KW, Zhang S, Peltz SW. 1995. Identification and
characterization of genes that are required for the accelerated
degradation of mRNAs containing a premature translational
termination codon. Genes Dev 9: 423–436.
Duffy JB, Harrison DA, Perrimon N. 1998. Identifying loci required
for follicular patterning using directed mosaics. Development 125:
2263–2271.
Eberle AB, Stalder L, Mathys H, Zamudio Orozco R, Mu¨hlemann O.
2008. Posttranscriptional gene regulation by spatial rearrangement
of the 39 untranslated region. PLoS Biol 6: e92. doi: 10.1371/
journal.pbio.0060092.
Eberle AB, Lykke-Andersen S, Mu¨hlemann O, Jensen TH. 2009.
SMG6 promotes endonucleolytic cleavage of nonsense mRNA in
human cells. Nat Struct Mol Biol 16: 49–55.
Fukuhara N, Ebert J, Unterholzner L, Lindner D, Izaurralde E, Conti
E. 2005. SMG7 is a 14-3-3-like adaptor in the nonsense-mediated
mRNA decay pathway. Mol Cell 17: 537–547.
Gatfield D, Izaurralde E. 2004. Nonsense-mediated messenger RNA
decay is initiated by endonucleolytic cleavage in Drosophila.
Nature 429: 575–578.
Gatfield D, Unterholzner L, Ciccarelli FD, Bork P, Izaurralde E. 2003.
Nonsense-mediated mRNA decay in Drosophila: At the intersec-
tion of the yeast and mammalian pathways. EMBO J 22: 3960–
3970.
Glavan F, Behm-Ansmant I, Izaurralde E, Conti E. 2006. Structures of
the PIN domains of SMG6 and SMG5 reveal a nuclease within the
mRNA surveillance complex. EMBO J 25: 5117–5125.
Grimson A, O’Connor S, Newman CL, Anderson P. 2004. SMG-1 is
a phosphatidylinositol kinase-related protein kinase required for
nonsense-mediated mRNA decay in Caenorhabditis elegans. Mol
Cell Biol 24: 7483–7490.
He F, Jacobson A. 1995. Identification of a novel component of the
nonsense-mediated mRNA decay pathway by use of an interacting
protein screen. Genes Dev 9: 437–454.
He F, Brown AH, Jacobson A. 1997. Upf1p, Nmd2p, and Upf3p are
interacting components of the yeast nonsense-mediated mRNA
decay pathway. Mol Cell Biol 17: 1580–1594.
He F, Li X, Spatrick P, Casillo R, Dong S, Jacobson A. 2003. Genome-
wide analysis of mRNAs regulated by the nonsense-mediated and
59 to 39 mRNA decay pathways in yeast. Mol Cell 12: 1439–1452.
Hodgkin J, Papp A, Pulak R, Ambros V, Anderson P. 1989. A new
kind of informational suppression in the nematode Caenorhabditis
elegans. Genetics 123: 301–313.
Huang L, Lou C-H, Chan W, Shum EY, Shao A, Stone E, Karam R,
Song H-W, Wilkinson MF. 2011. RNA homeostasis governed by
cell type-specific and branched feedback loops acting on NMD.
Mol Cell 43: 950–961.
Huntzinger E, Kashima I, Fauser M, Saulie`re J, Izaurralde E. 2008.
SMG6 is the catalytic endonuclease that cleaves mRNAs contain-
ing nonsense codons in metazoan. RNA 14: 2609–2617.
Hwang J, Maquat LE. 2011. Nonsense-mediated mRNA decay (NMD)
in animal embryogenesis: To die or not to die, that is the question.
Curr Opin Genet Dev 21: 422–430.
Kadlec J, Izaurralde E, Cusack S. 2004. The structural basis for the
interaction between nonsense-mediated mRNA decay factors
UPF2 and UPF3. Nat Struct Mol Biol 11: 330–337.
Kashima I, Yamashita A, Izumi N, Kataoka N, Morishita R, Hoshino
S, Ohno M, Dreyfuss G, Ohno S. 2006. Binding of a novel SMG-1-
Upf1-eRF1-eRF3 complex (SURF) to the exon junction complex
triggers Upf1 phosphorylation and nonsense-mediated mRNA
decay. Genes Dev 20: 355–367.
Kashima I, Jonas S, Jayachandran U, Buchwald G, Conti E, Lupas AN,
Izaurralde E. 2010. SMG6 interacts with the exon junction
complex via two conserved EJC-binding motifs (EBMs) required
for nonsense-mediated mRNA decay. Genes Dev 24: 2440–2450.
Drosophila NMD screens
www.rnajournal.org 1485
 Cold Spring Harbor Laboratory Press on February 14, 2013 - Published by rnajournal.cshlp.orgDownloaded from 
44
Kere´nyi Z, Me´rai Z, Hiripi L, Benkovics A, Gyula P, Lacomme C, Barta
E, Nagy F, Silhavy D. 2008. Inter-kingdom conservation of mecha-
nism of nonsense-mediated mRNA decay. EMBO J 27: 1585–1595.
Kerte´sz S, Kere´nyi Z, Me´rai Z, Bartos I, Pa´lfy T, Barta E, Silhavy D.
2006. Both introns and long 39-UTRs operate as cis-acting
elements to trigger nonsense-mediated decay in plants. Nucleic
Acids Res 34: 6147–6157.
Le T, Liang Z, Patel H, Yu MH, Sivasubramaniam G, Slovitt M,
Tanentzapf G, Mohanty N, Paul SM, Wu VM, et al. 2006. A new
family of Drosophila balancer chromosomes with a wdfd-GMR
yellow fluorescent protein marker. Genetics 174: 2255–2257.
Lee BS, Culbertson MR. 1995. Identification of an additional gene
required for eukaryotic nonsense mRNA turnover. Proc Natl Acad
Sci 92: 10354–10358.
Leeds P, Peltz SW, Jacobson A, Culbertson MR. 1991. The product of
the yeast UPF1 gene is required for rapid turnover of mRNAs
containing a premature translational termination codon. Genes
Dev 5: 2303–2314.
Leeds P, Wood JM, Lee BS, Culbertson MR. 1992. Gene products that
promote mRNA turnover in Saccharomyces cerevisiae.Mol Cell Biol
12: 2165–2177.
Lejeune F, Maquat LE. 2005. Mechanistic links between nonsense-
mediated mRNA decay and pre-mRNA splicing in mammalian
cells. Curr Opin Cell Biol 17: 309–315.
Lejeune F, Li X, Maquat LE. 2003. Nonsense-mediated mRNA decay
in mammalian cells involves decapping, deadenylating, and exo-
nucleolytic activities. Mol Cell 12: 675–687.
Longman D, Plasterk RHA, Johnstone IL, Ca´ceres JF. 2007. Mecha-
nistic insights and identification of two novel factors in the C.
elegans NMD pathway. Genes Dev 21: 1075–1085.
Luke B, Azzalin CM, Hug N, Deplazes A, Peter M, Lingner J. 2007.
Saccharomyces cerevisiae Ebs1p is a putative ortholog of human
Smg7 and promotes nonsense-mediated mRNA decay. Nucleic
Acids Res 35: 7688–7697.
Metzstein MM, Krasnow MA. 2006. Functions of the nonsense-
mediated mRNA decay pathway in Drosophila development. PLoS
Genet 2: e180. doi: 10.1371/journal.pgen.0020180.
Muhlrad D, Parker R. 1994. Premature translational termination
triggers mRNA decapping. Nature 370: 578–581.
Newsome TP, Asling B, Dickson BJ. 2000. Analysis of Drosophila
photoreceptor axon guidance in eye-specific mosaics. Development
127: 851–860.
Okada-Katsuhata Y, Yamashita A, Kutsuzawa K, Izumi N, Hirahara F,
Ohno S. 2012. N- and C-terminal Upf1 phosphorylations create
binding platforms for SMG-6 and SMG-5:SMG-7 during NMD.
Nucleic Acids Res 40: 1251–1266.
Page MF, Carr B, Anders KR, Grimson A, Anderson P. 1999. SMG-2 is
a phosphorylated protein required for mRNA surveillance in
Caenorhabditis elegans and related to Upf1p of yeast. Mol Cell
Biol 19: 5943–5951.
Rehwinkel J, Letunic I, Raes J, Bork P, Izaurralde E. 2005. Nonsense-
mediated mRNA decay factors act in concert to regulate common
mRNA targets. RNA 11: 1530–1544.
Reichhart JM, Ferrandon D. 1998. Green balancers. Drosoph Inf Serv
81: 201–202.
Ryder E, Ashburner M, Bautista-Llacer R, Drummond J, Webster J,
Johnson G, Morley T, Chan YS, Blows F, Coulson D, et al. 2007.
The DrosDel deletion collection: A Drosophila genomewide chro-
mosomal deficiency resource. Genetics 177: 615–629.
Serin G, Gersappe A, Black JD, Aronoff R, Maquat LE. 2001.
Identification and characterization of human orthologues to
Saccharomyces cerevisiae Upf2 protein and Upf3 protein (Cae-
norhabditis elegans SMG-4). Mol Cell Biol 21: 209–223.
Shiga Y, Tanaka-Matakatsu M, Hayashi S. 1996. A nuclear GFP/
b-galactosidase fusion protein as a marker for morphogenesis in
living Drosophila. Dev Growth Differ 38: 99–106.
Stowers RS, Schwarz TL. 1999. A genetic method for generating
Drosophila eyes composed exclusively of mitotic clones of a single
genotype. Genetics 152: 1631–1639.
Swisher KD, Parker R. 2011. Interactions between Upf1 and the
decapping factors Edc3 and Pat1 in Saccharomyces cerevisiae. PLoS
ONE 6: e26547. doi: 10.1371/journal.pone.0026547.
Takeshita D, Zenno S, Lee WC, Saigo K, Tanokura M. 2007. Crystal
structure of the PIN domain of human telomerase-associated
protein EST1A. Proteins 68: 980–989.
Wittkopp N, Huntzinger E, Weiler C, Sauliere J, Schmidt S, Sonawane
M, Izaurralde E. 2009. Nonsense-mediated mRNA decay effectors
are essential for zebrafish embryonic development and survival.
Mol Cell Biol 29: 3517–3528.
Xu T, Rubin GM. 1993. Analysis of genetic mosaics in developing and
adult Drosophila tissues. Development 117: 1223–1237.
Yepiskoposyan H, Aeschimann F, Nilsson D, Okoniewski M,
Mu¨hlemann O. 2011. Autoregulation of the nonsense-mediated
mRNA decay pathway in human cells. RNA 17: 2108–2118.
Frizzell et al.
1486 RNA, Vol. 18, No. 8















Biochemical analysis of nonsense mediated decay (NMD) has relied on a set of 
NMD genes that were originally identified in screens performed in yeast and C. elegans 
(Cali et al., 1999; Cui et al., 1995; Hodgkin et al., 1989; Leeds et al., 1991; 1992; 
Yamashita et al., 2009).  A subsequent screen using RNAi-based methods in C. elegans 
identified two additional factors that appear to be required for NMD.  These genes, called 
smgl-1 and smgl-2 (Longman et al., 2007; Rosains and Mango, 2012), are conserved in 
zebrafish (Anastasaki et al., 2011; Frizzell et al., 2012) and mammals (Cali et al., 1999; 
Longman et al., 2007), but their function in NMD is not well understood.  
Coimmunoprecipitation experiments with SMG-1 in HeLa cells identified SMG-8 and 
SMG-9 as protein interactors (Metzstein and Krasnow, 2006; Yamashita et al., 2009), 
which have been proposed to function in NMD.  However, a conserved functional role 
for these proteins in NMD in intact organisms has not been demonstrated.  Indeed, 
genetic analysis in C. elegans recently showed that smg-8 does not contribute to NMD in 
that organism (Rosains and Mango, 2012; Xu and Rubin, 1993). 
 We have performed forward genetic screens for genes functionally involved in 
nonsense mediated decay in Drosophila (Frizzell et al., 2012).  These screens are the first 
mutagen-based forward genetic screens since those performed in C. elegans that led to 
the identification of smg-7 (Cali et al., 1999; Frizzell et al., 2012) and are also the first 
specifically designed to identify NMD genes in Drosophila.  Our screening strategy 
utilizes an NMD-sensitive mRNA reporter (Frizzell et al., 2012; Metzstein and Krasnow, 
2006).  When this reporter is expressed in an NMD-deficient cell, fluorescent expression 
is drastically enhanced.  We screened the X and right arm of the third chromosome (3R) 
using a mosaic approach, which allowed for the identification of both viable and lethal 
alleles of genes that are involved in NMD (Xu and Rubin, 1993).  We identified multiple 
alleles on the X chromosome, all of which were alleles of the three previously identified 
NMD genes on this chromosome (Frizzell et al., 2012; Metzstein and Krasnow, 2006); 
therefore, the X chromosome is saturated for NMD genes identifiable by our methods.  
The screen on 3R resulted in the isolation of the first alleles of the known NMD gene 
Smg6 in Drosophila, and are described in Chapter 2 and 4 of this thesis (Frizzell et al., 
2012; Shiga et al., 1996).  Seven lines on 3R complemented Smg6 for NMD reporter 
enhancement and, since there are no other orthologs of previously identified NMD genes 
on this chromosome, these lines likely contain mutations in novel NMD genes.  This 









Materials and methods 
Fly stocks 
D. melanogaster lines were raised at 25°C on cornmeal/dextrose medium using 
standard conditions.  Complementation tests were performed using alleles described in 
(Frizzell et al., 2012), including e22c-GAL4, UAS-nlsDsRed2::SV40 3’UTR, UAS-
FLP/CyO; FRT82B Smg6292/TM6c Tb, Sb.  The control chromosome used was FRT82B 
(Frizzell et al., 2012; Xu and Rubin, 1993).  DrosDel deletions were obtained from the 
Bloomington Drosophila stock center and are listed in Table 3.2.  The UAS-eGFP:SV40 
3’UTR transgene was cloned as described in Chapter 5 and by (Metzstein and Krasnow, 
2006; Venken et al., 2009).  The breathless promoter btl-Gal4 (Shiga et al., 1996; 
Venken et al., 2009) was used in combination with UAS-GFP as the reporter in the 
CG33970 RNAi tests.  CG33970 RNAi lines w1118; P{GD297}v33088, w1118; 
P{GD7619}v38660/CyO, w1118; P{GD7619}v38661, w1118; P{GD297}v46838/CyO, and 
P{KK109988}VIE-260B and the Upf2 RNAi w1118 P{GD9763}v33507 were obtained 
from the Vienna Drosophila RNAi center (Dietzl, 2007).  Act5c-GAL4 was acquired from 




The X chromosome and right arm of the third chromosome (3R) were screened as 
described in (Frizzell et al., 2012; Venken et al., 2006).  Complementation tests on 3R 
were performed by crossing e22c-GAL4, UAS-nlsDsRed2::SV40 3’UTR, UAS-FLP/CyO; 
FRT82B*/TM6c Tb, Sb females (where * is the mutant being tested) to 
Df(3R)ED6220/TM6c Tb, Sb, or to e22c-GAL4, UAS-nlsDsRed2::SV40 3’UTR, UAS-
48
FLP/CyO; FRT82B Smg6292/TM6c Tb, Sb animals and scoring for DsRed enhancement in 
third-instar larvae.  The deficiency Df(3R)ED6220 removes approximately 644 kb of 3R, 
including the Smg6 transcriptional unit along with ~115 other predicted genes.  Smg6 
mutants, which fail to complement Df(3R)ED6220 for enhanced DsRed expression, are 
described in (Frizzell et al., 2012; Rees et al., 2009).  Seven lines on 3R complemented 
the NMD reporter enhancement when crossed to e22c-GAL4, UAS-nlsDsRed2::SV40 
3’UTR, UAS-FLP/CyO; FRT82B Smg6292/TM6c Tb, Sb mutant animals (Fig. 3.1).  To 
establish complementation groups, the lines were mated inter se and scored for loss of the 




A minimal set of deficiencies from the DrosDel (ED) deficiency collection were 
identified that tile across most of the right arm of the third chromosome (Table 3.2).  The 
deficiency stocks contain a balancer chromosome identifiable by the dominant bristle 
marker Sb.  Complementation tests were performed by crossing these deficiencies to 
FRT82B 44b /TM6c Tb Sb, a representative allele from the lethal complementation group, 
and scoring for failure to lose the balancer chromosome.  A single deficiency, 
Df(3R)ED6232, was identified that failed to complement the lethality associated with 44b.  
The other four lethal lines were crossed to ED6232, and were found to fail to complement 
for lethality.  Additional deficiencies (Table 3.2) were then used to further narrow down 






Sequence analysis of lethal complementation group candidate genes 
By deficiency mapping, the lethality associated with the lethal complementation 
group was mapped to a 181 kb region of 3R that contained twelve genes.  Tiling primers 
were designed using Primer3 (http://frodo.wi.mit.edu) across the open reading frames of 
each of these genes (Table 3.2).  For a template, each of the mutant lines was mated to 
the original FRT82B isogenized chromosome.  Individual nonbalancer adult flies were 
collected and DNA was isolated using a proteinase K protocol.  The sequencing primers 
were used to amplify ~500 bp amplicons, which were visualized on a 1% agarose gel 
using an Alpha Innotech Gel Doc System.  If a single band was present, the sample was 
treated with exo-SapIt (Affymetrix) and sequenced.  For primers that resulted in multiple 
bands, the band of the correct size was excised from the agarose gel and purified using a 
gel purification kit (Qiagen), and then sequenced (Fig. 3.2). 
 
 
Mosaic analysis of different fluorescent reporters in lethal  
group mutants 
To determine if the lethal complementation group affected NMD function, I tested 
reporter enhancement using a different fluorescent reporter.  For this assay e22c-GAL4, 
UAS-nlsDsRed2::SV40 3’UTR, UAS-FLP/CyO; FRT82B 56c /TM6c Tb, Sb or e22c-GAL4, 
UAS-nlsDsRed2::SV40 3’UTR, UAS-FLP/CyO; FRT82B 44b /TM6c Tb, Sb animals were 
mated to UAS-eGFP::SV40 3’UTR animals; Sb+ wandering third-instar larvae were 
collected that expressed both eGFP and DsRed reporters, heat fixed, and imaged using a 
Leica MZ16 fluorescence stereomicroscope and Leica DFC340 FX imager (Fig. 3.3 B,C).  
A Smg6 mutant, e22c-GAL4, UAS-nlsDsRed2:SV40 3’UTR, UAS-FLP/CyO; FRT82B 
50
Smg6292/TM6c Tb, Sb, was also mated and collected to show the eGFP fluorescence can 




 To knock down CG33970 using RNAi, five RNAi lines were mated to Btl-Gal4 
UAS-eGFP::SV40 3’UTR to test for NMD reporter enhancement.  Fluorescent animals 
were collected in glycerol and examined on a Leica MZ16 fluorescence stereomicroscope.  
All five RNAi lines were also mated to Act5c-GAL4 to test for adult lethality.   
 
 
Genomic rescue of CG33970 
 To clone a genomic rescue construct of CG33970, two BAC clones, CH321-
93I23 and CH321-44M01, were ordered from the BACPAC Genomic Resource Center 
(BPRC).  These clones were from the CHORI-321 collection of 83 kb average clone sizes 
(Duffy et al., 1998; Venken et al., 2009) in order to encompass the large ~47 kb gene 
region of CG33970.  The clones were grown according to the P[acman] protocol (Venken 
et al., 2009; Weaver and Krasnow, 2008) and plasmids were purified using the a large 
construct kit (Qiagen).  The CH321-44M1 clones were sent for injection by Genetic 
Services Inc.  Two injection sites were used, attp16 and attp40 (Venken et al., 2006; 
Weaver and Krasnow, 2008).  
 
 
cDNA rescue construct of CG33970 
 A cDNA clone encompassing CG33970 was ordered from the DGRC, clone # 
R14039, and transformed into TOP10 cells.  Plasmids were isolated using the QIAprep 
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spin miniprep kit (Qiagen) and the cDNA was amplified using primers with NotI and StuI 
restriction enzyme sites incorporated, CG33970cDNA L1 (GAAGGCGGCCGCATG) 
and CG33970cDNA R1 (GAAGAGGCCTTTCGGCAAAGTTTTTCTATC).  The 2,759 
bp amplicon was amplified using phusion high fidelity polymerase (NEB), digested using 
NotI and StuI (NEB), and ligated into pUAST attB (a gift from Jyoti Misra, Thummel lab).  
The resulting plasmid was then transformed into TOP10 cells (Invitrogen), sequenced, 
and restriction digested to verify the insert was correctly cloned into the vector.  The 
plasmid was then isolated using the plasmid midi kit (Qiagen) and prepared for injection 
using Genetic Services Inc. 
 
 
Imaging nonlethal complementation group alleles 
 Two alleles on 3R complemented both Smg6 and the lethal complementation 
group (Fig. 3.1).  Mosaics of these alleles were made by mating e22c-GAL4, UAS-
nlsDsRed2::SV40 3’UTR, UAS-FLP/CyO; FRT82B 49c or 92c /TM6c Tb, Sb males to 
FRT82B females.  Wandering third-instar larvae that had mosaic expression of DsRed 
were collected, heat fixed, and imaged using a Leica MZ16 fluorescence 




Mutations in the lethal complementation group map to the novel gene,  
CG33970 
To determine the identity of the gene causing lethality in the lethal 
complementation group, coding regions of 12 genes uncovered by deficiencies on 3R 
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were sequenced, revealing missense mutations in a single gene, CG33970 (Fig. 3.2 B).  
CG33970 is a predicted ABC transporter consisting of six transmembrane domains and 
an ATP binding cassette (Rees et al., 2009; Venken and Bellen, 2005; Venken et al., 
2006; 2009).  The lethal complementation group consists of five lines, four of which, 44b, 
44c, 43d, and 50a, encode the same missense mutation.  This mutation, C1883T, converts 
a serine to a phenylalanine at a moderately conserved residue in a predicted 
transmembrane domain (Fig. 3.2 B,C).  A single line, 56c, contains a distinct mutation in 
the same gene, G619A, which converts an aspartic acid to an asparagine in a highly 
conserved residue of a Walker domain in the ATP binding cassette.  The mutation in 56c 
is predicted to prevent ABC-transporter function (Fig 3.2 B,C).   
 
 
Mutations in CG33970 may not cause an NMD-defect 
One problem with the analysis of the lethal complementation group is that 
mapping was based on viability (Fig. 3.1), not complementation of an NMD defect.  
Therefore, it is not clear if the lethality associated with this complementation group is 
also responsible for the NMD defect.  I next tested if the lethal lines exhibit a hemizygous 
NMD defect that was detectable earlier in development.  A mutant line carrying the 
reporter was placed in trans to the deficiency that failed to complement lethality.  The 
resulting embryos were examined for enhanced reporter fluorescence (data not shown), 
which would indicate the NMD defect was associated with the lethality-mapped 
deficiency region.  However, mutant/Df lines exhibit embryonic lethality and while e22c-
GAL4 drives expression ubiquitously in embryos (Duffy et al., 1998; Venken et al., 2006; 
2009), the early lethality does not provide enough time for DsRed to mature, and no 
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fluorescent signal could be detected (Dean and Annilo, 2005; Weaver and Krasnow, 
2008).  These two difficulties made it impossible to determine if the NMD defect and 
lethal defect were linked using this assay.  In future work, this experiment could be done 
using a GFP-based NMD assay, as the maturation time of GFP is significantly less than 
that of DsRed (Rees et al., 2009; Weaver and Krasnow, 2008). 
 Another explanation for these lethal alleles not exhibiting an NMD defect is that 
the mosaic cells have a modestly different phenotype than other NMD mosaics.  First, the 
nuclei appear smaller than neighboring nuclei.  Second, mutant clones show very weak, 
albeit reproducible, reporter enhancement; I was able to positively identify them in 
several retests.  To verify the mosaic enhancement in the lethal complementation group is 
indeed an NMD defect and not a concentration of the DsRed protein caused by a 
condensed nucleus, the mutants were crossed to a different set of NMD reporters, which 
utilize the fluorescent transgene GFP instead of DsRed.  This GFP transgene has been 
used before to identify NMD-mutant mosaic cells.  As a positive control, I tested this 
transgene in a Smg6 mutant and was able to positively identify enhanced nuclear 
localized DsRed as well as enhanced cytoplasmically localized GFP in the same mosaic 
cells (Fig 3.3A).  When this test was performed in two lethal lines, 44b and 56c, the 
DsRed enhancement was weak, but identifiable.  However, the GFP showed no clear 
enhancement (Fig. 3.3 B,C).  
 
 
RNAi knockdown of CG33970 does not cause NMD defects 
 To test if loss of CG33970 is sufficient to cause enhancement of an NMD-
sensitive reporter, RNAi knock down of CG33970 was performed.  Five RNAi lines 
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directed against CG33970 were mated to Btl-Gal4 UAS-eGFP::SV40 3’UTR to determine 
if knockdown of CG33970 in the tracheal system results in enhancement of the GFP 
reporter.  I found none of these lines resulted in a visible enhancement of the GFP 
reporter (data not shown).  As a control, Upf2 RNAi was also crossed to Btl-Gal4 UAS-
eGFP:SV40 3’UTR, which resulted in increased GFP fluorescence in the trachea (data 
not shown).  As a second control, each of the CG33970 RNAi lines was crossed to Act5c-
GAL4 to test if ubiquitous CG33970 knockdown causes lethality, as would be expected 
based on the recovered alleles.  Of the five lines, only one, w1118; 




 To test if mutations in CG33970 indeed cause lethality in these lines, I made two 
attempts at cloning rescue constructs for CG33970.  First, I attempted to make a genomic 
rescue construct of CG33970.  To clone a rescuing construct I utilized the BACPAC 
clonal library, which consists of large, 83 kb on average, BAC-clones that contain the 
sequence.  This allowed for site specific integration using the P[acman] cloning and 
integration system (Dean et al., 2001; Venken and Bellen, 2005; Venken et al., 2006; 
2009).  Two injection sites were attempted with multiple injections; however, neither 
injection site resulted in the incorporation of a stable construct.  Failure to incorporate 
into the genome was verified by the lack of w+ transgene that marks the clone and lack of 
detectable transgene insertion via PCR of the BAC clone ends (data not shown).  
Attempts at rescue using any animals with portions of these constructs resulted in whole 
animal lethality.  The failure to isolate lines of this construct could have resulted for 
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several reasons: first, the efficiency of large >50 kb clones is low using this technique (2-
4% transformation efficiency) (Venken et al., 2006; 2009).  To overcome this obstacle we 
injected clones multiple times in different locations in the genome, but were unsuccessful 
in isolating a stable genomic rescue line.  Second, the presence of extra copies of 
CG33970 may not be tolerated for viability.  To avoid this possibility, I made a UAS-
CG33970 expression vector.  Perhaps this smaller vector encoding only the cDNA of 
CG33970 will provide an answer as to whether lethality of CG33970 can be rescued by 
expression of this gene.  This construct must still be injected and stable lines must be 
made to test whether CG33970 is the gene responsible for lethality in this interval.  
Additionally, more cloning attempts and integration sites could be tried to rescue 
CG33970.  Another route could be to test whether CG33970 is directly involved in NMD 
in S2 cells.  If so, this is an interesting candidate to continue rescue attempts, and if not, 
this may be a gene that needs no further analysis in our laboratory.   
 
 
Nonlethal complementation group genes 
 Out of the seven lines isolated on 3R that complemented Smg6, two lines 
complemented the lethality associated with the lethal complementation group.  These 
lines are called 92c and 49c.  These lines also complement each other for lethality and for 
reporter enhancement (Fig. 3.1), indicating they represent two potentially novel NMD 
genes.  49c displays a weak mosaic phenotype (Fig. 3.4), while 92c displays a variable 
weak to strong mosaic phenotype (Fig. 3.4).  These alleles occasionally have adult 
escapers, however, the frequency has not been quantified.  Mapping of these alleles 
should be performed using the minimal deficiency collection (Table 3.1) and would be 
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especially efficient if a fluorescent reporter were established in the mutant lines to test for 




 Mapping lethality and sequence analysis have thus far resulted in the 
identification of CG33970, a previously uncharacterized gene in Drosophila, whose 
potential role in NMD remains elusive.  Sequence and homology analysis suggest 
CG33970 belongs to the ABC transporter superfamily (Dean and Annilo, 2005).  ABC 
transporters are an extensive family of transmembrane proteins that translocate a variety 
of substances across both intra- and extra-cellular membranes (Rees et al., 2009).  
CG33970 belongs to a group, denoted ABCH, that contains only two other Drosophila 
genes.  Both of these are also uncharacterized and their domains more closely resemble 
prokaryotic domains than eukaryotic ABC domains (Dean et al., 2001).  Protein 
homology suggests CG33980 is conserved in invertebrates, but is not found in vertebrate 
lineages.  Intriguingly, the most closely related transporter in E. coli is a ribosome bound 
ABC transporter called RbbA, encoded by the transcriptional unit yhih (Cali et al., 1999; 
Cui et al., 1995; Dean and Annilo, 2005; Hodgkin et al., 1989; Kiel and Ganoza, 2001; 
Kiel et al., 1999; Leeds et al., 1991; 1992), which may function in ribosome translation 
termination (Longman et al., 2007; Xu et al., 2006).  A possible conservation of function 
between these two genes raises the possibility that CG33970 could be involved in an 
early step of NMD, potentially during translation termination and recognition of the 
premature termination codon.  If this were the case, the weak NMD defect might be due 
to compensation by other standard factors required for translation termination.  This 
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could also be a transcript-specific mechanism, which might explain the lack of enhanced 
GFP in mosaic epidermal cells, while DsRed is enhanced.  Another interesting possibility 
is the transmembrane domains of CG33970 could potentially link NMD to a specific 
organelle, like the endoplasmic reticulum, to allow for more localized regulation of RNA 
metabolism.  Localization of NMD components with the endoplasmic reticulum has been 
observed in C. elegans and HeLa cells (Anastasaki et al., 2011; Sakaki et al., 2012); thus, 
the discovery of CG33970 could represent an NMD factor that localizes NMD function 
to a particular organelle, potentially during times of stress.  Local regulation of 
translation and decay is a common feature of RNA control, indeed, this has been 
observed in neurons with NMD-targeted transcripts (Long et al., 2010; Longman et al., 
2007; Moore, 2005). 
Identification of mutations in a gene is not sufficient evidence that the particular 
gene plays a role in that process.  The gene should be capable of rescuing the mutant 
phenotype, and if this is not possible, a secondary loss of function method provides more 
evidence for the role of the gene in a given process.  In this case, several lines of evidence 
suggest CG33970 may not be involved in NMD.   
While two independent mutations were identified in CG33970, four lines 
contained the same coding change.  There are three possible explanations that may 
explain the presence of the same mutation in four lines.  First, the mutation could occur in 
a highly mutable region of the genome.  Second, the four lines may have been duplicated 
from a single isolated mutation.  A duplication of a line would be the result of human 
error, which, while possible, seems highly unlikely as two of the lines were isolated 
during independent rounds of screening.  Third, the mutations in CG33970 could be 
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SNPs present in the background of the mutagenized stocks.  This is unlikely as the 
parental stocks were isogenized and sequencing parental chromosomes did not reveal 
SNPs in CG33970 (data not shown).  However, not enough animals (one representative 
of each male and female) were sequenced to make a population level conclusion.  The 
presence of a SNP in CG33970 still could also be the result of the way these mutations 
were mapped, as complementation tests mapped lethality associated with these lines and 
assumed that the NMD defect was lethal.  There is a chance that the lethality of these 
lines is not associated with the putative NMD defect, resulting in the identification of an 
extraneous lethal mutation  
Another line of evidence that these alleles may not actually disrupt NMD function 
is that they exhibit weak nlsDsRed2 reporter stabilization in mosaics when compared to 
other NMD mutants.  When the lethal mutants were tested for stabilization of a different 
fluorescent reporter, no stabilization in homozygous mutant cells was observed.  The lack 
of stabilization of the GFP reporter in mosaic cells (recognized by DsRed enhancement) 
could have been caused by the diffuse localization of the GFP reporter, which may have 
prohibited detection of reporter stabilization using this technique.  One way to address 
whether CG33970 has an NMD defect would be to use a nuclear GFP; however, this will 
not differentiate between a defect in reporter accumulation due to other defects, like 
nuclear export, therefore, other methods to validate the role if this gene in NMD must be 
used.  These data support a non-NMD role for the defect in CG33970, as the cytoplasmic 
GFP reporter is clearly stabilized in other NMD mutants, such as Smg6.   
Another way to test if CG33970 is involved in NMD is RNAi knockdown of the 
transcript.  Five independent RNAi lines were crossed to NMD reporter lines, none of 
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which caused any detectable visible defects, however, more controls must be done to 
verify this result.  First, knock down of CG33970 needs do be verified using qRT-PCR.  
Expressing these RNAi lines using a ubiquitous driver was expected to cause lethality 
due to the mutant phenotype; however, only one of the five lines was lethal, suggesting 
there may be inefficient knockdown of CG33970.  In future experiments a variety of 
ubiquitous GAL4 drivers should be used and the knockdown should be verified using 
qRT-PCR.  In addition, the NMD defect should be re-tested using e22c-GAL4 UAS-
nlsDsRed:SV40 3’UTR, since this is the reporter originally used to identified the alleles of 
CG33970.  Mosaic cells were not identifiable using the GFP reporter that was used in this 
experiment.  This suggests this defect is either fluorescent reporter specific, and therefore 
not an NMD defect, or minor changes in expression are difficult to see using GFP in 
these alleles.  To detect minor perturbations in reporter expression, qRT-PCR against 
GFP and DsRed could be performed.   
 One method that could be utilized to determine if CG33970 is involved in NMD 
is to knock down CG33970 in Drosophila S2 cells.  NMD functions in S2 cells and if 
CG33970 is also expressed in this cell type, knock down followed by qRT-PCR of 
known NMD targets will provide a direct assay for whether CG33970 plays a role in 
NMD.   
In addition to the lethal complementation group, there are two lines that likely 
represent new NMD genes, 92c and 49c.  These lines have yet to be mapped or 
sequenced and will be an interesting new group to study.  The first thing that should be 
done with these lines is rebalancing an NMD reporter in the background to provide a 
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readout of NMD function; this will aid in deficiency mapping that can be performed to 
narrow down the region of the mutations.   
 The identification of new genes involved in a particular process is a primary goal 
of performing a forward genetic screen.  Using our reporter-based screening strategy we 
have potentially identified new genes involved in NMD.  There is, however, a large 
amount of work that still needs to be done to map, identify, verify, and finally 
characterize these genes and their role in NMD.  The low number of alleles, one of each 
in the last two complementation groups, suggest 3R is not yet saturated for alleles of 
genes identifiable by our reporter, so further screening to saturation could be fruitful.  
Characterizing lethal mutations is a difficult task.  The gene associated with the lethal 
complementation group, CG33970, has proven difficult to work with as cloning and 
rescue have not been possible, potentially due to the sheer size of the gene (47 kb).  
Rescue of both lethality and the NMD defect must be done to prove that CG33970 is the 
causative gene in this situation.  This may be challenging, as other genes, including Upf1, 
are sometimes difficult to rescue, presumably due to enhanced regulation of gene 
expression.  However, the cloning must first be accomplished to attempt further 
experiments.  In the future more screening should be performed to saturate the 
Drosophila genome for alleles of NMD genes.  Any tools we can establish in Drosophila 




Figure 3.1 Complementation tests for non-Smg6 3rd chromosome alleles.  When placed in 
trans to a deficiency uncovering Smg6, seven lines complement the deficiency for NMD-
reporter enhancement (white boxes) and viability.  Five of the lines are homozygous 
lethal, and are lethal as trans-heterozygotes (dark grey boxes).  Two of the lines are lethal 
as homozygotes (with some escapers), and are viable as trans-heterozygotes with each 
other or with representative alleles from the lethal complementation group (light grey 
boxes).  
 











Reporter expression not increased 
Fig. 3.1 
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Figure 3.2 Identification of lethal mutations.  (A) 181 kb region mapped by deficiencies 
that failed to complement the lethal complementation group.  (B) Sanger sequencing of 
amplicons in CG33970 in two representative alleles from the lethal complementation 
group.  Allele names listed on the right are alleles that contained the same mutation as the 
sequenced allele.  (C) Predicted CG33970 protein structure and locations of the mutations 
within the ATPase and transmembrane domains.  
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Figure 3.3 Mosaic analysis of NMD reporters in lethal mutants.  (A-C) Red channel, (A’-
C’) Green channel, (A’’-C’’) merge.  (A-A’’) e22c-GAL4, UAS-nlsDsRed2::SV40 
3’UTR, UAS-FLP/ UAS-eGFP::SV40 3’UTR; FRT82B Smg6292 /+. (B-B’’) e22c-GAL4, 
UAS-nlsDsRed2::SV40 3’UTR, UAS-FLP/ UAS-eGFP::SV40 3’UTR; FRT82B CG339744b 
/+. (C-C’’) e22c-GAL4, UAS-nlsDsRed2::SV40 3’UTR, UAS-FLP/ UAS-eGFP::SV40 












Figure 3.4 Mosaics in additional alleles.  (A) e22c-GAL4, UAS-nlsDsRed2::SV40 3’UTR, 
UAS-FLP/ +; FRT82B 49c / FRT82B.  (B) e22c-GAL4, UAS-nlsDsRed2::SV40 3’UTR, 
UAS-FLP/ +; FRT82B 92c / FRT82B.  Yellow arrowheads indicate a subset of enhanced 











6962 w[1118]; Df(3R)ED2, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}CG
31232[ED2]/TM6C, cu[1] Sb[1] 
91A5;91F1 (R4 estimated cytology), 
3R:14224953..14922493 (R4) 
Viable 
8029 w[1118]; Df(3R)ED5577, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}ED
5577/TM6C, cu[1] Sb[1] 




8091 w[1118]; Df(3R)ED5092, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}ED
5092/TM6C, cu[1] Sb[1] 
82A1;82E7 (R4 estimated cytology), 
3R:107408..912807 (R4) 
Viable 
8103 w[1118]; Df(3R)ED5177, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}ED
5177/TM6C, cu[1] Sb[1] 
83B4;83B6 (R4 estimated cytology), 
3R:1426351..1449817 (R4) 
Viable 
8104 w[1118]; Df(3R)ED5780, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}ED
5780/TM2 




8105 w[1118]; Df(3R)ED6232, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}ED
6232/TM6C, cu[1] Sb[1] 




8680 w[1118]; Df(3R)ED5138, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}ED
5138/TM6C, cu[1] Sb[1] 
82D5;82F8 (R4 estimated cytology), 
3R:606794..1090605 (R4) 
Viable 
8682 w[1118]; Df(3R)ED5230, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}ED
5230/TM6C, cu[1] Sb[1] 
84E6;85A5 (R4 estimated cytology), 
3R:3803496..4478856 (R4) 
Viable 
8683 w[1118]; Df(3R)ED5911, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}ED
5911/TM6C, cu[1] Sb[1] 
91C5;91F4 (R4 estimated cytology), 
3R:14568649..14991505 (R4) 
Viable 
8684 w[1118]; Df(3R)ED6096, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}ED
6096/TM6C, cu[1] Sb[1] 
94B5;94E7 (R4 estimated cytology), 
3R:18413403..19047691 (R4) 
Viable 
8685 w[1118]; Df(3R)ED7665, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}ED
7665/TM6C, cu[1] Sb[1] 




8922 w[1118]; Df(3R)ED5942, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}ED
5942/TM6C, cu[1] Sb[1] 




8925 w[1118]; Df(3R)ED6316, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}ED
6316/TM6C, cu[1] Sb[1] 




8957 w[1118]; Df(3R)ED5514, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}ED
5514/TM6C, cu[1] Sb[1] 




8960 w[1118]; Df(3R)ED6265, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}ED
6265/TM6C, cu[1] Sb[1] 
97E2;98A7 (R4 estimated cytology), 
3R:22937981..23405492 (R4) 
Viable 
8961 w[1118]; Df(3R)ED6310, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}ED
6310/TM6C, cu[1] Sb[1] 




8962 w[1118]; Df(3R)ED6076, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}ED
6076/TM6C, cu[1] Sb[1] 













8965 w[1118]; Df(3R)ED5156, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}E
D5156/TM6C, cu[1] Sb[1] 
82F8;83A4 (R4 estimated cytology), 
3R:1090655..1284574 (R4) 
Viable 
8967 w[1118]; Df(3R)ED5147, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}E
D5147/TM6C, cu[1] Sb[1] 
82E7;83A1 (R4 estimated cytology), 
3R:912842..1193526 (R4) 
Viable 
9082 w[1118]; Df(3R)ED5474, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}E
D5474/TM6C, cu[1] Sb[1] 
85F11;86B1 (R4 estimated cytology), 
3R:5935134..6176446 (R4) 
Viable 
9084 w[1118]; Df(3R)ED5518, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}E
D5518/TM6C, cu[1] Sb[1] 
86C7;86E13 (R4 estimated cytology), 
3R:6710720..7445622 (R4) 
Viable 
9086 w[1118]; Df(3R)ED5591, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}E
D5591/TM6C, cu[1] Sb[1] 
87B7;87C7 (R4 estimated cytology), 
3R:8176253..8545732 (R4) 
Viable 
9087 w[1118]; Df(3R)ED5610, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}E
D5610/TM6C, cu[1] Sb[1] 




9088 w[1118]; Df(3R)ED5612, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}E
D5612/TM6C, cu[1] Sb[1] 
87C7;87F6 (R4 estimated cytology), 
3R:8545707..9470856 (R4) 
Viable 
9090 w[1118]; Df(3R)ED5644, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}E
D5644/TM6C, cu[1] Sb[1] 
88A4;88C9 (R4 estimated cytology), 
3R:9843625..10451431 (R4) 
Viable 
9159 w[1118]; Df(3R)ED10257, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}E
D10257/TM6C, cu[1] Sb[1] 
83A7;83B4 (R4 estimated cytology), 
3R:1344078..1426000 (R4) 
Viable 
9198 w[1118]; Df(3R)ED5142, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}E
D5142/TM6C, cu[1] Sb[1] 
82B2;82F8 (R4 estimated cytology), 
3R:279018..1090605 (R4) 
Viable 
9204 w[1118]; Df(3R)ED5339, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}E
D5339/TM6C, cu[1] Sb[1] 




9209 w[1118]; Df(3R)ED6025, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}E
D6025/TM6C, cu[1] Sb[1] 
92A11;92E2 (R4 estimated cytology), 
3R:15468450..16135241 (R4) 
Viable 
9210 w[1118]; Df(3R)ED6255, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}E
D6255/TM6C, cu[1] Sb[1] 
97D2;97F1 (R4 estimated cytology), 
3R:22624758..23107623 (R4) 
Viable 
9211 w[1118]; Df(3R)ED6220, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}
ED6220/TM6C, cu[1] Sb[1] 




9215 w[1118]; Df(3R)ED5495, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}E
D5495/TM6C, cu[1] Sb[1] 
85F16;86C7 (R4 estimated cytology), 
3R:5996223..6712482 (R4) 
Viable 
9229 w[1118]; Df(3R)ED5797, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}E
D5797/TM6C, cu[1] Sb[1] 
90C2;90F10 (R4 estimated cytology), 
3R:13543832..14068391 (R4) 
Viable 
9338 w[1118]; Df(3R)ED5296, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}E
D5296/TM6C, cu[1] Sb[1] 
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9478 w[1118]; Df(3R)ED6235, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}E
D6235/TM6C, cu[1] Sb[1] 




9481 w[1118]; Df(3R)ED10639, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}E
D10639/TM6C, cu[1] Sb[1] 
89B7;89D2 (R4 estimated cytology), 
3R:12038635..12306942 (R4) 
Viable 
9482 w[1118]; Df(3R)ED10642, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}E
D10642/TM2 
89C7;89D5 (R4 estimated cytology), 
3R:12279479..12450993 (R4) 
Viable 
9483 w[1118]; Df(3R)ED10809, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}E
D10809/TM6C, cu[1] Sb[1] 
92F1;93B8 (R4 estimated cytology), 
3R:16376838..16886270 (R4) 
Viable 
9486 w[1118]; Df(3R)ED10820, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}E
D10820/TM6C, cu[1] Sb[1] 




Cambridge w[1118]; Df(3R)ED6058/TM6C, cu[1] 
Sb[1] 
93D4; 93F6 Viable 
Cambridge w[1118]; Df(3R)ED6105/TM6C, cu[1] 
Sb[1] 
94E9; 94E11 Viable 
Cambridge w[1118]; Df(3R)ED6290/TM6C, cu[1] 
Sb[1] 
98C3; 98E5 Viable 
Cambridge w[1118]; Df(3R)ED6332/TM6C, cu[1] 
Sb[1] 
99E4; 99F2 Viable 
Cambridge w[1118]; Df(3R)ED6346/TM6C, cu[1] 
Sb[1] 
100A5; 100B1 Viable 
Cambridge w[1118]; Df(3R)ED6361/TM6C, cu[1] 
Sb[1] 
100C7; 100E3 Viable 
Europe/FB
ab0044431 
Df (3R) ED 10894 95A7;95E1 Viable 
Europe/FB
ab0037564 
Df (3L) ED 6346 100A5;100B1 Viable 
Europe/FB
ab0044486 
Df (3R) ED 10951 96B20;96D1 Viable 
Europe/FB
ab0036895 
Df (3R) ED 5660 88D1;88E5 Viable 
24516 w[1118]; Df(3R)ED50003, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}E
D50003/TM6C, cu[1] Sb[1] 
100E1;100F5 Viable 
24136 w[1118]; Df(3R)ED5416, 
P{w[+mW.Scer\FRT.hs3]=3'.RS5+3.3'}E
D5416/TM6C, cu[1] Sb[1] 
85D16;85E6 Viable 
5601* Df(3R)Espl3/TM6C, cu[1] Sb[1] Tb[1] 
ca[1] 
96F1;97B1 Viable 










26850* w[1118]; Df(3R)BSC752/TM6C, Sb[1] 
cu[1] 
97A2;97C5, 3R:22005377;22551031 
(R5 flank;R3 author statement->R5) 
Lethal 
25000* w[1118]; Df(3R)BSC496/TM6C, Sb[1] 
cu[1] 
97A6;97D4, 3R:22084363--
22084371;22702382 (R5 flank;R3 
author statement->R5) 
Lethal 
Grey shading: deficiency that fails to complement lethal mutants.   
Bold: deficiency that uncovers Smg6.   
* Deficiencies used to narrow down the lethal mutant region.   
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Table 3.2: Primers used for sequencing candidate ORFs. 
Primer 
Name 
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Smg6 was originally identified along with five other Smg genes, in an 
informational suppressor screen performed in C. elegans (Hodgkin et al., 1989), and was 
subsequently shown to be required for destabilization of nonsense-containing transcripts 
(Pulak and Anderson, 1993).  Orthologs of Smg6 are conserved in Drosophila and 
mammalian genomes and are known to be required for NMD in both Drosophila S2 and 
mammalian cells (Eberle et al., 2009; Gatfield et al., 2003; Huntzinger et al., 2008).  
Smg6, along with Smg5 and Smg7, two other genes required for NMD, contains a PIN 
domain (Chiu et al., 2003; Gatfield et al., 2003).  The PIN domain is an evolutionarily 
conserved endonuclease domain that functions in diverse RNA processing enzymes 
(Schoenberg, 2011).  However, both the Smg5 and Smg7 PIN domains contain amino 
acid substitutions in the conserved triad of aspartic acid residues known to be required for 
catalytic function (Glavan et al., 2006; Takeshita et al., 2007).   
Endonucleolytic cleavage of transcripts targeted by nonsense mediated decay has 
been shown in Drosophila and mammalian (Eberle et al., 2009; Huntzinger et al., 2008) 
cell lines to be carried out by the NMD-specific nuclease Smg6.  In Drosophila cell 
culture, cleavage of PTC-containing mRNA is initiated by Smg6-dependent cleavage that 
occurs near the premature termination codon (Gatfield and Izaurralde, 2004).  This 
endonucleolytic cleavage is attributed to the catalytic function of Smg6 in both 
Drosophila and mammalian cells (Eberle et al., 2009; Hodgkin et al., 1989; Huntzinger et 
al., 2008) and has also been shown to occur in zebrafish (Pulak and Anderson, 1993; 
Wittkopp et al., 2009). 
Prior to the discovery that endonucleolytic cleavage was involved in NMD, other 
degradation steps were thought to be important for NMD.  In yeast, which lacks a Smg6 
ortholog, rapid degradation of NMD targets is initiated by deadenylation-independent 
decapping followed by 5’-3’ exonucleolytic degradation by XRN1 (Eberle et al., 2009; 
Gatfield et al., 2003; He and Jacobson, 2001; Huntzinger et al., 2008).  Experimental 
inactivation of XRN1 revealed a compensatory mechanism dependent on a rapid 
deadenylation pathway (Chiu et al., 2003; Gatfield et al., 2003; Muhlrad and Parker, 
1994).  Mammalian cells have also been shown to utilize deadenylation-independent 
decapping coupled to NMD (Lejeune et al., 2003; Schoenberg, 2011), and a rapid 
deadenylation pathway (Chen and Shyu, 2003; Couttet and Grange, 2004; Glavan et al., 
2006; Lejeune et al., 2003; Takeshita et al., 2007).  Neither deadenylation independent 
decapping or rapid deadenylation have been observed in Drosophila S2 cells, and only 
endonucleolytic cleavage fragments of NMD targeted transcripts have been detected 
(Eberle et al., 2009; Gatfield and Izaurralde, 2004; Huntzinger et al., 2008).  
Endonucleolytic cleavage by Smg6 occurs in both Drosophila and mammalian cells, 
however, the lack of NMD-dependent deadenylation-independent decapping and rapid 
deadenylation activity in Drosophila suggests more complex organisms may have co-
opted multiple degradation pathways for NMD.   
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Our data in Drosophila suggest degradation of NMD-targeted transcripts may be 
more complicated in vivo than has been observed in Drosophila S2 cells, as loss of Smg6 
only causes a modest NMD defect in vivo (Frizzell et al., 2012; Gatfield and Izaurralde, 
2004).  If cleavage by Smg6 were the only nuclease pathway utilized in Drosophila, a 
much more severe NMD defect might be expected as transcripts targeted by NMD would 
be incapable of the accelerated decay that results from endonucleolytic cleavage.  The 
modest NMD defect associated with Smg6 mutants suggests other pathways, or partially 
redundant endonucleases, are utilized for degradation in Drosophila.  One hypothesis is 
that Smg6 exonuclease activity is the only cleavage mechanism used in Drosophila S2 
cells, and that different cell types within Drosophila utilize other degradation pathways 
like those seen in mammalian cells.  Another, nonexclusive, hypothesis is that 
endonucleolytic cleavage by Smg6 is the primary method of degradation, but that other 
compensatory pathways can initiate cleavage in the absence of Smg6 function.  We can 
use the Smg6 allelic series identified in our screen (Frizzell et al., 2012) to begin testing 
these hypotheses in vivo.   
Additionally, Smg6 may be an important factor to explain the mechanistic 
differences of NMD targeting seen in vertebrate lineages.  Smg6 is recruited to target 
transcripts by interactions between its 14-3-3-like domain and phosphorylated Upf1 
bound to target mRNA (Okada-Katsuhata et al., 2011).  The C-terminal region of 
vertebrate Smg6 contains two conserved domains in vertebrates, termed the exon-junction 
complex binding domains (EBMs) (Kashima et al., 2010). The presence of an exon 
junction complex downstream of a PTC stimulates NMD in mammalian cells (Buchwald 
et al., 2010; Hwang et al., 2010; Singh et al., 2008), but does not appear to have any 
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affect on NMD in Drosophila (Gatfield et al., 2003).  Indeed, Drosophila Smg6 lacks 
EBM domains, suggesting the absence of EJC-dependent NMD stimulation in 
Drosophila is due to a loss, or nonacquisition, of these domains during Drosophila 
evolution.  
Here, I present further in vivo characterization of the role of Smg6 in Drosophila. 
First, I investigate the phenotypes associated with trans-heterozygous combinations of 
the Smg6 alleles.  Next, I establish an in vivo assay to map the location and efficacy of 
Smg6 cleavage of NMD targets.  Finally, I discuss ways to further analyze Smg6 in vivo, 
in particular, the importance of separating out potentially redundant pathways of target 
degradation in vivo.  
 
 
Materials and methods 
Fly stocks 
D. melanogaster lines were raised at 25°C on cornmeal/dextrose medium using 
standard conditions.  Control chromosomes used for the screens were y w FRT19A and 
FRT82B (Xu and Rubin, 1993).  Pacman RNAi (III) y1 sc* v1; P{y[+t7.7] 
v[+t1.8]=TRiP.HMS01169}attP2, the daughterless driver (III) w1118; P{da-GAL4.w[-
]}3/TM3 Sb1, P{Act5C-GAL4-w}E1/CyO, and Ub-GAL4 were obtained from the 
Bloomington Drosophila stock center.  Control crosses utilized Smg6 alleles from our 3R 
screen w; FRT82B Smg62a/ TM6B, P{Dfd-EYFP} Sb1 ca1, and included w; FRT82B Smg6292/ 
TM6B, P{Dfd-EYFP} Sb1 ca1 (Frizzell et al., 2012).  The hypomorphic allele of the 
Drosophila homolog of XRN1, called pacman, pcm5, was a gift from Sarah Newbury 
(Grima et al., 2008; Jones et al., 2012; Zabolotskaya et al., 2008).  For the balancer 
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chromosomes we used w*; ry506 Dr1/ TM6B, P{Dfd-EYFP} Sb1 ca1 (Le et al., 2006).  
Complementation tests and deficiency experiments for Smg6 were performed using 




To test the viability of Smg6 alleles in trans, female FRT82B, or FRT82B 
Smg6*/TM6B, P{Dfd-EYFP} Sb1 ca1 flies were mated to FRT82B Smg6*/TM6B, P{Dfd-
EYFP} Sb1 ca1 males.  Progeny adults were analyzed for the presence and absence of the 




To map the location of endonucleolytic cleavage of NMD targets by Smg6 in 
Drosophila, the 5’-3’ exonuclease, pacman (pcm), was knocked down by RNAi.  
Females carrying the daughterless driver P{da-GAL4.w[-]}3 were mated to males 
carrying the pcmRNAi construct y1 sc* v1; P{y[+t7.7] 
v[+t1.8]=TRiP.HMS01169}attP2/TM3 Sb1; hereafter this RNAi construct will be called 
pcmRNAi.  Sb+ adult male progeny were collected.  In addition to this cross, Ub-GAL4 
and Act5c-GAL4 females were mated to P{y[+t7.7] v[+t1.8]=TRiP.HMS01169}attP2 
/TM3 Sb1.  Sb+ adult male progeny were collected.  Samples were flash frozen in 








RNA isolation and quantitative RT-PCR 
RNA isolation and qRT-PCR were performed as described in (Frizzell et al., 
2012).  Briefly, total RNA was isolated from five to ten flash-frozen samples of adult 
males using Trizol reagent (Invitrogen) and phase-lock tubes (5-Prime), and the RNeasy 
mini kit (Qiagen).  Genomic contamination was reduced by on-column DNAse treatment 
(Ambion).  RNA concentration was determined using a spectrophotometer and 
normalized for reverse transcription using the MuMulv reverse transcriptase Retroscript 
Kit (Ambion).  Quantitative RT-PCR was performed on a BioRad iCycler thermocycler 
using SYBR green supermix (Bio-Rad).  All experimental reactions were performed in 
triplicate with a minimum of two biological replicates.  For quantification samples were 
normalized to RpL32. 
 
 
Results and discussion 
Viability of trans-heterozygous Smg6 alleles 
The viability of Smg6 alleles was measured in trans to a deficiency uncovering 
Smg6 (Frizzell et al., 2012).  As a control, two null alleles, Smg652a and Smg6292, were 
also mated to verify the combination of two null Smg6 alleles was not more severe than 
either allele in trans to a deficiency.  All animals were collected as trans-heterozygous 
adults.  We found the null alleles were about 60% viable, both in trans to each other, or 
in trans to a Smg6 deficiency (Fig. 2.1).  We found the viability associated with one of 
the hypomorphic alleles, Smg621a, did not fit the trend associated with other alleles.  
While other hypomorphic alleles were 80% viable in trans to a deficiency, Smg621a was 
only ~60% viable (Fig. 4.1) (Frizzell et al., 2012).  To test if the decreased fitness of 
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Smg621a was due to the particular mutation in Smg6 or to another mutation on the Smg621a 
chromosome, trans-heterozygous combinations of the three hypomorphic alleles, Smg621a, 
Smg691a, and Smg62a, were measured for viability.  Interestingly, when the hypomorph, 
Smg621a, was crossed to either Smg691a or Smg62a, it decreased the viability of the alleles 
from 80% viable to 60% viable.  However, Smg691a in trans to Smg62a was nearly 90% 
viable.  This result suggests Smg621a acts as a null allele when scored for viability.  The 
lesion in Smg621a is a premature termination codon only a few base pairs downstream of 
the lesion in Smg691a, and previous work showed this allele has a hypomorphic NMD 
defect (Frizzell et al., 2012).  It is more likely that the Smg621a chromosome has picked 
up a second mutation that is haploinsufficient for viability, but does not affect NMD.  In 
order to more accurately judge whether this defect in viability is due to the Smg6 
mutation or to a second site effect, more trans-heterozygous combinations need to be 
made; in particular, trans-heterozygous null alleles over hypomorphic alleles need to be 
tested.  If Smg621a has an extra mutation on the chromosome that affects viability, a 
greater decrease in viability in the Smg621a /null combination would be expected.   
 To further test the roles of the partial and full loss of Smg6 function in these 
alleles, more direct tests of NMD function must be done, including testing the stability of 
known NMD targets in these trans-heterozygous combinations.  
 
 
Mapping Smg6 cleavage using pacman knockdown 
To test the site specificity and efficacy of Smg6 cleavage of NMD targeted 
transcripts, we modified an assay that has previously been performed in tissue culture 
(Franks et al., 2010; Gatfield and Izaurralde, 2004; Rehwinkel et al., 2005) to detect the 
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cleavage products that result from Smg6-mediated cleavage of an NMD target.  Smg6 
endonucleolytic activity has been demonstrated in Drosophila S2 (Huntzinger et al., 
2008) and mammalian cell culture (Eberle et al., 2009) to cleave NMD-targeted 
transcripts near the premature termination codon (Gatfield and Izaurralde, 2004).  This 
cleavage frees the 3’ end of the 5’ fragment for degradation by the exosome, and the 5’ 
end of the 3’ fragment for degradation by the exonuclease, pacman (pcm), called XRN1 
in other organisms (Gatfield and Izaurralde, 2004; He and Jacobson, 2001).  We set out to 
determine if, following endonucleolytic cleavage, pcm and exosome mediated 
degradation occurs in intact Drosophila.  We did this by measuring relative expression 
levels of the 5’ and 3’ degradation fragments of targets in Smg6 mutant backgrounds, 
where both fragments should be stabilized.  We also measured relative expression in pcm 
knockdown animals, where the 3’ fragment should be stabilized relative to the 5’ 
fragment, whose 3’ end is still susceptible to degradation by the exosome.  
This assay can also be used to address whether cleavage occurs on endogenous 
transcripts that harbor no premature termination codon, but are nonetheless targeted for 
degradation by NMD.  To detect where the cleavage occurs, and whether the cleavage is 
dependent on Smg6 function, we first designed primers to well-characterized NMD 
targets.  The primers were designed to detect amplicons that lie 5’ or 3’ to the predicted 
cleavage site of either a premature or a native termination codon (Fig. 4.2 B).  For this 
experiment two different NMD targets were utilized.  The first target, transformer (tra), 
is a sex-specific splicing regulator that is alternatively spliced into a PTC-containing 
isoform in males, and represents our PTC-containing transcript (Metzstein and Krasnow, 
2006).  Stabilization of tra fragments has been previously seen in Drosophila S2 cells 
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using northern analysis (Rehwinkel et al., 2005).  The second target is Gadd45.  Gadd45 
contains no introns or splice forms that would make it an obvious NMD target; however, 
it has a relatively long 3’ UTR and is a direct NMD target in Drosophila (A. Chapin, in 
prep) and mammals (Viegas et al., 2007).  Gadd45 represents our endogenous NMD 
target that lacks a PTC.  Primers for the Gadd45 transcript were designed 5’ and 3’ to the 
native termination codon.  Both tra and Gadd45 were stabilized relative to wild-type 
controls in microarrays of Smg6292 and Smg62a, and were stabilized in microarrays of 
other NMD genes, Upf225G and Smg132AP (Frizzell et al., 2012; Metzstein and Krasnow, 
2006).  Alleles of Upf2 and Smg1 are used as controls for NMD function in the following 
experiments.   
To determine relative levels of tra 5’ and 3’ amplicons, we first determined if 
both amplicons were stabilized in Smg6 mutants.  We predicted that the endonucleolytic 
cleavage does not occur in Smg6 mutants, therefore the relative levels of the amplicons 
should be stabilized to approximately equal levels as compared to a wild-type control. 
However, this analysis could be confounded if another degradation pathway is utilized. 
We found that in Smg6292, a null Smg6 allele, both the tra 5’ and tra 3’ amplicons were 
stabilized about 1.5 fold over the same amplicons in a wild-type background (Fig. 4.2 C, 
D).  Interestingly, in Smg62a, a hypomorphic allele that harbors a missense mutation in 
the endonuclease domain of Smg6 (Frizzell et al., 2012), the 3’ amplicon was stabilized 
more, about 1.8 fold relative to the 5’ amplicon, which was barely stabilized over wild-
type controls (Fig. 4.2 C, D).  This indicates that the hypomorphic mutation in Smg62a 
somehow stabilizes the 3’ fragment, while the 5’ end is degraded as if NMD was not 
disrupted.  As a control we also analyzed the levels of the 5’ and 3’ tra amplicons in male 
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animals hemizygous for Smg132AP, which has a weak NMD defect, and Upf225G, which 
has a complete loss of NMD function.  Both 5’ and 3’ amplicons were stabilized about 
1.5-2.5 fold in Smg132AP, and there was no significant difference in the overall expression 
level between the amplicons (Fig. 4.2 C, D).  In Upf225G, there was a significant 
stabilization of the 3’ amplicon relative to the 5’ amplicon (Fig. 4.2 C, D).  
To determine if endonucleolytic cleavage of tra occurs at the isoform-specific 
premature termination codon we assayed whether the 3’ amplicon was stabilized relative 
to the 5’ amplicon in male animals ubiquitously expressing pcmRNAi from the da-GAL4 
promoter.  Two other drivers were tested for this experiment.  The first, Act5c-GAL4 did 
not result in a detectable knockdown of pcm transcript (data not shown).  A second driver, 
Ub-GAL4, resulted in adult lethality, a result that is not surprising as null alleles of 
pacman result in pupal lethality (Jones et al., 2012).  Male flies expressing da-
GAL4/UAS:pcmRNAi displayed a nearly two-fold reduction in pacman transcript (Fig. 
4.2 A).  In these animals, the 3’ tra fragment was stabilized two-fold relative to the 5’ tra 
fragment (Fig. 4.2 C, D).  This indicates the cleavage does occur somewhere between the 
two amplicons and that this method can detect 3’ fragments stabilized upon loss of the 5’ 
exonuclease, pacman.  
Next, we determined if Gadd45 is cleaved by Smg6 in the vicinity of its normal 
termination codon.  Using the same approach as the tra experiment, the relative levels of 
Gadd45 3’ and Gadd45 5’ fragments were measured in wild type animals along with 
Smg62a, and Smg6292 mutants.  Interestingly, in both the Smg6 mutants, the 5’ fragment 
was stabilized two-fold relative to the 3’ fragment (Fig.4.2 E, F).  The stabilization of the 
5’ fragment relative to the 3’ fragment was also seen in Upf225G mutants, but was not 
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observed in Smg132AP mutants where they were not stabilized at all (Fig. 4.2 E, F).  The 
difference in stabilization of the Gadd45 amplicons could be due to many reasons.  First, 
the efficiency of primer binding to the transcripts could introduce technical errors with 
detection of the transcripts; more primer pairs to the different amplicons should be used 
to recapitulate these results.  Second, the 5’ amplicon stabilization is strange in light of 
the 3’ stabilization seen in the tra amplicons.  Perhaps this difference is a result of a 
premature versus native termination codon targeted by NMD.  As predicted by our model, 
when pacman is knocked down using RNAi, the 3’ fragment is stabilized relative to the 5’ 
fragment (Fig. 4.2 E, F).  This indicates that Gadd45 is cleaved near the normal 
termination codon.  However, the degree of Smg6 cleavage necessary for this 
stabilization will need to be determined using double mutant analysis.  
To ensure the phenotype is due to Smg6-mediated endonucleolytic cleavage of tra 
or Gadd45 the 5’ and 3’ fragments should be assayed in a Smg6 and pacman double 
mutant.  Unfortunately both the da-GAL4 driver and pcmRNAi are inserted on the third 
chromosome, which makes an RNAi, mutant/deficiency double mutant technically 
challenging.  However, this experiment can be done in one of two ways; first, the da-
GAL4 promoter can be used to knock down both pcm and Smg6.  The Smg6RNAi has 
been tested for an NMD defect and it causes stability of an NMD reporter (A. Chapin 
personal communication), however, the 5’ and 3’ amplicons would have to be 
characterized in this background before an experiment can be performed.  Second, pcm5; 
Smg6*/Df mutant can be made, however, the pcm5 allele has not yet been tested using 
these methods and needs to be verified.  Additionally, the pcm5 allele is temperature 
sensitive (Grima et al., 2008) and may be sick when combined with Smg6.  To perform 
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this experiment efficiently, male L3 larvae of the double mutant should be collected to 
avoid developmental defects associated with loss of Smg6 and pcm.  However, all 
experiments would need to be optimized in L3 larvae.   
 This analysis of Smg6 provides the basis for more assays of NMD function in vivo 
in Drosophila.  First, measuring viability in trans-heterozygous combinations of 
hypomorphs indicates that additional factors on one of the chromosomes may dominantly 
affect viability without having a significant affect on NMD function (Frizzell et al., 2012).  
More trans-heterozygous combinations and determining the NMD defects in these 
combinations can provide more information on the roles of different Smg6 domains on 
NMD function.   
The XRN1-based assay developed in this chapter has been used extensively in 
tissue culture (Behm-Ansmant et al., 2007; Eberle et al., 2009; Franks et al., 2010; 
Gatfield and Izaurralde, 2004; Huntzinger et al., 2008; Lejeune et al., 2003), with the 
assumption that it provides a read-out of direct versus indirect NMD targets (Rehwinkel 
et al., 2005).  Upon loss of XRN1, direct targets are predicted to display stabilization of 
the 3’ fragment; however, general loss of NMD function should result in direct targets 
showing equal fragment amplification.  In contrast, indirect targets will not show 
amplicon specific stabilization.  Applying this assay to mutants, instead of RNAi 
knockdown of NMD components, adds another level of complexity to the experiment.  
Hypomorphic mutants such as Smg62a and Upf225G may have residual function that 
allows the NMD complex to assemble on targeted mRNA, but may prevent dissociation 
of the NMD mRNP leading to stabilization of the fragment that is bound by the NMD 
complex.  Indeed, this type of stabilization has been observed in mammalian cells upon 
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loss of Upf1 hydrolysis of ATP (Franks et al., 2010).  In these experiments, expressing 
Upf1 mutants that were unable to hydrolyze ATP resulted in components of the NMD 
complex remaining bound to each other and to the 3’ fragment of PTC-containing mRNA, 
this resulted in protection of the 3’ fragment from degradation by the 5’ exonuclease, 
XRN1 (Franks et al., 2010).  One possibility is that Upf225G is behaving similarly to the 
Upf1 mutants.  Upf225G mutants have a strong NMD defect (Avery et al., 2011; Frizzell et 
al., 2012; Metzstein and Krasnow, 2006) and the lesion in Upf225G changes the natural 
stop codon to an arginine, extending the Upf2 protein by fifteen residues (Metzstein and 
Krasnow, 2006).  The extra C-terminal amino acids added to the Upf225G polypeptide 
could hinder interactions between Upf1 and Upf2.  These are required to stimulate ATP 
hydrolysis by Upf1 (Clerici et al., 2009) which is required for mRNP remodeling and 
recycling of NMD components (Franks et al., 2010).  In the presence of Upf225G protein, 
the mRNP might remain associated with the end of the transcript, protecting that 
fragment from degradation, as has been observed in mammalian cells (Franks et al., 
2010).  The mRNP association may even vary between transcripts based on the efficiency 
or mechanism of recognition.  This observation might explain why tra transcripts, which 
encode a PTC, have a stabilized 3’ fragment in Upf225G mutants while Gadd45 transcripts, 
which do not have an obvious PTC, have the 5’ fragments stabilized in Upf225G mutants.    
The idea that the NMD mRNP could protect cleaved transcripts is also interesting 
in light of our data that shows a Smg6 hypomorph predicted to contain a catalytically 
dead endonuclease (Glavan et al., 2006; Takeshita et al., 2007) domain may have residual 
endonuclease activity.  In the null allele, Smg6292, amplicons representing the 5’ and 3’ 
cleavage fragments are stabilized equally, as would be predicted in the complete absence 
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of endonuclease function.  However, in the hypomorph Smg62a, we found that the 3’ 
amplicon was stabilized relative to the 5’ amplicon (Fig. 2 C, D).  The lesion in Smg62a 
converts a conserved catalytic residue in the PIN endonucleolytic domain from an 
aspartic acid to a valine, presumably disrupting the function of the catalytic domain, but 
likely leaving the overall structure of the protein intact.  The stabilization of the 3’ 
amplicon suggests the mutation may allow Smg62a to assemble with the NMD complex 
and that inefficient cleavage, due to the active site mutation, might result in inefficient 
mRNP remodeling and thus, protection of the 3’ tra fragment.  However, these results are 
not mirrored in the Gadd45 amplicons, where the 5’ amplicon is stabilized relative to the 
3’ amplicon in both Smg62a and Smg6292 mutants (Fig. 4.3 E, F).  This is intriguing 
because the Gadd45 transcript may be targeted differently from tra because it lacks a 
PTC.  These observations generate models that can be tested using the aforementioned 




 Work on this cleavage assay for determining relative levels of cleavage products 
of NMD targets is still in a preliminary phase of optimization.  However, several other 
experiments using this assay can be hypothesized.  Additionally, alleles of NMD genes 
can be utilized for further characterization of the role of NMD in vivo.  This section 
describes some such future experiments.  
First, to confirm results and to examine if there is a trend in stabilization of 
cleavage products in hypomorphic NMD mutants, all the pcmRNAi experiments need to 
validated using additional primer pairs against the 5’ and 3’ cleavage products of tra, 
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Gadd45, and other targets.  Additional targets that may be informative include Smg5, a 
known NMD component and NMD target (Rehwinkel et al., 2005; Yepiskoposyan et al., 
2011), and fluorescent reporters containing the SV40 3’UTR.  Both Smg5 and the SV40 
3’UTR are targets that do not contain a PTC (Metzstein and Krasnow, 2006).   Bona fide 
PTC-containing alleles should also be assayed, such as Adhn4 (Chen et al., 2005; Chia et 
al., 1987; Metzstein and Krasnow, 2006), to determine if there is a difference in 
stabilization between different types of NMD targets, such as PTC-containing versus 
endogenous targets.   
Further characterization of cleavage products can be performed in a pacman 
mutant, as opposed to RNAi, as was described in this chapter.  We have obtained a 
hypomorphic temperature sensitive allele of pacman, pcm5 (Zabolotskaya et al., 2008).  
This allele is viable at permissive temperatures, so characterization of cleavage fragments 
at any developmental stage should be possible (Grima et al., 2008).  One benefit of using 
a mutant, as opposed to RNAi, is that all cells are defective, which allows for analysis of 
the effect of loss of function of pcm in whole animals.  Also, the pcm5 mutation is present 
on the X chromosome, so double mutant analysis with Smg6 or other NMD mutants can 
be performed using hemizygous pcm5 males.  However, characterization of the pcm5 still 
needs to be performed in our laboratory.  
   In addition to using an allele of pcm, we should look at NMD cleavage products 
in different NMD mutant backgrounds.  Alleles of Smg5, for example, may be interesting 
as Smg5-dependent dephosphorylation has been shown biochemically to promote 
remodeling of the NMD mRNP (Chiu et al., 2003; Okada-Katsuhata et al., 2011).   
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The stabilization of either the 3’ fragment of tra or the 5’ fragment of Gadd45 in 
Smg6 mutants is intriguing and could be followed up on using protein-based assays.  One 
experimental option is to use either UV or formaldehyde crosslinking followed by 
immunoprecipitation of NMD proteins and qRT-PCR to identify sequences associated 
with the NMD mRNP (Darnell, 2012).  If this can be used quantitatively, we can test if 
the mRNP is associating upstream or downstream of the predicted cleavage position.    
Since we can use probes, such as qRT-PCR or northern blot analysis, to identify 
differences in stability of an NMD target that has undergone endonucleolytic cleavage by 
Smg6, we may be able to expand our assays to identify more direct targets of NMD.  
Detection of endonucleolytic cleavage products could easily be expanded to either RNA-
sequencing, or to transcripts that have multiple probes on a microarray that lie throughout 
the transcript.  We already have microarray data for the two alleles of Smg6 that were 
used in this experiment (Frizzell et al., 2012); further analysis could include reannotating 
the array to identify probes that could detect the 5’ and 3’ ends of transcripts.  Once this 
is done, microarrays on pacman RNAi or mutants and pacman; Smg6 double mutants 
could be an efficient way to detect transcripts directly targeted by Smg6.  These could 
then be verified by qRT-PCR.   
 Another aspect of the NMD screen is that, while it efficiently identifies genes 
with a primary role in NMD, it might miss genes that provide a secondary or 
compensatory role.  Of particular note, Smg6 mutations result in a minor NMD defect 
(Frizzell et al., 2012), suggesting other degradation pathways are utilized by NMD.  In 
yeast (He and Jacobson, 1995) and mammalian cells (Chen and Shyu, 2003; Couttet and 
Grange, 2004; Muhlrad and Parker, 1994), deadenylation independent decapping and 
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rapid deadenylation contribute to the rapid decay characteristic of NMD.  However, this 
has not been demonstrated to occur in Drosophila S2 cells (Gatfield and Izaurralde, 
2004).  Potentially, deadenylation and decapping, or novel ribonuclease pathways, may 
be used as a secondary degradation mechanism in vivo.  Deadenylation and decapping 
coupled to NMD may not be active in NMD in S2 cells, or could be cell, tissue, or 
developmental stage dependent and so would have been missed when analyzed in tissue 
culture.  We could perform a screen looking for secondary decay pathways that are 
utilized by NMD.  One way to do this would be to use a candidate-based RNAi screen.  
There are 200 genes in Drosophila that contain the GO-term “ribonuclease”.  Forty-three 
of these ribonuclease genes have identified alleles or previously made RNAi constructs 
directed against them.  A whole organism and tissue directed screen looking for synthetic 
lethality between alleles of Smg6 and RNAi against other candidate ribonucleases could 
be performed using such reagents.  A ubiquitous driver, as well as a nervous system 
specific driver, that are sufficient for rescue of NMD-based lethality of Upf2 (A. Chapin, 
personal communication), could be used to drive RNAi in a viable Smg6 background; 
RNAi lines that result in synthetic lethality using both drivers could then be tested for 
NMD reporter enhancement.  This method may uncover genes that would have been 
missed due to Smg6 being the primary nuclease used by NMD, therefore a functioning 
Smg6 would have compensated for minor NMD defects resulting from loss of other 




 Figure 4.1  Viability of Smg6 mutants.  Percentage survival to adulthood of Smg6 trans-
heterozygous combinations.  Alleles shown in trans to a deficiency are percentages first 
presented in (Frizzell et al., 2012).  Alleles are classified as null or hypomorphic based on 
molecular criteria.  Percentage survival is calculated relative to balancer containing 
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Figure 4.2  Analysis of Smg6 cleavage products and pacman knockdown.  (A) Levels of 
pcm transcript in daGAL4 control animals and daGAL4/pcmRNAi animals.  Error bars 
indicate 1X S.E.M, n=4.  (B) NMD target transcripts and location of 5’ and 3’ primers in 
tra and Gadd45.  (C) Effect of Smg6, Smg1, Upf2 mutations and knockdown of pcm on 
levels of the 5’ and 3’ cleavage fragments of the endogenous NMD target tra in males.  
Levels for Smg6 alleles are normalized to FRT82B/Df animals; Smg132AP/Y and Upf225G/Y 
are normalized to FRT19A/Y.  daGAL4/pcmRNAi animals are normalized to daGAL4.  
Error bars indicate S.E.M., n=2 for Smg6, Upf2, and Smg1; n=4 for daGAL4 and 
daGAL4/pcmRNAi.  (D) Fold change of tra 3’ over tra 5’ expression in Smg6, Smg1, 
Upf2, and pcmRNAi animals. (E) Effect of Smg6, Smg1, Upf2 mutations and knockdown 
of Gadd45 on levels of the 5’ and 3’ cleavage fragments of the endogenous NMD target 
Gadd45 in males.  Levels for Smg6 alleles are normalized to FRT82B/Df animals; 
Smg132AP/Y and Upf225G/Y are normalized to FRT19A/Y.  daGAL4/pcmRNAi animals are 
normalized to daGAL4.  Error bars indicate S.E.M., n=2 for Smg6, Upf2, and Smg1; n=4 
for daGAL4 and daGAL4/pcmRNAi.  (D) Fold change of Gadd45 3’ over Gadd45 5’ 
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CHARACTERIZATION OF CIS-ACTING SEQUENCES IN THE  




 While performing a forward genetic screen in Drosophila for genes required for 
cell morphogenesis, a serendipitous discovery was made: the fluorescent reporter used to 
identify homozygous mutant cells was subject to regulation by nonsense mediated decay 
(NMD) (Metzstein and Krasnow, 2006).  NMD pathway mutants show a dramatic up-
regulation of the fluorescent reporter expression attributable to stabilization of the 
reporter transcript.  The fluorescent reporter does not contain a premature termination 
codon (PTC).  However, independent features of the reporter were tested for NMD-
dependent destabilization and it was determined that the 3’UTR utilized in the fluorescent 
reporter was specifically targeted by NMD (Metzstein and Krasnow, 2006).  This 3’UTR 
is found in cloning plasmids used in early Drosophila molecular genetic experiments 
(Thummel et al., 1988), and is derived from the Simian virus 40 (SV40), a double 
stranded DNA virus that infects both primates and humans.  The SV40 3’UTR is derived 
from the small t antigen intron sequence and it is unclear why the SV40 3’UTR is 
specifically targeted by NMD, but there are a few potential mechanisms.  For example, 
long 3’UTRs have been shown in other systems to trigger NMD (Amrani et al., 2004; 
Eberle et al., 2008; Hogg and Goff, 2010; Kertész et al., 2006; Muhlrad and Parker, 1999; 
Singh et al., 2008).  The SV40 3’UTR is 720 bp long and the average length of a 
Drosophila 3’UTR is ~400 bp (Celniker and Rubin, 2003); thus, the length of the SV40 
3’UTR may cause it to trigger NMD in a length-dependent manner.  However, many 
endogenous 3’UTRs in Drosophila are 400 bp or longer and are not NMD targets 
(Rehwinkel et al., 2005).  This suggests that targeting of 3’UTRs, and in particular, this 
reporter, is more complicated than a pure length-measuring mechanism.   
Another potential mechanism depends on the exon junction complex (EJC) 
promoting NMD, as is seen in plants (Kerényi et al., 2008; Kertész et al., 2006), zebrafish 
(Wittkopp et al., 2009), and mammalian cells (Buchwald et al., 2010; Carter et al., 1996; 
Le Hir et al., 2001; Maquat, 2004; Zhang et al., 1998).  The SV40 3’UTR contains an 
inefficiently spliced intron (M. Metzstein personal communication), which could 
stimulate NMD in an EJC-dependent manner.  However, the EJC does not on its own 
stimulate NMD targeting in Drosophila S2 cells (Gatfield et al., 2003), and loss of EJC 
components does not result in a visible increase in SV40 3’UTR-based reporter 
enhancement (J. Nelson personal communication).  This suggests EJC-dependent 
targeting is not the primary mechanism of targeting the SV40 3’UTR.  Additionally, 
deleting the intron sequence did not result in a significant reduction in NMD targeting, 
based on a visual assay of reporter expression levels (Metzstein and Krasnow, 2006).  
However, EJC-dependent NMD may represent only one of multiple NMD pathways and 
therefore be dependent on the individual NMD mutant used for testing the reporter 
expression.  Additionally, visual fluorescence may not be reliably quantitative, whereas 
qRT-PCR provides a more quantitative assay of transcript stability.  Another possibility 
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is that the intron only plays a minor stimulatory role in Drosophila; thus, detection of this 
stimulation may be difficult to resolve if length-dependent targeting is intact. 
Finally, the SV40 3’UTR may be targeted by NMD due to specific sequence 
features.  The SV40 3’UTR is derived from a virus.  Many viral messages are sensitive to 
NMD because they contain long, polycistronic messages that are inefficiently spliced 
(Withers and Beemon, 2010a).  Polycistronic messages appear similar to PTC-containing 
transcripts since the multiple open reading frames look like upstream open reading 
frames, the first termination codon of which is identified as a PTC, making the rest of the 
transcript appear as a long 3’UTR.  Unspliced or inefficiently spliced transcripts may be 
marked with exon junction complexes downstream of the polycistronic termination 
codons, and since the EJC is thought to stimulate NMD targeting (Maquat, 2004) the 
viral transcript should be rapidly degraded by NMD.  Interestingly, at least one example 
of a viral transcript containing these NMD-target features is known that actually evades 
NMD.  The Rous sarcoma virus (RSV) is an avian retrovirus that, when transcribed by 
the host cellular machinery, encodes a polycistronic transcript with inefficiently spliced 
introns.  The polycistronic transcript mimics a long 3’UTR and the introns may have EJC 
components associated after intron splicing, two features that make this viral transcript a 
potential NMD target.  However, RSV evades NMD through a mechanism that is 
dependent on a ~400 nt structured RNA segment called the Rous stability element (RSE) 
(Withers and Beemon, 2010b; 2011).  While the mechanism by which the RSE evades 
NMD is unclear, its structure might allow for folding of the capped and polyadenylated 
transcript such that the poly-A-tail lies in close proximity to the first termination codon; 
thus, preventing detection of its abnormally long 3’UTR.  It has been proposed that NMD 
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may have evolved to detect aberrant endogenous transcripts along with invading 
transcripts, such as those seen with an invading retrovirus or those produced by 
transposable elements.  Thus, NMD may have evolved another strategy to identify 
aberrant transcripts that has not been identified.  
The SV40 3’UTR is remarkably sensitive to NMD, such that mutations in genes 
that are absolutely required for NMD, including alleles of Upf1 and Upf2, as well as 
genes that cause only a minor NMD defect, such as Smg1 (Chen et al., 2005), are 
identifiable using a fluorescent reporter with the SV40 3’UTR (Metzstein and Krasnow, 
2006).  One hypothesis is that using only a part of the original viral genome in the SV40 
3’UTR has separated it from any NMD insulating factors, similar to the RSV, allowing 
for efficient target recognition based on features like length and inefficient intron splicing.   
Here, we analyze how the SV40 3’UTR is targeted by NMD in Drosophila.  
While we found the SV40 3’UTR is targeted by NMD, two features stimulate targeting 
including both length and intron; however, these may not be the only mechanisms 
involved in targeting the SV40 3’UTR.  These data suggest that in contrast to the stability 
element in RSV, the SV40 3’UTR may contain a sensitizing element, like the 
downstream stability element (DSE) proposed in yeast (Peltz et al., 1993; Zhang et al., 
1995), or the sensitizing sequence seen in immunoglobulin mu (Bühler et al., 2004).   
 We set out to determine what aspects of the SV40 3’UTR contribute to its NMD 
targeting by mapping features of the SV40 3’UTR that are required for NMD recognition.  
To this end, altered versions of the SV40 3’UTR were generated including constructs 
containing deletions or truncations, as well as a mutation in the splice donor of the 
inefficiently spliced intron, and constructs that completely lacked the intron.  These 
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constructs contain an open reading frame encoding a GFP fluorescent reporter that are 
stably integrated into a unique site in the Drosophila genome; thus, providing a consistent 
level of transcription that allows expression levels of different constructs to be compared 
directly.  Animals containing fluorescent reporter constructs harboring the altered SV40 
3’UTRs were then examined in wild type and NMD loss of function backgrounds to 
determine features that were necessary for recognition of the SV40 3’UTR by NMD.   
 
 
Materials and methods 
Fly stocks 
D. melanogaster lines were raised at 25°C on cornmeal/dextrose medium using 
standard conditions.  The control chromosome used was y w FRT19A (Xu and Rubin, 
1993), the mutant chromosome used was y w FRT19A Upf225G.  The e22c-GAL4 (Duffy et 
al., 1998; Takeshita et al., 2007) was used to drive expression of the reporters.  The 
breathless promoter, btl-Gal4, used in combination with UAS-GFP as the reporter, (Shiga 
et al., 1996) was a secondary mechanism of expressing the reporter constructs.  The 
nlsDsRed2::SV40 3’UTR reporter transgene was provided by M. Galko (M.D. Anderson 
Cancer Center).  e22c-GAL4, UAS-nlsDsRed2::SV40 3’UTR was built using standard 
recombination methods (M.M.M., unpublished).  Reporter constructs were injected into 
flies using ΦC31-mediated transgenesis (Venken et al., 2006) by Genetic Services Inc.   
 
 
Cloning deletions and truncations of the SV40 3’UTR 
 To clone deletion and truncation constructs of the SV40 3’UTR, PCR primers 
were designed to amplify the SV40 3’UTR from a template pUASTeGFP::SV40 3’UTR 
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plasmid.  Forward primers designed to amplify the 5’ end of the SV40 3’UTR contained 
a fill sequence followed by an XbaI restriction site and a stop codon.  Reverse primers 
near the 3’ end of the SV40 3’UTR contained a fill sequence followed by a StuI 
restriction site.  Primers were designed to make deletions and truncations within the 
SV40 3’UTR using a combination of outer restriction site-containing primers and inner 
primers with overlapping ends to zipper fragments of the SV40 3’UTR together.  The 
SV40 3’UTR was amplified using phusion polymerase (NEB).  Amplicons were imaged 
using an Alpha Innotech Gel Doc System and if a single band was present, the sample 
was treated with exo-SapIt (Affymetrix) or, if multiple bands were present, gel purified 
(Qiagen).  Isolated amplicons were digested using XbaI and StuI, imaged using an Alpha 
Innotech Gel Doc System and gel purified (Qiagen).  The XbaI-StuI digested products 
were ligated into the XbaI-StuI digested pUAST attB plasmid (a gift from Jyoti Misra, 
Thummel lab) and UAS-eGFP was cloned into the KpnI site.  The pUAST attB plasmids 
were transformed into TOP10 cells (Invitrogen) and plasmids were isolated using a midi-
prep (Qiagen).  All constructs were sequenced and then sent to Genetic Services Inc. for 
injection into attp16 (Venken et al., 2006) on the second chromosome.   
 
 
Testing reporter enhancement 
 UAS-eGFP::SV40 3’UTR deletion and truncation males were mated to either y w 
FRT19A; e22c-GAL4, UAS-nlsDsRed2::SV40 3’UTR/CyO, or y w FRT19A Upf225G; e22c-
GAL4, UAS-nlsDsRed2::SV40 3’UTR/CyO females.  Wandering third instar larvae 
expressing both DsRed and GFP were observed using a Leica MZ16 fluorescence 
stereomicroscope, collected and frozen.  Animals were also imaged using a Leica MZ16 
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fluorescence stereomicroscope and axiocam camera.  A second round of collections was 
performed using a Btl-GAL4 driver.  For this experiment y w FRT19A Upf225G/FM7c or y 
w FRT19A females were mated to Btl-GAL4 UAS-DsRed::SV40 3’UTR males; the F1 
progeny were mated to flies harboring UAS-GFP::SV40 3’UTR deletion and truncation 
reporters and were scored and collected as described above.  
 
 
RNA isolation and quantitative RT-PCR 
Total RNA was isolated from five to ten flash-frozen samples of adult males 
using Trizol reagent (Invitrogen) and phase-lock tubes (5-prime), and the RNeasy mini 
kit (Qiagen).  Genomic contamination was reduced by on-column DNAse treatment 
(Ambion).  RNA concentration was determined using a spectrophotometer and 
normalized for reverse transcription using the MuMulv reverse transcriptase Retroscript 
Kit (Ambion).  Quantitative RT-PCR was performed on a BioRad iCycler thermocycler 
using SYBR green supermix (Bio-Rad).  All experimental reactions were performed in 





To test what features of the SV40 3’UTR are required for targeting by NMD, 
twenty versions of the SV40 3’UTR were constructed.  These constructs consisted of 
deletions and truncations of four sections of the SV40 3’UTR, which allowed us to test 
both length and sequence dependent detection of the SV40 3’UTR by NMD.  For this 
experiment, samples were collected from two genotypes, a wild-type genotype where 
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NMD is functioning, along with an NMD mutant genotype, Upf225G, which is a 
hypomorphic allele that has a severe NMD defect (Avery et al., 2011; Frizzell et al., 
2012; Metzstein and Krasnow, 2006).  Animals were collected based on an internal 
control; a DsRed reporter with a full length SV40 3’UTR was expressed in the 
background of experimental GFP::SV40 3’UTR test reporters.  Animals expressing the 
DsRed reporter at high intensity were collected in Upf225G mutants, while wild-type 
males expressing a reduced level of DsRed were collected.  The different reporters were 
quantified using qRT-PCR with primers that detect either DsRed or GFP.   
 
 
NMD targeting of the SV40 3’UTR is length dependent 
 To determine if NMD targeting of the SV40 3’UTR is dependent on the length of 
the SV40 3’UTR, a series of constructs were cloned that contain deletions and truncations 
of the SV40 3’UTR.  Three sets of constructs were designed to also test whether the 
inefficiently spliced intron stimulates NMD independently of SV40 3’UTR length.  The 
first set of constructs contain the sequence of the 66 bp inefficiently spliced intron; if the 
intron does somehow stimulate NMD, these constructs should be more sensitive to NMD 
than those not containing the intron.  The second set of constructs contain the 66 bp 
sequence but have a mutation that changes the splice donor from GT to CC, which would 
presumably prevent splicing of the intron sequence, but would still provide the length of 
the 66 bp intron that would not be removed.  Hence, these constructs could still 
theoretically stimulate NMD in a length dependent manner.  The third set of constructs 
have the 66 bp intron sequence completely removed, so these would be predicted to be of 
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a shorter length and not undergo intron-based NMD stimulation, and thus might be less 
susceptible to NMD degradation.   
All twenty constructs were tested for degree of NMD targeting by comparing the 
stability of the reporter in an NMD mutant to the stability in animals with functioning 
NMD.  This analysis led to several observations that did not fit with our original 
predictions.  First, the introduction of the GT-CC mutation in the splice donor site of the 
intron in the SV40 3’UTR completely destabilized the reporter (Fig. 5.1 A, B).  This 
result corresponded with a low level or fluorescent protein expression seen in both wild 
type and NMD loss of function larvae.  This mutation appears to have introduced 
sequence that destabilizes the reporter in an NMD-independent manner.  No further 
analysis of these constructs was performed.   
Next, it appears that overall, NMD targeting does depend on length, as the longer 
the SV40 3’UTR, the more efficiently it is targeted by NMD (Fig. 5.1 B).  There does 
appear to be a length-dependent cutoff at 400 bp, below which no section of the SV40 
3’UTR is capable of stimulating NMD-dependent destabilization.  This is interesting 
because 400 bp is the average length of 3’UTRs in Drosophila and therefore may 
represent a general length-dependent threshold of NMD targeting in Drosophila.  While 
these data support length-dependent targeting of the SV40 3’UTR, this interpretation 
cannot explain all the data, as there are several constructs that are not targeted by NMD 
even though others of the same length are targeted (Fig. 5.1 A, B).  This phenomenon 
suggests there is some other feature of the SV40 3’UTR that is required for NMD-




Intron in the SV40 3’UTR stimulates NMD 
Analysis of the intron-containing and intron deleted constructs demonstrate that 
deleting the intron does not prevent the SV40 3’UTR from being targeted by NMD in the 
full length transcript (Fig. 5.1 A, B).  This data agrees with a prior observation that 
deletion of the intron does not affect NMD targeting (Metzstein and Krasnow, 2006).  
However, the presence of the intron, or potentially the additional 66 bp left behind if the 
intron is not removed, does stimulate NMD targeting in the full-length constructs.  
However, the presence of the intron is not sufficient for targeting in the truncated 
constructs (Fig. 5.1 A, B).  This finding is interesting as neither the presence of introns 
downstream of a termination codon, nor the presence of the exon junction complex 
components have been previously shown to stimulate NMD in Drosophila (Gatfield et al., 
2003).  Future studies will need to determine if the EJC is actually associated with the 
SV40 3’UTR, or if it is the presence of additional sequence that is causing this 
stimulation.   
 
 
The 5’ region of the SV40 3’UTR stimulates NMD targeting 
 To determine what other features of the SV40 3’UTR are required for NMD, I 
performed pairwise comparisons of the five segments of the SV40 3’UTR that were 
either deleted or truncated in the constructs (Fig. 5.2 A).  Through these comparisons, I 
found the presence of the sequence in the 5’ 3rd of the SV40 3’UTR (segments A and D 
in Figure 5.2 A, B) was the most likely region to stimulate NMD past what appears to be 
the length-dependent cut-off of ~400 bp.  The presence of many of the segments in the 5’ 
end of the SV40 3’UTR contribute to NMD targeting (Fig. 5.2 B, C, G, H).  However, the 
106
greatest stimulation came from having segments A and D (Fig. 5.2 B); these regions are 
the first segment after the termination codon and the section directly after the intron 
sequence.  The presence of this 5’ section provided even more stimulation of NMD 
targeting than the presence of the intron sequence (Fig. 5.2 C, F, I, K).  
In contrast to the 5’ end of the 3’UTR, the presence of the 3’ 3rd of the SV40 
3’UTR did not appear to have any effect on NMD targeting.  The 3’ (C segment in Figure 
5.2 A, D, E, I, J) segment contains one of the two polyadenylation signals found in the 
SV40 3’UTR.  Thus, I had predicted that disrupting this section, and therefore preventing 
polyadenylation, might alter the susceptibility of the SV40 3’UTR to NMD targeting.  
The observation that deleting this section had very little effect on NMD targeting 
suggests that it does not contain sequence important for NMD recognition, and suggests 
that the remaining polyadenylation signal is sufficient for proper polyadenylation of the 
reporter transcripts.  The status of polyadenylation in these constructs could be tested in 
the future by performing 3’ RACE on the different reporter transcripts to determine if 




This work describes features necessary for NMD targeting of an exogenous 
3’UTR commonly used in Drosophila cloning constructs.  Constructs were made that 
contained deletions and truncations of segments of the SV40 3’UTR to determine if there 
existed length, intron, or sequence specific features that render this 3’UTR an NMD 
target.  We found that there is indeed a length-dependent threshold of about 400 bp, 
below which any region of the SV40 3’UTR is no longer an NMD target.  The 
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confirmation that the SV40 3’UTR is targeted in a length-dependent manner was not 
particularly surprising as this is the proposed targeting mechanism utilized in Drosophila.   
An observation that was surprising is that we did find some stimulation of NMD 
due to the presence of an inefficiently spliced intron in the SV40 3’UTR.  The presence 
of an exon junction complex (EJC) deposited near the intron splice site is a feature that 
stimulates NMD recognition in plants (Kertész et al., 2006) and mammalian cells 
(Buchwald et al., 2010; Carter et al., 1996; Le Hir et al., 2001; Maquat, 2004; Zhang et 
al., 1998).  However, this has not been shown before in Drosophila (Gatfield et al., 2003) 
and evidence even suggests that the EJC model of transcript targeting does not exist in 
this organism.  One caveat to this observation is that using these particular constructs, I 
could not distinguish whether the EJC is associated with targeted SV40 3’UTR mRNA or 
if the unspliced intron sequence is extending the length of the 3’UTR, resulting in 
stimulation of length-dependent targeting.  Unfortunately, the experiment that was 
originally designed to distinguish between length and EJC deposition did not work.  A 
series of constructs were designed that contained a mutation, changing the GT-CC of the 
splice donor.  These mutant transcripts would have retained the intron sequence and 
provided a direct test of length versus possible EJC deposition.  However, the presence of 
this particular mutation completely destabilized the SV40 3’UTR in an NMD-
independent manner, as there was no stabilization of these reporter transcripts in Upf225G 
mutant animals.  Another option to test whether the added length of the intron stimulates 
NMD is to clone different filler sequence into the intron, which might avoid the 
destabilizing effects observed when the splice donor was mutated.  Finally, a more direct 
test of the whether the EJC associates with the SV40 3’UTR involves cross-linking 
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immunoprecipitation of the EJC components and detection of associated mRNA 
sequences by qRT-PCR.  However, this is a technically challenging experiment.  While 
this experiment could determine if EJC-components interact with the SV30 3’UTR, it 
would not directly test whether EJC-bound mRNA is destabilized by NMD.   
The most intriguing finding from mapping features of the SV40 3’UTR required 
for NMD targeting was a potential sequence-dependent targeting mechanism.  Features 
near the 5’ end of the SV40 3’UTR appear to be required for NMD targeting, whereas 
more 3’ features appear to be dispensable for NMD targeting.  The intron sequence is 
located in the 5’ end of the SV40 3’UTR; however, the sequence directly after the stop 
codon and directly 3’ of the intron sequence appear to be required for targeting, 
regardless of the presence or absence of the intron.   
Experiments to follow up this observation should test whether the 5’ sequence is 
sufficient for NMD targeting independent of length, which would suggest that there is 
sequence within the SV40 3’UTR that stimulates NMD.  Since I was unable to make 
every combination of SV40 3’UTR rearrangement, it would be interesting in the future to 
see if just the 5’ end of the SV40 3’UTR is sufficient for degradation by NMD.  
Combined, the A and D segments would result in a 258 bp 3’UTR, far below the 
threshold of the 400 bp length cut-off.  Thus, any NMD degradation of this section would 
be extremely interesting and suggest there exists some sequence-dependent targeting that 
occurs in the SV40 3’UTR.    
Interestingly, deleting the 3’ 3rd of SV40 3’UTR appeared to have no effect on 
NMD targeting, suggesting that it does not contain sequence important for NMD 
recognition.  This section contains one of the two polyadenylation signals, thus the 
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remaining polyadenylation signal may be sufficient for proper polyadenylation of the 
reporter transcripts.  The status of polyadenylation in these constructs could be tested in 
the future by performing 3’ RACE on the different reporter transcripts to determine if 
they are indeed polyadenylated.   
A sequence-dependent targeting feature is interesting considering the Rous 
stability element discussed in the introduction.  Sequence-dependent targeting could 
result from NMD evolving a mechanism to detect particular features of viral RNA that 
has itself evolved mechanisms to evade NMD.  One hypothesis is that NMD may detect 
mRNA that looks more like a 3’UTR than an open reading frame.  Sequence in 3’UTRs 
does not encode functional transcripts and tends to have more frequent stop codons in 
every reading frame.  We looked at the number of stop codons found in each reading 
frame of the twenty constructs and found no difference in the proportion of stop codons 
that may make this sequence appear different to the NMD machinery.  Another 
possibility is that the SV40 3’UTR does contain some sequence specific features that 
stimulate NMD.  The downstream sequence element (DSE) was originally identified as a 
feature downstream of the termination codon that stimulates NMD (Peltz et al., 1993).  
While the concept of a consensus sequence stimulating NMD is intriguing and resembles 
other features known to direct targeting, like the AU-rich element (ARE) (Barreau et al., 
2005), there is little evidence to suggest these are a common feature of NMD targets.  
Interestingly, the 5’ end of the SV40 3’UTR contains four sequences that resemble the 
DSE consensus sequence identified in yeast (Table 5.1) (Zhang et al., 1995).  In contrast, 
the 3’ end of the SV40 3’UTR contains no sequence resembling the DSE.  Further 
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analysis of the SV40 3’UTR will be interesting to see if there is some sequence-
dependent NMD occurring in this 3’UTR.   
In addition to mapping the cis-acting features required for targeting the SV40 
3’UTR, the trans-acting NMD factors could also be tested for targeting efficiency.  All of 
the NMD mutant analysis performed in this experiment was done in the Upf225G mutant.  
These constructs could be tested in other NMD mutants to determine if multiple NMD 
pathways target this construct.  Finally, all these experiments must be repeated as all 
graphs in this section are based on only one biological replicate of five to ten pooled 
larvae.  The qRT-PCR data is also consistent with reporter fluorescence observed and 
imaged using two different GAL4 drivers, e22c-GAL4 and Btl-GAL4, indicating the 
results described in this chapter will not vary drastically with the addition of more 




Figure 5.1 Length and intron-dependent stimulation of NMD targeting.  (A) SV40 3’UTR 
constructs analyzed either contain an inefficiently spliced intron (Intron), contain a splice 
donor mutation GT-CC (Splice mutant), or the intron sequence has been deleted (no 
intron).  Full-length constructs are shown.  Yellow bars = polyadenylation sites.  (B) 
Degree of NMD targeting determined by the ratio of GFP expression for each construct 
in Upf225G mutants over the expression in wild-type controls with functioning NMD.  
Values above one thus indicate the transcript is subject to NMD-dependent 
destabilization.  The X-axis denotes the length of the transcript.  Full length transcripts, 
are 720 bp, the original SV40 3’UTR (black circle, 720 bp) exhibits the maximum degree 
of NMD targeting.  The full-length splice mutant (grey circle, 720 bp) was not subject to 
regulation by NMD.  The full-length transcript with intron deleted (black open circle, 656 
bp) exhibits a moderate degree of NMD targeting.  Additional constructs containing the 
intron, splice mutant, or intron deletion are shown at decreasing lengths due to deletion of 
additional segments of the SV40 3’UTR.  These exhibit a general length dependent 
targeting as the NMD-sensitivity decreases with SV40 3’UTR length.  However, other 
features deleted within the SV40 3’UTR are required for NMD targeting as some 
transcripts fall below the targeting threshold of 1 on the Y-axis, but are longer than the 





































Figure 5.2 Features of the SV40 3’UTR required for NMD targeting.  (A) SV40 3’UTR 
construct color-coded for sequences that mapped in the different SV40 3’UTR constructs.  
Five features were analyzed, including the presence or absence of intron sequence E, 
green segment.  Yellow bars = polyadenylation sites.  (B-K) Degree of NMD targeting 
determined by the ratio of GFP expression for each construct in Upf225G mutants over the 
expression in wild-type controls with functioning NMD.  Data points with values above 
one are subject to NMD-dependent destabilization.  The X-axis denotes length of the 
transcript, which varies based on the segment (SV40 3’UTR A-E) deleted in the construct.  
For example, the 250 bp contains segments D and E.  Each graph represents the NMD-
targeting of all the examined constructs, however, the colors indicate the inclusion of that 
segment in the construct.  (B) The combination of A and D segments stimulates NMD.  
Constructs containing both the A and D segments are in blue-purple stripes.  Constructs 
containing only the A segment are purple, only the D segment are blue, constructs that 
contain neither A or D are grey.  The differences in length are due to deletion of different 
segments of the SV40 3’UTR.  The combination of A and D stimulates NMD targeting as 
all constructs containing A and D above 400 bp in length are subject to NMD (above one 
on the Y-axis).  This stimulation is most apparent at 550 bp, where the constructs 
containing only A (purple) or only D (blue) are below the NMD target threshold of one 
on the Y-axis but are above the length threshold.  However, the combination of A and D 
(blue-purple stripes) stimulates NMD targeting.  (C) The combination of A and E (intron) 
can stimulate NMD targeting, but the combination of both segments is not required for 
targeting and E is never sufficient on its own for targeting.  Constructs containing only A 
are purple, those containing only E are green and those containing both are green and 
purple striped.  Constructs containing both A and E can stimulate targeting above the 400 
bp length threshold, but this is dependent on the presence of segment A.  No segments 
that contain only E (the intron) without the A segment are targeted by NMD.  Perhaps the 
inclusion of the A segment is required for efficient splicing of E.  (D)  The C segment 
does not contribute to NMD targeting.  The A segment alone (purple) or the C segment 
alone (red) or the combination of the two (red-purple stripes) shows that the C segment 
on its own, even at 550 bp (above the 400 bp length threshold) is not sufficient to cause 
NMD targeting.  The only segments the contain C that are targeted by NMD also contain 
the A segment.  However, the A segment can be targeted without the presence of the C 
segment (see purple data points at 480 bp and 550 bp).  (E) Neither B or C, nor the 
combination of B and C stimulate NMD targeting.  The combination of B and C (red-
orange stripes) falls below the targeting threshold of 1 on the Y-axis in most transcripts 
above 400 bp, so these sections likely do not contain features targeted by NMD.  (F) The 
combination of D (blue) and E (green) does not show a pattern of NMD targeting.  No 
constructs of only E were made.  These two segments are the smallest in the series, so 
even length dependent stimulation of these segments will be difficult to determine.  (G) 
The combination of the A and B segments may stimulate NMD targeting.  The 
combination of the A and B segments (orange-purple striped) tends to be targeted by 
NMD; however, at 400 bp the A segment alone (purple) is targeted, whereas the B 
segment alone (orange) is not, suggesting A may contribute more important sequence to 
NMD targeting than B.  (H) The combination of B (orange) and D (red) does not result in 
a pattern indicative of one or the combination of these two segments stimulating NMD 
targeting in these constructs.  (I) The C and E segments do not contribute to NMD 
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targeting together.  The combination of C (red) with E (green) actually seems to reduce 
NMD targeting of these constructs between 400-550 bp (red-green stripes).  (J) The C 
and D segments do not contribute to NMD targeting together.  The combination of C 
(red) with D (blue) actually seems to reduce NMD targeting of these constructs between 
400-550 bp (red-blue stripes).  (K) The combination of B (orange) and E (green) may 
stimulate NMD in longer constructs, but E is not sufficient for targeting in the longer 








































































































































































































































































































































































1 Consensus sequence found in (Zhang et al., 1995).  Y = C or T, Bold = match between 
SV40 3’UTR sequence and consensus.  
2 A segment (Fig. 5.2) sequence 3’ to the intron, B segment (Fig. 5.2) sequence in the 
middle of the SV40 3’ UTR. 
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A T G A T G A T G A G G C 
B A T T T G A T G T A T A 
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Nonsense mediated decay (NMD) is a cellular surveillance mechanism originally 
identified for its role in clearing mRNAs encoding premature termination codons (PTCs) 
from the cell (Chang and Kan, 1979; Hodgkin et al., 1989; Leeds et al., 1991; Losson and 
Lacroute, 1979).  More recent efforts have shown that a large proportion, up to 10% of 
the genome in many organisms, of endogenous transcripts are also regulated by NMD 
(He et al., 2003; Mendell et al., 2004; Rehwinkel et al., 2005; Weischenfeldt et al., 2008; 
Wittmann et al., 2006).  This suggests NMD plays a role in development and physiology.  
Thus, it is important to perform in vivo analysis of nonsense mediated decay. 
The work presented in this thesis focused on three broad questions relevant to the 
mechanism of NMD.  First, have all the genes required for NMD been identified?  
Second, what are the roles of NMD pathway genes in vivo?  Third, how does NMD 
differentiate a native termination codon from a premature termination codon?  
 Chapter 2 and Chapter 3 describe work to address whether all genes required for 
NMD have been identified.  Chapter 2 presents work performed for the first forward 
genetic screen for genes involved in NMD in Drosophila (Frizzell et al., 2012).  Using a 
mosaic approach we identified both viable and lethal alleles of previously known NMD 
genes; including alleles of Upf1, Upf2, Smg1, and Smg6.  While alleles of Upf1, Upf2, 
and Smg1 had previously been analyzed in Drosophila (Chen et al., 2005; Metzstein and 
Krasnow, 2006), Chapter 2 provides the first mutant analysis of the NMD gene, Smg6 
(Frizzell et al., 2012).  Through this work we were able to address a key question in the 
NMD field: what roles do the NMD pathway genes play in vivo?  Our mutant analysis of 
Smg6 resulted in two surprising observations.  First, alleles of Smg6 are viable, (albeit, 
not fully) in complete loss-of-function mutants.  The viability of Smg6 was surprising 
considering loss of Smg6 function may result in lethality in C. elegans (Cali and 
Anderson, 1998).  Additionally, zebrafish morpholino data indicates Smg6 knockdown 
results in more severe developmental defects than knockdown of the core NMD 
component, Upf1 (Wittkopp et al., 2009).  Our results could show that Smg6 is less 
essential for viability in Drosophila, suggesting that additional lethal mutations near the 
Smg6 locus and morpholino off-target effects could have caused the lethality seen in C. 
elegans and zebrafish, respectively.   
The second surprising result is loss of Smg6 in Drosophila does not result in a 
severe NMD defect.  Smg6 is an endonuclease that cleaves targeted mRNAs near the 
PTC (Eberle et al., 2009; Gatfield and Izaurralde, 2004).  In Drosophila S2 cells 
endonucleolytic cleavage was the only mechanism observed to free the ends of the 
mRNA for the rapid degradation that is characteristic of NMD (Huntzinger et al., 2008).  
Our in vivo results suggest other degradation mechanisms are utilized in Drosophila.  
Indeed, in addition to endonucleolytic cleavage by Smg6, NMD is also known to result in 
deadenylation-independent decapping followed by degradation by the exonuclease, 
XRN1 (pacman in Drosophila), and to a lesser extent, rapid deadenylation followed by 
degradation by the exosome in mammalian cells (Chen and Shyu, 2003; Couttet and 
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Grange, 2004; Lejeune et al., 2003) and yeast (He and Jacobson, 2001).  Perhaps these 
alternative mechanisms are used in vivo in Drosophila, but are absent in S2 cells, hence 
the lack of detection of these mechanisms in previous studies (Gatfield and Izaurralde, 
2004; Huntzinger et al., 2008).   
One final observation resulting from the analysis of Smg6 involves the role of 
Smg1 in NMD.  Smg1 is a phosphatidylinositol kinase-like kinase (PIKK) that 
phosphorylates Upf1 (Denning et al., 2001; Yamashita et al., 2001), providing binding 
sites for NMD components, including Smg6 (Okada-Katsuhata et al., 2011).  Loss of 
Smg1 in Drosophila results in minor NMD defects (Chen et al., 2005; Metzstein and 
Krasnow, 2006).  However, it is thought that phosphorylation of Upf1 by Smg1 is 
essential for Smg6 recruitment to the targeted transcript.  Surprisingly, Smg6 mutants 
have a more severe NMD defect than Smg1 mutants (Frizzell et al., 2012).  This result 
suggests that either Smg6 is recruited to the complex independent of the Smg1 
phosphorylation of Upf1, or alternatively, another kinase may be capable of 
phosphorylating Upf1, thus providing the binding platform required for NMD 
recruitment.  Our data from analysis of Smg6 provides preliminary evidence that more 
genes, potentially other nucleases and kinases, may be involved in NMD in vivo.  Thus, 
alleles of Upf1, Upf2, Smg1, and Smg6 identified in our screens have provided valuable 
insight into the possibility of additional genes or pathways utilized for NMD dependent 
degradation, and will provide the community with valuable reagents for further study of 
NMD in Drosophila.  
In addition to alleles of known NMD genes, our screen resulted in the isolation of 
seven new lines that could be new NMD genes.  Chapter 3 describes preliminary 
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mapping data and analysis of these seven lines.  Five lines make up a single lethal 
complementation group that was mapped to CG33970, a previously uncharacterized gene.  
CG33970 encodes a putative ABC-transporter that is conserved in invertebrates (Dean 
and Annilo, 2005) and has sequence homology to a ribosome-bound ABC-transporter, 
RbbA, that may function in translation termination in E. coli (Kiel and Ganoza, 2001; 
Kiel et al., 1999; Xu et al., 2006).  However, evidence described in Chapter 3 suggests 
CG33970 may not be the gene responsible for the NMD defect, but instead is only 
responsible for the lethality associated with these five lines.  Further work should be done 
to verify the role of CG33970 to determine if it really is a novel NMD gene.  Two 
additional lines isolated in the screen on 3R complement alleles in the lethal 
complementation group, and complement each other.  Mapping and characterization of 
these two lines may result in the identification of novel NMD genes.   
Chapter 4 of this thesis provides a method that utilizes alleles of Smg6 and other 
NMD components to address the role of NMD in vivo.  In this chapter, I begin to 
characterize the endonucleolytic cleavage products produced after NMD targeting, and 
(presumably), Smg6 cleavage.  This analysis utilizes RNAi knockdown of the 5’ 
exonuclease pacman (pcm), allowing for detection of the 3’ cleavage products whose 5’ 
end would be free to degradation by pcm after endonucleolytic cleavage by Smg6 (Chang 
and Kan, 1979; Franks et al., 2010; Hodgkin et al., 1989; Leeds et al., 1991; Losson and 
Lacroute, 1979; Rehwinkel et al., 2005).  Smg6 is known to cleave NMD-targeted 
mRNAs near the PTC (Eberle et al., 2009; Gatfield and Izaurralde, 2004; He et al., 2003; 
Huntzinger et al., 2008; Mendell et al., 2004; Rehwinkel et al., 2005; Weischenfeldt et al., 
2008; Wittmann et al., 2006), however this has only been shown in tissue culture.  In vivo, 
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this assay could provide a way to characterize the different defects associated with Smg6 
hypomorphic alleles.  For instance, a hypomorphic allele, Smg62a, contains a missense 
mutation predicted to disrupt endonuclease function (Frizzell et al., 2012; Glavan et al., 
2006; Takeshita et al., 2007).  However, we find this allele appears to have some residual 
endonuclease activity, suggesting that the missense mutation does not fully disrupt the 
endonuclease domain as predicted (Chen et al., 2005; Glavan et al., 2006; Metzstein and 
Krasnow, 2006; Takeshita et al., 2007).  Additionally, this type of cleavage assay can be 
used to determine whether a transcript is directly or indirectly targeted by NMD (Frizzell 
et al., 2012; Rehwinkel et al., 2005).  An indirect target may be stabilized upon loss of 
NMD function, but will not show endonuclease-specific stabilization of the 3’ end of the 
transcript in a pcm knockdown.  However, a direct target should result in 3’ fragment 
stabilization using this assay.  Transcript fragment specific stabilization is a read-out of 
the endonuclease-specific cleavage by Smg6 and both 5’ and 3’ fragments should be 
stabilized in a Smg6 mutant.  While work must be done to optimize this assay, there is 
potential for interesting results regarding the cleavage characteristics of Smg6.  
Additionally, characterizing other NMD genes using this assay may provide insight as to 
the specific mechanism of NMD action.  A key observation was that a strong 
hypomorphic allele of Upf2, Upf225G, resulted in 3’ fragment stabilization of one NMD 
target and 5’ stabilization of another NMD target.  One hypothesis is that stabilization 
resulted from transcript protection by an NMD mRNP that was locked on the mRNA due 
to the nature of the mutation in Upf225G (Cali and Anderson, 1998; Metzstein and 
Krasnow, 2006).  While this is currently speculative, it could represent an interesting 
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avenue of investigation into the composition and location of the NMD mRNP on targeted 
transcripts (Franks et al., 2010; Wittkopp et al., 2009).    
Finally, Chapter 5 of this thesis addresses the question of how a premature 
termination codon is differentiated from a natural termination codon.  This chapter 
describes mapping of features of the exogenous SV40 3’UTR, that are required for 
targeting by NMD (Eberle et al., 2009; Gatfield and Izaurralde, 2004; Metzstein and 
Krasnow, 2006).  Three features were determined to stimulate NMD targeting of the 
SV40 3’UTR.  The first feature was length; the full length (720 bp) SV40 3’UTR is 
targeted by NMD.  Deleting sections of the SV40 3’UTR resulted in NMD targeting until 
the length dropped below a threshold of ~400 bp.  This result correlates with the current 
length-dependent model of NMD targeting.  The length model posits that longer 3’UTRs 
or PTCs are subject to NMD because translation termination at an early termination 
codon appears as a long 3’UTR due to inefficient interactions between eRF3 and poly-A-
binding proteins associated with the poly-A-tail.  Thus, allowing Upf1 to compete with 
poly-A-binding protein for an interaction with eRF3.  Upf1 association with eRF3 then 
initiates assembly of the SURF complex, which triggers NMD (Amrani et al., 2004; 
Behm-Ansmant et al., 2007; Eberle et al., 2008; Hogg and Goff, 2010; Huntzinger et al., 
2008; Kashima et al., 2006; Muhlrad and Parker, 1999; Singh et al., 2008).  The length-
dependent mechanism is likely utilized for targeting the SV40 3’UTR for degradation as 
NMD targeting is relieved upon truncation of the SV40 3’UTR.  Length, however, cannot 
be the only method utilized for transcript targeting, as several of the reporters are larger 
than 400 bp and are not NMD substrates.  While the SV40 3’UTR is considered long for 
an NMD target in Drosophila, where the average 3’UTR length is ~400 bp, there must be 
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other targeting features as there is little correlation between 3’UTR length and targeting 
of endogenous transcripts in NMD mutants (A. Chapin, personal communication) 
(Barberan-Soler et al., 2009; Chen and Shyu, 2003; Couttet and Grange, 2004; Frizzell et 
al., 2012; Lejeune et al., 2003; Lewis et al., 2003; Metzstein and Krasnow, 2006; Nguyen 
et al., 2012; Ramani et al., 2009; Rehwinkel et al., 2005).   
The second feature that stimulates NMD targeting of the SV40 3’UTR is the 
presence of an intron.  A proposed model of NMD targeting depends on the presence of 
an intron downstream of a premature termination codon.  Upon splicing and removal of 
the intron sequence, a protein complex called the exon junction complex (EJC) is 
deposited on the mRNA 20-24 nt upstream of the splice site (He and Jacobson, 2001; Le 
Hir et al., 2000).  The EJC provides a binding site for Upf3, a component of the NMD 
machinery (Gatfield and Izaurralde, 2004; Huntzinger et al., 2008; Le Hir et al., 2001).  
The EJC is normally removed or remodeled during translation.  However, if the ribosome 
terminates prior to the last splice site or if there is an intron found in the 3’UTR, the EJC 
remains associated with the message, which triggers NMD (Buchwald et al., 2010; 
Denning et al., 2001; Ivanov et al., 2008; Singh et al., 2008; Yamashita et al., 2001).  
While the EJC has been shown to stimulate NMD in plants (Kerényi et al., 2008; Kertész 
et al., 2006; Okada-Katsuhata et al., 2011) and mammalian cells (Chen et al., 2005; Isken 
and Maquat, 2007; Metzstein and Krasnow, 2006), there is currently no evidence 
showing NMD is stimulated by an EJC in Drosophila (Frizzell et al., 2012; Gatfield et al., 
2003).  Data in Chapter 5 suggest the presence of an intron in the SV40 3’UTR stimulates 
NMD.  If this is due to the presence of an EJC associated with the SV40 3’UTR, it would 
be the first time this mechanism of target recognition has been shown in Drosophila.  
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One caveat to this result is that the intron could remain intact, thus providing extra 
sequence and length to the 3’UTR by introducing confusion with the length-dependent 
model of NMD.  The status of the intron in the SV40 3’UTR needs to be determined 
before a final conclusion can be made on this observation.     
 The final feature determined to stimulate NMD targeting the SV40 3’UTR is the 
presence of a specific sequence in the 5’ end of the SV40 3’UTR.  This observation is 
reminiscent of a feature identified in yeast, termed the downstream sequence element 
(DSE) (Dean and Annilo, 2005; Peltz et al., 1993; Zhang et al., 1995).  Indeed, much of 
the consensus sequence identified in the DSE (Kiel and Ganoza, 2001; Kiel et al., 1999; 
Xu et al., 2006; Zhang et al., 1995) is found in the SV40 3’UTR, but only in the segments 
constituting the 5’ end of the 3’ UTR.  A similar, sequence dependent result was also 
observed in mammalian cells, where a 177 bp 5’ region of the immunoglobulin mu 
transcript was shown to be required for efficient NMD (Bühler et al., 2004).  This data 
suggests that some sequence-dependent NMD may occur, whether this is due to direct 
binding of RNA-binding proteins to a particular sequence or to secondary structure that 
results from the particular sequence is not known.  However, this result does suggest the 
SV40 3’UTR could be used to determine the minimal SV40 3’UTR sequence sufficient 
for NMD targeting, and this could be very interesting if that sequence contained that 
putative DSE.   
 In conclusion, work presented in this thesis suggests several possibilities for 
NMD in Drosophila.  First, analysis of alleles recovered in the X and 3R screens suggest 
more genes are likely required for NMD in Drosophila.  These screens only covered 
~40% of the genome and the 3R screen is not yet saturated.  Second, further work on 
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these alleles will be important for addressing whether lethality associated with loss of 
particular NMD genes is due to loss of NMD function or non-NMD roles of those genes.  
Data presented here suggest that the severity of NMD defects observed with loss of Smg6, 
Upf2, or Smg1 correlate with the severity of the developmental defects associated with 
loss of those genes.  It will be interesting to see if this pattern persists with other known 
NMD genes.  Third, additional tests that can differentiate between direct and indirect 
NMD targets, like the pcm knockdown assay described in Chapter 4, will be useful for 
further characterization of these alleles and the transcripts targeted by NMD in vivo.  
Future work characterizing cleavage and mRNP composition are ways to begin assaying 
mechanistic features of NMD in vivo.  Finally, work in Chapter 5 suggests that in 
addition to a length-dependent targeting mechanism, Drosophila may also utilize intron-
dependent and sequence-dependent targeting in particular cases.  Future experiments are 
needed to validate these observations, but these data could present a new way of thinking 
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